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Abstract 
 
(-)-Zampanolide is a microtubule-stabilising marine natural product, with promise as a cancer 
drug candidate. The potential therapeutic application of zampanolide has fuelled worldwide 
interest in its total synthesis, but few analogue studies have been 
reported. Analogues afford the possibility of examining the structure-
activity relationships with a view to optimising for potency and 
medicinal viability. This project seeks to devise a new route to 
zampanolide and generate a series of analogues for bioactivity 
evaluation.  
 
The initial approach to zampanolide and a number of designed analogues was through 
disconnections at C20 by an N-aldol reaction, at C1 by Yamaguchi esterification, at C8-C9 by 
metathesis and at C15-C16 by alkynylation. During the development of fragment syntheses, 
problems were encountered with protection of the secondary hydroxyl group at C19 and 
establishment of an aldehyde at C15. Useful natural and analogue fragments were generated 
during this exploratory phase. 
 
The order of connections was revised, and effort has been put towards the improvement of the 
synthetic efficiency. A three-component reaction involving (triphenylphosphoranylidene)-
ketene, also known as Bestmann ylide, as a linchpin was envisaged to provide the dienoate of 
zampanolide. This is an expanded application of Bestmann ylide and therefore the scope of this 
linchpin reaction was investigated using simple alcohols and aldehydes. Success in the scoping 
study fortified this approach, and the coupling of the C3-C8 and C16-C20 fragments of 
zampanolide proceeded with good yields and stereoselectivity of the E,Z-geometry. 
 
The planned late stage connections were tested on model substrates. The side arm attachment 
by a chiral boron reagent-promoted aza-aldol reaction failed to produce desired product on a 
simple model.  However, model substrates that better account for the functionality of the 
zampanolide macrocycle are proposed for subsequent studies.  In case these also do not succeed, 
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reliable alternative methods described in the literature would be used. Several methods were 
scanned for the asymmetric alkynylation required for the C15-C16 bond connection.  That 
involving ProPhenol and diethylzinc produced an excellent yield with a model alkyne. 
Although the stereoselectivity of the alkynylation is yet to be optimized, it was also tested on 
the full zampanolide fragment generated from the Bestmann ylide reaction. A small amount of 
the desired product was isolated, establishing 16 out of the 18 carbons of the macrocycle. 
Formation of a macrocycle is close at hand. 
 
 
  
 iii 
 
Acknowledgements 
 
Doing a PhD is one of the best decisions I have made in my life. I enjoyed the highs and the 
lows of research, and the tricky balance of life and work. During it, the awesome people I have 
met made this journey of PhD so much more exciting, memorable and fulfilling. 
 
First, I want to give my greatest thanks to my primary supervisor Dr. Joanne Harvey for the 
guidance and support through the years. There is never a day I remembered Joanne with a low 
spirit. Her enthusiastic attitude is captivating, and helped me to stay optimistic and motivated, 
especially when things were not going smooth. Her extensive knowledge on organic chemistry 
guided me to find solutions in research. Additionally, thanks to Joanne’s in-depth editing and 
comments, it has helped me to improve my writing skill. Joanne not only helped me to learn 
so much more organic chemistry, but also has been a role model that I can look up to. 
 
I would also like to thank my secondary supervisor Dr. Paul Teesdale-Spittle for his help. I am 
so fortunate to have worked in such a great research group. We shared knowledge to solve 
problems, joy for success and great times outside the lab. These are treasured memories. I 
would like to thank the past and current group members: Sophie Geyrhofer, Thomas Bevan, 
Sam Ting, Dr. Kalpani Somarathne, Dr. Hemi Cumming, Dr. Mark Bartlett, Peter Moore, 
Amira Brackovic, Loïc Lassueur, Sarah Brown, Ben Durrant, Dan Phipps, Chris Orme, José 
Pinedo Rivera, Claire Turner, Dylan Davies, Scott Riordan, Jasmin Riesterer. I especially thank 
Sophie Geyrhofer, Peter Moore, Chris Hasenöhrl and Chris Orme for proof-reading, Claudia 
Gray and Sam Ting for all the preliminary work, and Sophie Geyrhofer again for running all 
my MS samples this years and carrying on the zampanolide project. 
 
The School of Chemical and Physical Sciences at Victoria University of Wellington has been 
a great place to work, and I would like to thank everybody for the amazing experience I had. 
In particular, Ian Vorster and Rob Keyzers often helped me with NMR and MS. I do apologise 
for all the weekend emails and after-hour calls to Ian for NMR problems. I also thank Teresa 
 iv 
 
Gen for letting me borrow solvents when the chemical store was closed, and Peter Northcote 
for useful comments on purification and spectroscopic data. I am extremely grateful for the 
PhD scholarship from New Zealand Health Research Council, travel and conference grants 
from VUW, New Zealand Institute of Chemistry, Centre of Biodiscovery, and the thesis 
submission scholarship from Faculty of Graduate Research. Without the financial support this 
thesis would not be possible. 
 
Friends and family have also given me huge support. The person deserves the biggest thank 
you is my husband Marcus Sheerin. He has been taking such good care of me, so that I could 
concentrate on my work. Without his love and support, especially all the delicious lunches and 
dinners he cooked for me, I would not have achieved nearly as much or stayed healthy during 
the time of thesis writing. Sharing a life with Marcus is the best thing in my life. I also want to 
thank Marcus’ bosses Rob, Mike and Fay for arranging Marcus to work from home, so that we 
could be together in Wellington. My parents and Marcus’s family have given us great help. 
Marcus and I got married during my PhD. Thanks to everybody in Marcus’ family, especially 
Rowene, Brian, David, Alana, Nat and Sharolyn, our wedding was perfect, and I would not 
have wanted anything different. 
 
Fourteen years ago, my parents Zhigang and Huixia made the decision to use their lifesavings 
to send me to New Zealand for better education. Because of this decision, I had the chance to 
experience this very exciting life in New Zealand: finding a passion for chemistry and 
mountains, meeting Marcus, making lifetime friends and so much more. This achievement is 
not mine alone, but builds on the years of care, support and guidance from my parents.  
  
 v 
 
Table of contents 
 
Abstract           i 
Acknowledgements          iii 
List of contents          v 
Abbreviations           ix 
Chapter 1: Introduction         1 
 1.1 A brief history of marine natural products      1 
1.2 Microtubule-targeting agents and paclitaxel     2 
1.3 (-)-Zampanolide and (+)-dactylolide      7  
1.4 Published total synthesis of zampanolide      10 
  1.4.1 Synthetic methods for formation of the pyran fragment  12 
  1.4.2 Synthetic methods of macrocyclization     15 
  1.4.3 Synthesis of N-acyl hemiaminal linkage    16 
 1.5 Published total synthesis of dactylolide      18 
  1.5.1 Synthetic methods for formation of the pyran fragment  19 
  1.5.2 Other methods for the formation of dactylolide macrocycle  21 
 1.6 Analogue studies         23 
 1.7 Efficiency of total synthesis: linchpin synthesis     26 
 1.8 References         32 
Chapter 2: Aim and preliminary work       37 
 2.1 Aim          37 
 2.2 Preliminary work         38 
 vi 
 
  2.2.1 Preliminary work on side-arm variants     38 
  2.2.2 Preliminary work on fragment synthesis    40 
 2.3 References         43 
Chapter 3: First generation and fragment synthesis      45 
 3.1 Retrosynthetic analysis        45 
 3.2 Proposed synthesis of C1-C8 fragment      47 
  3.2.1 Synthesis of the natural C1-C8 fragment    48 
  3.2.2 Synthesis of the des-methyl C1-C8 analogue fragment  52 
 3.3 Synthesis of C16–C20 fragment       57 
 3.4 Proposed synthesis of C9-C15 fragment      63 
  3.4.1 Synthesis of the natural C9-C15 fragment    64 
  3.4.2 Synthesis of C9-C15 analogue fragments    68 
 3.5 Experimental data         74 
 3.6 References         92 
Chapter 4: Second generation synthesis and Bestmann ylide linchpin   97 
 4.1 Second generation retrosynthetic analysis     97 
 4.2 Bestmann ylide         98 
 4.3 Scope of the Bestmann ylide cascade in the synthesis of 
      α,β,γ,δ-unsaturated esters        102 
4.4 Applying the Bestmann ylide linchpin to macrocyle fragments   107 
4.5 Experimental data         113 
4.6 References         129 
 
 vii 
 
Chapter 5: Exploration of late-stage connections      131 
 5.1 Formation of N-acyl hemiaminal       131 
 5.2 Model study of C20 oxidation       141 
 5.3 Asymmetric alkynylation of aldehydes for C15-C16 connection  142 
 5.4 Summary          156 
 5.5 Experimental data         157 
 5.6 References         169 
Chapter 6: Summary and Future work        173 
 6.1 Alternatives to the acrolein-dependent C3-C8 fragment    174 
 6.2 A new strategy involving a dithiane at C15     175 
 6.3 References         177 
Appendix: NMR spectra         179 
 
  
 viii 
 
  
 ix 
 
Abbreviations 
 
(S)-TRIP  
(S)-3,3′-Bis(2,4,6-triisopropylphenyl)-1,1′-binaphthyl-2,2′-diyl 
hydrogenphosphate 
Ac Acetic 
Ad Adamantyl 
aq. Aqueous 
Asn Asparagine 
ATR Attenuated total reflectance  
BAIB  1,1-Diacetateiodobenzene 
BINOL 1,1'-Bi-2-naphthol 
Bn Benzyl 
Boc2O Di-tert-butyl dicarbonate 
BSA N,O-Bis(trimethylsilyl)acetamide 
Bz Bezoyl 
CIGAR Constant time inverse-detection gradient accordion rescaled  
COSY Correlation spectroscopy  
Cp 1,3-Cyclopentadiene 
CSA Camphorsulphonic acid 
DBU 1,8-Diazabicycloundec-7-ene 
DCE 1,2-Dichloroethane 
DCM Dichloromethane 
DDQ 2,3-Dichloro-5,6-dicyano-1,4-benzoquinone 
DIBAL-H Di-iso-butylaluminum hydride 
DIP-chloride Chlorodiisopinocampheylborane 
DMAP 4-(N,N-Dimethylamino)pyridine 
DME 1,2-dimethoxyethane 
DMF Dimethylformamide 
DMP Dess-Martin periodinane 
DMSO Dimethyl sulfoxide 
EDCI N-(3-Dimethylaminopropyl)-N′-ethylcarbodiimide hydrochloride 
ee Enantiomeric excess 
Et Ethyl 
FCC Flash column chromatogrphy 
FT-IR Fourier transform infrared spectroscopy 
GI Growth inhibition concentration 
Grubbs II Grubbs 2nd generation catalyst 
HBTU O-(Benzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate  
His Histidine 
HMBC Heteronuclear multiple-bond correlation  
HRMS High resolution mass spectrometry 
HSQC Heteronuclear single quantum coherence spectroscopy 
 x 
 
HWE Horner-Wadsworth-Emmons  
IBX 2-Iodoxybenzoic acid 
IC50 Half maximal inhibitory concentration  
Imid. Imidazole 
LiHMDS Lithium bis(trimethylsilyl)amide 
MDA Microtubule-destabilizing agents  
Me Methyl 
MIDA N-Methyliminodiacetic acid  
MOM Methoxymethyl 
MRP Multidrug resistance-associated proteins  
MS Molecular sieve 
MSA Microtubule-stabilizing agents  
MTA Microtubule-targeting agent  
MTPA α-Methoxy-α-trifluoromethylphenylacetic acid 
MTT 3-(4,5-Dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide 
NaHMDS Sodium bis(trimethylsilyl)amide 
NHC N-Heterocyclic carbene  
NMR Nuclear magnetic resonance  
NOESY Nuclear Overhauser effect spectroscopy  
ox. Oxidation 
PCC Pyridinium chlorochromate 
PG Protecting group 
Piv Pivaloyl 
PMB para-Methoxybenzyl  
PMP para-Methoxyphenyl  
PPTS Pyridinium p-toluenesulfonate 
ProPhenol 2,6-Bis[2-(hydroxydiphenylmethyl)-1-pyrrolidinyl-methyl]-4-methylphenol 
Py Pyridine 
r.t. Room temperature 
RCM Ring-closing metathesis 
ROESY Rotating frame Overhauser effect spectroscopy 
SAR Structure-activity relationship 
TBAF Tetra-n-butylammonium fluoride 
TBAI Tetra-n-butylammonium iodide 
TBDPS tert-Butyldiphenylsilyl 
TBHP tert-Butyl hydroperoxide  
TBS tert-Butyldimethylsilyl 
TCBC 2,4,6-Trichlorobenzoylchloride 
TEMPO 2,2,6,6-Tetramethyl-1-piperidinyloxy free radical 
 
TEOC Trimethylsilylethylcarboxy  
TES Triethylsilyl 
Tf triflate 
TFA Trifluoroacetic acid 
TfO Triflic  
 xi 
 
THF Tetrahydrofuran 
TLC Thin layer chromatography 
TMEDA Tetramethylethylenediamine 
TMS Trimethylsilyl 
TPPO Triphenylphosphine oxide  
XTT 2,3-Bis-(2-methoxy-4-nitro-5-sulfophenyl)-2H-tetrazolium-5-carboxanilide 
 
  
 xii 
 
 
 1 
 
 
Chapter 1: Introduction 
        
1.1  A brief history of marine natural products  
 
Historically, natural products have played an important role in drug development. From the 
herbal medicines used in ancient times and traditional medicines to industrially produced 
pharmaceuticals in modern days, nature has provided us with a rich mine of potential drugs 
with enormous diversity in structure and biochemical activities. The boom of marine natural 
product chemistry came with the invention of SCUBA.  Prior to SCUBA, only shallow water 
species had been accessible. Isolation of natural products from marine organisms has proven 
to be a great source of pharmaceuticals. The first isolated marine products were the nucleosides 
spongothymidine (1) and spongouridine (2), discovered in 1951 (Figure 1.1).1 Since then, the 
field of marine natural products has attracted increasing attention, resulting in the discovery of 
a vast number of marine products, that could be used in fighting numerous diverse illnesses, 
for example fungal infections, tumour growth, cancer and Alzheimer’s disease. 
 
Figure 1.1: Structure of spongothymidine (1) and spongouridine (2). 
 
Marine natural products are commonly secondary metabolites, which evolved for the 
natural defence of the organisms. Unlike vertebrates, marine sponges, corals and algae are 
sessile, meaning they don't have mobility; they also generally don’t have external fighting 
facilities to defend themselves. Their defence is totally chemical and thus dependent on 
these secondary metabolites. The nature of their defence system determines that these 
metabolites have to be potent in order to be effective because, once released, they are 
diluted instantly by sea water. One example of current medicines that are derived from 
marine organisms is the breast cancer drug eribulin (3) (Figure 1.2). It is the simplified and 
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optimized analogue of halichondrin B (4), which was isolated from the marine sponge, 
Halichondria okadai.2  
 
Figure 1.2: Structures of eribulin (3) and halichondrin B (4). 
 
1.2 Microtubule-targeting agents and paclitaxel  
  
Eribulin (3) is an example of the microtubule-targeting agents (MTAs), a group of largely 
nature-derived drugs or candidates that affect cell function by influencing the microtubules. 
They have been identified as good candidates for cancer treatment, and a number of such anti-
cancer drugs are already in regular clinical use, such as vinorelbine (5), estramustine (6) and 
ixabepilone (7) (Figure 1.3).3 This success can be attributed to the important roles that 
microtubules play in cells, especially in proliferation and growth regulation. The first MTAs 
discovered were the vinca alkaloids.4 Their effect on microtubules was observed as the 
development of honeycomb-shaped crystals under the electron microscope, which were 
identified as abnormally large tubules resulting from the binding of vinca alkaloids. Since then 
a large number of such natural products have been reported, and enormous effort has been put 
towards better understanding of these compounds and their effects on microtubules.  
Figure 1.3: Examples of approved microtubule-targeting drugs. 
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Microtubule-targeting agents can affect microtubules through different mechanisms. 
Microtubule formation is a dynamic process, such that both assembly and disassembly of 
tubule monomers occur simultaneously. By maintaining a healthy equilibrium, normal function 
of microtubules, such as cell division and proliferation, can be carried out. Interruption of either 
end of the equilibrium can be disruptive or lethal for cells. Most MTAs disturb this dynamic 
by binding directly to microtubules, but some were also found to bind to microtubule-
associated proteins, whose function is to regulate microtubule dynamics.5 Generally, MTAs 
are classified into two categories according to their outcomes: microtubule-destabilizing agents 
(MDAs) and microtubule-stabilizing agents (MSAs). Compounds that bind to the vinca domain 
(at the end of microtubules) or colchicine domain (soluble tubulin dimers) are MDAs. This 
type of binding disrupts polymerization of microtubules, and as a result the microfibers 
essential to pull cells apart cannot be formed, thus cell proliferation is halted. Vinca-domain 
binders include drugs such as eribulin (3), vinorelbine (5), vinblastine and romidepsin. 
Colchicine-domain binders are a smaller group, and contain the potential drugs fosbretabulin, 
verubulin and ombrabulin that are currently in clinical trials. On the other hand, those that bind 
to the paclitaxel domain (inner surface of microtubules) are MSAs. In this case, microtubule 
disassembly is interrupted and multiple asters are often formed, resulting in cell lysis. Although 
MSAs were discovered later, they have become a more active area of research than the MDAs.  
 
The most well-known example of a microtubule-stablizing drug is paclitaxel (8), trade-marked 
as Taxol. It is one of the most successful anti-cancer drugs on the market. Discovered in the 
late 1960’s,6-7 paclitaxel’s biological activity was extensively studied during the following 
decade,8 and it was finally approved for treatment of ovarian and breast cancer in 1992 and 
1994, respectively. Because the natural source of paclitaxel (8), the Pacific yew tree (Taxus 
brevifolia), is highly scarce, isolation alone cannot meet the demand of the clinic. During the 
1990s, the structure of paclitaxel (8) attracted around 30 groups worldwide towards its total 
synthesis,9 which contains a core 6-8-6 tricyclic ring system with appended hydroxyls, esters 
and a fused oxetane (Scheme 1.1). In addition to the tricyclic ring system, the existence of 
multiple quaternary and stereocenters makes the synthesis of 8 very challenging. In 1994, two 
of these total syntheses were published. Holton’s synthesis utilized an epoxide-alcohol 
rearrangement strategy for the core synthesis (Scheme 1.1),10,11 which was developed by their 
group in 1988 to synthesize a similar taxane, taxusin.12 The saturated six-membered ring in 9 
was formed via Dieckmann cyclization and the side-arm was sourced from Ojima’s β-lactam 
(10). Holton’s synthesis also included a route starting from baccatin III (11), which was also 
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isolated from the Pacific yew tree. Although this could increase the production of paclitaxel 
(8), it is still far from meeting the market demand.  
  
Scheme 1.1: Holton’s synthesis of paclitaxel (8). 
 
Nicolaou’s synthesis used the same β-lactam 10 for the side-arm, but the core structure was 
constructed around the central 8-membered ring, via Shapiro and McMurry coupling reactions 
(Scheme 1.2).13 Due to the complexity of the structure, a total synthesis approach would be too 
expensive for industry-scale production. Nevertheless, Holton and Nicolaou’s research was a 
valuable development in synthetic methodology, and researchers continued to find more 
methods and reliable sources for mass production of paclitaxel (8).  
Scheme 1.2: Key steps of Nicolaou’s synthesis of paclitaxel (8). 
 
 
The source problem was resolved by Bristol-Myers Squibb. They re-discovered paclitaxel from 
the leaves of ornamental yew tree in a mixture with related taxanes (12) that differ at the amide 
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on the side-arm (Scheme 1.3). Compared to the 100-200 years growth cycle needed to harvest 
paclitaxel from the bark of the Pacific yew trees, the leaves of ornamental yew trees only need 
3-4 years to regenerate.14 A sequence was developed to convert the mixture of taxanes (12) to 
8 in two simple steps, owing to a previously reported method of imine synthesis with 
Schwartz's reagent15,16 (Scheme 1.3). The amide on the side-arm was converted to an amine 
(13) via hydridozirconation to produce imine (14), followed by hydrolysis. The subsequent 
esterification afforded taxol (8). This method of production allows industry-scale manufacture 
Scheme 1.3: Bristol-Myers Squibb’s synthesis of paclitaxel (8). 
of paclitaxel (8) for commercialization, which also enables derivatives of paclitaxel (8) to be 
accessed readily and studied. Fruitfully, a few related drugs have since been developed and 
approved by FDA for various types of cancer, for example docetaxel (15), cabazitaxel (16) 
(Figure 1.4) and nanoparticle albumin-bound paclitaxel (nab-paclitaxel). The derivatization of 
paclitaxel (8) is still a very active area of study.17 
 
Figure 1.4: Structure of docetaxel (15) and cabazitaxel (16). 
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During the clinical application of those drugs, some patients were found to be developing 
resistance. The first cause for this resistance was identified as an overexpression of P-
glycoprotein efflux pumps.18-21 This mechanism is part of the energy-dependant transport of 
small molecules through the cell membrane, and provides the cell’s natural defence against 
toxins. It has the ability to remove toxins, in this case drugs, from the cell, resulting in 
ineffective chemotherapy.22 Elevated P-glycoprotein level is the most common cause of drug-
resistance amongst many cell lines, and against various small-molecule drugs.18 Later, another 
resistance pathway was observed, involving multidrug resistance-associated proteins (MRP). 
The first MRP was isolated from drug-resistant lung cancer cells with normal P-glycoprotein 
levels,23 and six more members of the MRP family were subsequently discovered.24 Both P-
glycoprotein and MRP are validated targets for overcoming the problem of drug resistance. 
Research targeting these mechanisms include suppression of these small-molecule efflux 
pumps by inhibitors and reducing the toxicity of drugs to allow higher application dose.20 There 
is also a potential solution offered by microtubule-stabilizing agents that bind covalently to 
microtubules. In 2005, Hamel’s study on the previously isolated natural product cyclostreptin 
(17), also known as FR182877 (Figure 1.5),25-27 produced a puzzling outcome:28 although 
cyclostreptin (17) was 7- and 12-fold less potent than paclitaxel (8) against cell lines MCF-7 
(breast cancer) and 1A9 (ovarian cancer) respectively, its cytotoxicity was less affected by 
paclitaxel-resistant cell lines (1A9PTX10, 1A9PTX22). While the effectiveness of paclitaxel 
was reduced by 33/34-fold against its resistant strains, that of cyclostreptin (17) was only 
reduced 2-fold. A follow-on study ascribed the cause of this observation to covalent binding 
between 17 and microtubules.29 This finding shed light on the problem of drug-resistance 
through small-molecule transporter channels: if the drug binds to microtubules irreversibly, the 
cell can no longer “pump” it out. In 2008, another group of natural products, taccalonolides,30-
37 was confirmed to covalently bind to microtubules.38,39 Six members of this family of 
compounds demonstrated cytotoxicity, with taccalonolide AJ (18) leading the chart (Figure 
1.5).40 However, all of taccalonolides and cyclostreptin (17) have relatively weak cytotoxicity, 
with their IC50 values only at µM-scale.
28,38 Even against the paclitaxel-resistant strains, they 
are less or only marginally more potent than paclitaxel (8). It wasn’t until the discovery of 
another two marine natural products, (-)-zampanolide (19) and (+)-dactylolide (20), which are 
covalently binding microtubule-stabilizing agents, that new hope was found for this potential 
solution to drug-resistance. 
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Figure 1.5: Structure of cyclostreptin (17) and taccalonolide AJ (18). 
 
1.3 (-)-Zampanolide and (+)-dactylolide  
 
 (-)-Zampanolide (19) was first isolated in 1996 from a marine sponge called Fasciospongia 
rimosa, which was discovered at Cape Zampa in Japan (Figure 1.6).41 Its unique structure 
consists of an 18-membered macrolactone with an unusual N-acyl hemiaminal substituent at 
C19.  The macrolide core is highly unsaturated and bears an embedded pyran with an exo-
methylene motif. The stereochemistry at C20 was not defined in the isolation paper and was 
later determined through the total synthesis by Smith, Safonov and Corbett.42  
 
Figure 1.6: The structure of (-)-zampanolide (19). 
 
(-)-Zampanolide (19) was found to exhibit potent anticancer activity comparable with the 
widely used cancer chemotherapy drug paclitaxel (8) (see Figure 1.4).43 It also displays a 
similar biochemical mode of action to paclitaxel (8), both being microtubule stabilizing 
agents.44 A detailed mechanistic study of (-)-zampanolide (19) has been reported by researchers 
at Victoria University of Wellington.43 The cytotoxicity was determined as a half maximal 
inhibitory concentration (IC50), which is the concentration required to inhibit normal function 
of 50% of the cells in the assay. In this case, the inhibited cells can be evaluated by an MTT 
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dye reduction assay. The IC50 values of (-)-zampanolide (19) were 4.3 ± 1.1 nM and 14.3 ± 2.4 
nM against HL-60 (human promyelocytic leukemia) and 1A9 (human ovarian carcinoma) cells 
respectively. More remarkably, the cytotoxicity of (-)-zampanolide (19) was similar against the 
parental strain A2780 or the paclitaxel-resistant human ovarian cancer cell line A2780AD, with 
an IC50 value of 7.5 ± 0.6 nM against A2780AD, which is over 50-fold more potent than 
paclitaxel (8).43  Studies have found that (-)-zampanolide (19) causes the stabilization of 
microtubule bundles at interphase and multiple asters during mitosis; as a result, the cell is 
divided unevenly into three or more non-viable daughter cells.43 
 
In 2001, a similar natural product dactylolide (20) was isolated and identified by Cutignano 
(Figure 1.7).45 Uenishi’s thermolysis and degradation study of (-)-zampanolide (19) found that, 
although (+)-20 could be produced by thermolysis of (+)-19, no (-)-20 was observed subjecting 
(-)-19 to Riccio’s isolation conditions. Therefore dactylolide (20) was thought not to be the 
decomposition product of (-)-zampanolide (19) from the isolation process, but a distinct natural 
product.46 Surprisingly, the core macrocyclic structure of dactylolide (20) was initially 
proposed to have the same structure, but opposite configuration to (-)-zampanolide (19) based 
on optical rotation data of isolated and synthetic samples.45 However, evidence has since 
accumulated from the optical rotation values of synthetic dactylolide (20) to suggest that the 
opposite sign of optical rotation of isolated dactylolide is merely due to contamination of the 
natural sample by a highly absorbing species with a positive rotatory effect on plane polarised 
light (Figure 1.7).47 The structural similarity of zampanolide and dactylolide indicates that they 
are likely to be synthesized by the same biosynthetic pathways, yet they were isolated from 
different sponges. It would be unusual for the configuration of a metabolite to be inverted at a 
late stage of a biosynthesis. However, the hypothesis of contamination has not been proved yet. 
Like (-)-zampanolide (19), dactylolide (20) is a microtubule stabilizing agent, but has much 
lower potency. The cytotoxicity of 20 was reported together with the isolation. The inhibition 
percentages of dactylolide (20) at 3.2 µg/mL were 63% for the L1210 cell line (lymphatic 
leukaemia of mice) and 40% for SK-OV-3 (carcinoma of the ovaries).45 
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Figure 1.7: The structure and optical rotation data of dactylolide (20). 
 
More insight into the protein binding sites of (-)-zampanolide (19) was provided by a report in 
July 2012, which included (-)-dactylolide (20) for comparison.44  High resolution mass 
spectrometry (HRMS) and nuclear magnetic resonance (NMR) data indicated that both 
compounds bind to the luminal site on β-tubulin, adjacent to the paclitaxel-binding site, and 
thus disrupt the function of microtubule. More excitingly, the binding is covalent and 
irreversible, and the binding of (-)-zampanolide (19) is at least 8 times faster than the binding 
of (-)-dactylolide (20). The irreversible binding could mean low drug dosage and application 
frequency if (-)-zampanolide (19) were eventually commercialised. The HRMS study showed 
that the covalent binding is either between an Asn amide and C3, or a His and C9 of the 
zampanolide ring (Figure 1.8), which are the result of conjugate additions of the nucleophilic 
side-arms on the amino acids to the electrophilic α,β-unsaturated carbonyl moieties. For (-)-
zampanolide (19), significant hydrogen bonding interaction was also seen between tubulin and 
the N-acyl hemiaminal linkage. In addition, hydrogen bonding from tubulin to the carbonyl at 
C7 also occurs, and the exocyclic methylene group at C13 interacts hydrophobically with its 
resident protein pocket. Interestingly, modelling study indicated that the orientation of (-)-
dactylolide (20) in the binding site is reversed relative to 19, yet the covalent bonds form at the 
same positions. The ester and aldehyde provide the major hydrogen bonding in (-)-20, and the 
eastern side of (-)-dactylolide (20) occupies the pocket where the side-arm of (-)-19 resides. A 
hydrophobic interaction of the methylene still occurs, but with a hydrophobic pocket adjacent 
to the one involved in the (-)-zampanolide (19) binding.44  
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Figure 1.8: Binding of (-)-zampanolide (19) and (-)-dactylolide (20). 
 
In 2013, the high resolution X-ray crystallography of zampanolide (19) complexed with αβ-
tubulin was published,48 which agreed with most of the findings from the HRMS study, and 
the covalent binding between His and C9 was confirmed. The most recently published study 
on zampanolide (19) binding resorted to computational methods, using molecular docking and 
dynamics stimulation to calculate the orientation and binding of zampanolide (19) in the taxane 
pocket.49 It concluded that the C3 binding should be major, because of the short distance 
between C3 and the His nitrogen (3.667 Å) leading to the preferred nucleophilic attack. 
Although the major site for covalent binding interaction is still debatable, it is certain that the 
covalent binding between 19 and the taxane binding pocket enhances the cytotoxicity of 
zampanolide (19) and makes it a good anti-cancer drug candidate. 
 
1.4   Published total syntheses of zampanolide 
 
The potential for zampanolide (19) to become an effective anti-cancer drug has motivated 
research groups around the globe to target its total synthesis and obtain a better understanding 
of its mode of action.47 A number of total syntheses of zampanolide (19) have been published 
since 2001 (Table 1.1), as well as the total syntheses of dactylolide (20) and formal synthesis 
of 19, which will be described in section 1.5. A few analogues of 19 were also generated, which 
provided some structure-activity relationships. However, more insightful information on the 
tubulin binding of 19 was obtained from the mode of action studies.43,44,48,49 The structural 
complexity of the compound sets many challenges for its synthesis, especially the pyran ring 
synthesis, the macrocyclization step and formation of the N-hemiaminal linkage. 
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Table 1.1: Timeline of published zampanolide (19) syntheses and mode of action studies. 
Year Authors Major finding 
2001 Smith, A. B.; Safonov, I. G.; Corbett, R. M.42,50  Synthesis of (+)-19 
2003 Hoye, T. R.; Hu, M.51 Synthesis of (-)-19 
2009 Field, J. J.; Singh, A. J.; Kanakkanthara, A.; 
Halafihi, T.; Northcote, P. T.; Miller, J. H.43 
19 identified as a microtubule-
stabilizing agent 
2009 Uenishi, J.; Iwamoto, T.; Tanaka, J.46 Synthesis of (-)-19 
2012 Field, J. J.; Pera, B.; Calvo, E.; Canales, a.; 
Zurwerra, D.; Trigili, C.; Rodriguez-Salarichs, 
J.; Matesanz, R.; Kanakkanthara, A.; Wakefield, 
J.; Singh, J.; Jimenez-Barbero, J.; Northcote, P.; 
Miller, J. H.; Lopez, J. A.; Hamel, E.; Barasoain, 
I.; Altmann, K-H.; Diaz, J. F.44 
Binding site of 19 to tubulin 
determined 
2012 
2012 
Ghosh, A. K.; Cheng, X.; Bai, R.; Hamel, E.52 
Zurwerra, D.; Glaus, F.; Betschart, L.; Schuster, 
J.; Gertsch, J.; Ganci, W.; Altmann, K-H.53 
Synthesis of (-)-19 
Synthesis of (-)-19 
2013 Prota, A. E.; Bargsten, K.; Zurwerra, D.; Field, 
J. J.; Diaz, J. F.; Altmann, K. H.; Steinmetz, M. 
O.48 
X-ray crystallography structure 
of zampanolide-tubulin complex 
2014 Liao, S. Y.; Mo, G. Q.; Chen, J. C.; Zheng, K. 
C.49 
Computational study of 19 
binding mode on tubulin. 
 
The disconnections dictating the retrosynthetic strategies of the previous total syntheses are 
summarised in Figure 1.9. Although each total synthesis has its unique features, there are a 
few retrosynthetic disconnections that are popular strategies: in the forward direction, all of the 
total syntheses of zampanolide (19) have the formation of the N-acyl hemiaminal group as the 
last step; a majority adopt esterification or macrolactonization at C1, with either Mitsunobu or 
Yamaguchi condition; alkenes are generally chosen as major disconnection points, due to the 
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abundance of well-established olefination methods, such as the Horner-Wadsworth-Emmons 
reaction (HWE), Wittig reaction, ring-closing metathesis (RCM) with Grubbs’ catalyst and 
Julia-Kocienski olefination. On the other hand, the synthetic methods diverge with respect to 
the pyran motif. 
Figure 1.9: Reported major disconnections for (-)-zampanolide (19). 
 
1.4.1  Synthetic methods for formation of the pyran fragment 
 
In Smith’s seminal total synthesis of the unnatural enantiomer, (+)-19, the C9-C17 pyran 
fragment was constructed by dioxanone formation, followed by a Petasis-Ferrier 
rearrangement (Scheme 1.4).42,50 This acid-promoted cyclization of trimethylsilyl (TMS) ester 
21 with (E)-3-bromo-but-2-enal (22) can be carried out with triflic acid generated in situ from 
trimethylsilyl triflate (TMSOTf), but the addition of a catalytic amount of triflic acid (5 to 10 
mol%) was essential in scaled-up reactions to initiate the reaction. The subsequent Petasis-
Ferrier reaction sequence involves methylenation of the dioxanone 23 by Cp2TiMe2 to produce 
24, which then transformed to an aluminum enolate and rearranged in Ferrier-fashion. The 
pyran 25 was produced with the correct cis-configuration, which agrees with the prediction 
based on the substituent pattern.54 
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Scheme 1.4: Smith’s Petasis-Ferrier rearrangement. 
 
Although Smith’s method produced the pyran with the correct stereochemistry in a satisfying 
yield, some other syntheses have chosen to use one-step methods for the pyran synthesis. Hoye 
and Ghosh both used an acid-catalyzed Sakurai-type reaction to produce the pyran with an exo-
methylene in one step (Scheme 1.5).51,52 This reaction is driven by the β-silicon effect.55 The 
electron deficient carbocation that forms at the β-position to the silyl is stabilized by the 
molecular orbitals of the trimethylsilyl group, which promotes the nucleophilic addition to the 
oxonium intermediate. Hoye used camphorsulfonic acid (CSA) to catalyze the union of the two 
fragments 26 and 27, and the product 28 was obtained with a good yield (78%) and exclusively 
  
Scheme 1.5: Hoye and Ghosh’s Sakurai-type reactions. 
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in the desired configuration.51 Ghosh achieved the pyran cyclization of 29 via an oxidative and 
intramolecular Sakurai-type reaction.  An oxocarbenium intermediate (30) was generated by 
2,3-dichloro-5,6-dicyano-1,4-benzoquinone (DDQ) in the presence of a weak Lewis acid 
(PPTS) that enhances the oxidative ability of DDQ (Scheme 1.5).52   
 
Uenishi also used a Sakurai-type reaction in the pyran synthesis, in conjunction with an O-
Michael cyclization, producing the pyran fragment C9-C20 (Scheme 1.6).46 No 
stereoselectivity was observed for this Hosomi-Sakurai reaction, and a mixture of R- and S-32 
was obtained. Fortunately, the two isomers were separable, and the undesired R-isomer was 
converted to the S-isomer in 65% yield over a two-step process involving Mitsunobu reaction 
and methanolysis. This inversion of the configuration at C15 proceeded mechanistically 
through a SN2-type nucleophilic substitution of the activated alcohol followed by deacetylation 
to afford the inverted alcohol. After establishing a conjugated unsaturated methyl ester at C11, 
an intramolecular O-Michael addition was performed to complete the pyran (33) formation.  
Scheme 1.6: Hosomi-Sakurai reaction and O-Michael addition in Uenishi’s synthesis. 
 
In Altmann’s synthesis, a Prins cyclization was used to construct the pyran. The starting 
material 34 proceeded through a six-membered transition state 35 similar to Ghosh’s Sakurai-
type transition state to produce the pyran 36 with an appending iodide (Scheme 1.7). The iodide 
was transformed to a methylene via substitution by acetate, saponification, oxidation and 
Wittig reaction. 
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Scheme 1.7: Prins cyclization in Altmann’s synthesis. 
 
1.4.2  Synthetic methods of macrocyclization 
 
Most of the total syntheses of 19 used well-established chemistry for macrocyclization. The 
most common ones are Yamaguchi esterification at C1,56 Horner-Wadsworth-Emmon reaction 
to form alkene C2-C350 and ring-closing metathesis to link C8 to C951,52,57 (Figure 1.10).  
 
Figure 1.10: Common macrocyclization methods. 
 
Hoye’s synthesis planned to use a unique epoxide opening as their final macrolactonization 
step.51 However, the reaction had poor regioselectivity and lactonization at C20 became a 
problem. Therefore, this strategy was revised, and ring-closing metathesis was chosen as the 
final macrocyclization, after intermolecular epoxide opening (Scheme 1.8). The tetra(tert-
butoxy)titanium-catalyzed epoxide opening of 37 by carboxylic acid 38 created the desired 
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stereochemistry at C19, and the product was subjected to RCM to macrocycle 39, which 
proceeded through to produce (-)-dactylolide (20) and zampanolide (19) (Scheme 1.8). 
Scheme 1.8: Hoye’s tetra(tert-butyoxy)titanium-catalyzed epoxide opening. 
 
1.4.3 Synthesis of N-acyl hemiaminal linkage 
 
The N-acyl hemiaminal functionality is more common within ring structures, and scarcely 
found in the linear form within natural products, thus little research has previously been done 
on the construction of groups such as that in the zampanolide side-arm. Smith’s connection of 
the N-acyl hemiaminal side-arm to the core was achieved with Curtius rearrangement of 40 
and acylation in good yield (Scheme 1.9).42 The Curtius rearrangement begins with a 
rearrangement of the acyl azide intermediate (41) to produce an isocyanate (42), which then 
  
Scheme 1.9: Smith’s N-acyl hemiaminal formation by Curtius rearrangement. 
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reacts with trimethylsilylethyl alcohol to afford the trimethylsilylethyl carboxy (TEOC)-
protected amine (43). Upon coupling with an acyl chloride and deprotection, the desired N-
acyl hemiaminal (44) structure was formed. 
 
Hoye and Uenishi chose to attach the side-arm with aza-aldol reactions, which were promoted 
by di-i-butylaluminum hydride (DIBAL-H) and camphorsulfonic acid (CSA), respectively 
(Scheme 1.10).51 In both cases the desired product was formed from (-)-20 and Z,E-hex-2,4-
dienamide (45), but no stereoselectivity was observed. Hoye’s 1:1 mixture of the two C20-
epimers (46) was not separated, and no yield was reported. Uenishi only achieved a poor yield 
of 12% (Scheme 1.8).46 The low yield of zampanolide (19) was attributed primarily to 
incompletion of the reaction (35% recovery of (-)-20), disubstitution by the amide 45 to form 
47 (16%) and the lack of stereoselectivity (12% of C20-epimer (48)). 
Scheme 1.10: Hoye and Uenishi’s aza-aldol reactions for connection of the side-arm. 
 
The most efficient method so far reported is the amidation employed in Ghosh’s total 
synthesis.52 This amidation was catalyzed by a chiral Brønsted acid, (S)-TRIP (Scheme 1.11). 
This catalyst is one of the chiral cyclic phosphoric acids derived from BINOL, which have 
found use in asymmetric catalysis only within the last ten years.  They have succeeded in 
catalyzing a number of processes, such as Mannich-type, Pictet-Spengler, Friedel-Crafts-type 
and aza-Diels-Alder reactions.58 The phosphoric acid motif in the promoter is bifunctional, 
containing both Lewis basic and Brønsted acidic parts. In this reaction, both aldehyde and 
amide substrates are thought to be activated by hydrogen bonding with the phosphoric acid. 
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Dictated by the BINOL scaffold, the hydrogen bonding also brings the two substrates into close 
proximity. The stereoselectivity was provided by the relative positions of the two 2,4,6-tri(i-
propyl)phenyl groups. This reaction totally eliminated the formation of the disubstituted 
product 47, and the desired product 19 and its C20 epimer (48) were produced in a 3:1 ratio. 
Scheme 1.11: Ghosh’s N-acyl hemiaminal connection. 
 
1.5  Published total syntheses of dactylolide 
 
Due to the high structural similarity of dactylolide (20) and zampanolide (19), examination of 
the total syntheses of dactylolide (20) can provide good guidance to the macrolide core 
synthesis. In fact, all (-)-zampanolide (19) syntheses go via (-)-dactylolide (20) as an 
intermediate. A number of total syntheses of both (+)-20 and (-)-20 have been published (Table 
1.2), including Smith et. al. and Altmann et. al. who also used their strategy to complete the 
total synthesis of (-)-zampanolide (19).53,56,59-62 
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Table 1.2: Timeline of published dactylolide (20) syntheses. 
Year Authors 
2002 
2005 
Smith, A. B.; Safonov, I. G.59 
Aubele, D. L.; Wan, S. Y.; Floreancig, P. E.56 
2005 Sanchez, C. C.; Keck, G. E.60  
2006 
2008 
Louis, I.; Hungerford, N. L.; Humphries, E. J.; McLeod, M. D.61 
Ding, F.; Jennings, M. P.63 
2010 Yun, S. Y.; Hansen, E. C.; Volchkov, I.; Cho, E. J.; Lo, W. Y.; Lee, D.64 
2010 Zurwerra, D.; Gertsch, J.; Altmann, K. H.62 
2012 Lee, K.; Kim, H.; Hong, J. Y.65 
 
1.5.1  Synthetic methods for formation of the pyran fragment 
 
The strategies for the major disconnections in total syntheses of dactylolide (20) are similar to 
those of zampanolide (19), with Horner-Wadsworth-Emmon reaction followed by 
esterification to construct the dienoate and ring closing metathesis between C8 and C9 
commonly used. As in the zampanolide (19) syntheses, the methodology for formation of the 
pyran in dactylolide (20) is diversified, and some very good methods with high yields and 
stereoselectivities were found. Floreancig’s pyran synthesis from 49 used excess 
trimethylsilylmethylmagnesium chloride and cerium(III) chloride to form the substrate for 
Peterson olefination and Prins cyclization in situ, which smoothly produced 50 in a multi-step, 
one-pot reaction (Scheme 1.12).56 
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Scheme 1.12: Floreancig’s pyran synthesis. 
 
McLeod used a hetero-Diels-Alder reaction catalyzed by a chiral Lewis acid to construct the 
pyran motif. Upon desilylation, the pyranone 51 was produced with excellent yield and ee 
(Scheme 1.13).61 The Lewis acid catalyst was Jacobsen’s chiral tridentate chromium(III) 
Schiff’s base complex, containing an adamantyl (Ad) group for steric shielding, and was made 
conveniently in three steps. It provided excellent regio- and stereoselectivity in the formation 
of 51.66  
 
Scheme 1.13: McLeod's hetero-Diels-Alder reaction in pyran synthesis.  
 
Hong employed an O-Michael addition with a chiral proline-derived catalyst (Scheme 1.14).64 
This type of reactions usually proceed through an iminium intermediate resulted from the 
aldehyde. Although the chiral directing groups on the catalyst are further away from the 
reacting carbon in this 1,6-conjugate addition, excellent yield and diastereoselectivity were still 
obtained. Deprotection of the dithiane to a ketone sets up for the subsequent Wittig reaction to 
produce the exo-cyclic methylene. 
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Scheme 1.14: Hong's O-conjugate addition in pyran synthesis. 
 
Jennings’ method proceeds via an α,β-unsaturated lactone (52) (Scheme 1.15).63 A 
diastereoselective epoxidation controlled by the configuration of the substrate 52 followed by 
epoxide ring-opening afforded the β-hydroxy lactone (53) as a single diastereoisomer. Allyl 
addition to the carbonyl and deoxygenation then established the terminal alkene (54) for 
macrocyclic RCM.  
 
Scheme 1.15: Jenning’s lactone method. 
 
1.5.2  Other methods for the formation of dactylolide macrocycle 
 
While the conjugated diene moiety is commonly made by Horner-Wadsworth-Emmons or 
Wittig reactions, in Yun’s synthesis a Suzuki cross-coupling reaction was used (Scheme 
1.16).64 Formation of a cyclic boronic acid 55 from boronate 56 was achieved by [1,3]-
transposition of the allylic oxygen.67  The cyclic boronic acid 55 then underwent a Pd-mediated 
Suzuki reaction to provide the precursor for macrocyclization by RCM, viz. 57. Despite the 
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complexity of functional groups in the structure, the two steps proceeded with a satisfactory 
combined yield of 51%. 
 
Scheme 1.16: Yun’s Suzuki reaction. 
 
Hong’s N-heterocyclic carbene (NHC)-catalyzed oxidative macrolactonization is also quite 
unique (Scheme 1.17).65 In this interesting redox process, the aldehyde in 58 is activated by 
nucleophilic addition of the NHC formed by deprotonation of triazonium, and then oxidized to 
acyl azolium ion (59) by 3,3',5,5'-tetra-tert-butyl-diphenoquinone (inset box). It was observed 
that, without N,N-dimethylaminopyridine (DMAP), a very low yield was obtained for this 
reaction, thus activation of the carbonyl by DMAP may be required for the addition of NHC. 
 
Scheme 1.17: Hong’s macrolactonization. 
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Hong’s synthesis included the protection of C7 ketone with TBS-cyanide (Scheme 1.18).65 The 
TBS-protected cyanohydrin 60, upon deprotonation at the geminally substituted carbon, serves 
as an acyl anion equivalent to achieve α-alkylation with the C1-C6 fragment. An excellent yield 
of 86% was obtained over two steps to produce 61. Conveniently, the protected cyanohydrin 
was inert to several subsequent transformations, and was later deprotected to afford the ketone 
after macrocyclization in a good yield (75%). 
Scheme 1.18: Lee’s TBSCN protection and deprotection. 
 
1.6  Analogue studies 
 
Although the total syntheses of zampanolide (19) and dactylolide (20) have been hotly 
contested, not many analogues have been reported. All of the analogues were reported before 
the publication of Field’s paper that describes the covalent binding of (-)-zampanolide (19) and 
(-)-20 to β-tublin,44 and the main purpose for analogue formation was to perform structure-
activity relationship (SAR) studies by determining the regions in the molecule that are 
important for its cytotoxicity. The structural similarity of 19 and 20 means that they can be 
considered as analogues of each other, and the fact that (-)-19 is about one thousand-fold more 
potent than 20 suggests that both the N-acyl hemiaminal side-arm and the configuration of the 
macrolide are crucial to its activity. 
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The first unnatural analogue was published by Ding and Jennings, and they concentrated on 
altering the absolute configuration of the macrolide. Their synthesized (-)-20 displayed slightly 
more potent cytotoxicity than (+)-20,63 but it is still not comparable with (-)-zampanolide (19) 
(Table 1.3). This result confirmed the importance of the side-arm for the cytotoxicity of 
zampanolide (19). 
Table 1.3: IC50 and GI values of (-)-zampanolide (19), (-)- and (+)-dactylolide (20).
41,43,45,63 
Cell line (-)-zampanolide (19)  (-)-dactylolide (20) (+)-dactylolide (20)c 
A549 (lung) 3.2 nMa 301 nMa  
HCT116 (colon) 7.2 nMa 0.133 μg/mL (GI50)b  
MCF-7  (breast) 6.5 nMa 0.076 μg/mL (GI50)b  
SK-OV-3 (ovary)  1.8 µg/mL (GI50)
b 3.2 µg/mL (GI50)
c  
L1210 (leukemia)   3.2 µg/mL (GI40)
c 
a Methylene blue staining, IC50 value; 
b MTT assay, GI50 value; 
c XTT assay, and GI value with 
inhibition percentage indicated. 
 
The next two analogues were side products obtained from the CSA-catalyzed aza-aldol reaction 
in Uenishi’s total synthesis of (-)-zampanolide (19).46 One of them is the C20 epimer of (-)-
zampanolide (48), which is 10-fold less active than (-)-zampanolide (19) (Table 1.4). The other 
one is the disubstitution product (47), which is 500-fold less active. These two analogues 
provided some information about the importance of the side-arm. It was suggested that the 
stereochemistry at C20 has some significance in the cytotoxicity, and a bulkier group at C20 
was not favorable. 
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Table 1.4: IC50 values
a (nM) of Uenishi’s analogues. 
 
 
 
  
Cell line (-)-zampanolide 
(19) 
C20 epimer 
(48) 
Disubstitution product 
(47) 
SKM-1 (leukemia) 1.1 10 490 
U937 (lymphoma) 2.9 27 950 
a MTT assay. 
Another study of analogues used (-)-dactylolide (20) as a model, in order to study the 
requirement of both the carbonyl at C20 and the methylene substituent on the tetrahydrofuran 
ring.62 Four analogues were produced and studied by Altmann et al. (Table 1.5). By comparing 
the IC50 values of compounds 20 and 63, it can be seen that removal of the methylene at C13 
from 20 has little effect on the inhibition concentration, if anything, enhancing it by 0.5 to 1.5 
fold. The effect of a hydroxyl group at C20 is not clear. While 62 displayed a lower inhibitory 
concentration against cell lines A549 and MCF-7, the cytotoxicity against HCLT116 was 
slightly increased. In comparison, analogue 64, having both no exo-cyclic methylene and a 
hydroxyl group improved on the cytotoxicity of 20. 
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Table 1.5: IC50 values
a (nM) of compounds 20 to 64. 
                                
Cell line 20 
R = CHO 
62 
R = CH2OH 
63 
R = CHO 
64 
R = CH2OH 
A549 (lung) 301.5 149.0 127.5 189.0 
MCF-7 (breast)  247.6 68.0 106.0 114.4 
HCLT116 (colon) 210.4 249.5 155.8 74.1 
a MTT assay. 
 
1.7  Efficiency of total synthesis: linchpin synthesis 
 
In recent years, chemists have placed increasing importance on chemical efficiency and the 
“greenness” of a chemical process. Many renowned chemists have published accounts on 
different aspects of this matter,68-73 which Anastas and Eghbali summarized as the 12 principles 
of green chemistry. Poliakoff et. al. further concentrated the 12 principles as the acronym 
“PRODUCTIVELY” (Figure 1.11).74-76 Synthetic chemists have also envisaged better 
chemical efficiency in total synthesis. Trost developed the concept of atom economy in 1995,69 
and Nicolaou published an account, “Tandem reactions, cascade sequences and biomimetic 
strategies in total synthesis” in 2003, which illustrated the use of these methods to reduce the 
number of synthetic steps, increase yields and minimize the amount of waste.70 In 2008, 
Wender introduced the function-oriented synthesis, where simplified analogues of complex 
natural products were designed to retain the functionalities important for bioactivity, while 
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reducing the synthetic effort and increasing efficiency.77 Following these concepts, many 
syntheses of natural products with excellent efficiency have been developed.78 
 
Figure 1.11: 12 principles of green chemistry. 
 
One of the most frequently considered aspects of multistep syntheses is the convergence of the 
sequence. While in a linear synthesis, small building blocks are assembled in sequential order, 
a convergent synthesis builds larger fragments from the building blocks, and joins the 
fragments at a later stage. Linear synthesis has its own advantages, especially for highly 
repetitive molecules with well-established and reliable chemistry, in which case the synthesis 
can be automated. Examples are the routinely used peptide79-84 and oligonucleotide85-87 
synthesizers, and the recent development of a small molecules synthesizer by Burke. Burke’s 
initial study claimed that, with an iterative Suzuki-Miyaura reaction and 12 alkene-based 
building blocks, most of the polyene natural products can be made by an automated or semi-
automated synthesis.88 The potential of expanding this process to more areas of natural product 
synthesis was then explored. This library of building blocks, now known as N-
methyliminodiacetic acid (MIDA) boronates, has been extended to include aryl, alkyl, alkynyl, 
and cyclic functionalities and a list of over 160 MIDA boronates are commercially available. 
With these building blocks, Burke’s group produced precursors that can be converted to 
structures such as polycyclic natural products in a few steps (Scheme 1.19).89  
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Scheme 1.19: Burke’s semi-automated syntheses of natural products.89 
 
For complex and diversified structures, convergent synthesis has more advantages: shortened 
longest linear sequence; comparably better yield; easier diversification. This strategy has been 
widely applied to the synthesis of dendrons and dendrimers,90,91 polycyclic ethers92 and 
alkaloid natural products93-99. One useful synthetic tool in convergent synthesis of natural 
product is the use of “linchpin”.100-104 The term “linchpin” was first used for total synthesis in 
1983, to describe the use of the dithiane (66) to link two 5-carbon units in the form of the allylic 
chloride 65, producing the 11-carbon precursor 67 of the spiroketal natural product 68 (Scheme 
1.20).105 
Scheme 1.20: Use of a dithiane linchpin in the total synthesis of talaromycin B (68). 
 
This linchpin approach is a crafty strategy for total syntheses: linking two fragments with a 
small fragment is a good way to build up molecular weight fast. Chemists have developed 
various small fragments to serve as linchpins. Dithiane has been proven to be a valuable one-
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carbon linchpin. Not only does the acidic methylene facilitate nucleophilic addition, dithiane 
is often used as a protecting group for carbonyls, thereby providing easy access to carbonyls in 
the product; alternatively, it can be simply removed reductively by desulfurization. In Smith’s 
synthesis of alkaloid (-)-205B (69), the dithiane linchpin was used to form the linear precursor 
of the di-cyclic product 70 (Scheme 1.21). At a late stage, the dithiane provided access to the 
tri-substituted alkene upon deprotection to a ketone, Wittig reaction and bond migration.106 
Dithiane linchpin has also been used in the synthesis of small and macrocyclic lactones, for 
example (+)-cryptocarya diacetate (71) and 11-α-methoxycurvularin (72). After assisting the 
construction of larger fragments, the dithiane was converted to an acetate in 71 and simply 
removed in 72.107,108  
Scheme 1.21: Dithiane in natural product syntheses.106-108 
 
Unlike dithiane, the majority of the linchpins are bifunctional small fragments. The design of 
linchpins is often tied with advancement of methodology. With the development of the 
Zn/Prophenol-catalyzed alkynylation of aldehyde by Trost, methyl propiolate (73) has become 
a useful linchpin (Scheme 1.22).109 Alkynylation is a powerful way to form C-C bonds, and 
the resulting propargylic alcohol is also highly versatile synthetically. The ester end can either 
be saponified to a carboxylic acid or reduced to an alcohol or aldehyde, all of which are well-
established synthetic handles for further elaboration. Using this methodology, Trost’s group 
has successfully synthesized several natural products including soraphen A,103 aspergillide B101 
and asteriscunolide D.110 
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Scheme 1.22: Trost’ asymmetric alkynylation and examples in natural product synthesis. 
 
Another linchpin that relies on alkyne chemistry is a phosphonium salt connected to a silylated 
alkyne (74), where the phosphonium is set up for a Wittig reaction, and the silylated alkyne is 
readily deprotected for further connection through alkynylation (Figure 1.12). The potential of 
this linchpin hasn’t been explored fully, however, it has been used to produce E,E-dienes upon 
reduction of alkyne, which further went through a Diels-Alder cyclization to produce the 
octahydronaphthalene structure in Marshall’s kijanolide subunit (75) synthesis.111 Later, 
Rizzacasa’s group used this linchpin 74 to produce the E,Z,E,E-tetraene motif in resolvin D2 
(76).112  
 
Figure 1.12: Phosphonium salt 74 in natural product synthesis. 
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Although the term “linchpin” is not very often used in literature, linchpin-type strategies are 
well-established in natural product synthesis and relevant to this thesis, in macrolactone 
synthesis. Looking at several recently published syntheses of macrolactones, many of them 
contain linchpin-type fragments (Figure 1.13).113-116 However, the assembly of fragments with 
the aid of a linchpin often takes multiple steps, because protection, deprotection, and/or 
conversion of functional groups are often required. This does not utilize the full potential 
efficiency of the linchpin strategy and, arguably, is not truly a linchpin strategy. An efficient 
linchpin should be easy to prepare, have reasonable stability, and require mild reaction 
conditions that are compatible to various functional groups. Furthermore, it should ideally react 
with the fragments in a multi-component fashion in a single step, without additional 
manipulation between the reactions at each reacting site of the linchpin. In this project, a three-
component linchpin method that meets the above criteria was explored and applied to the 
synthesis of a major portion of the (-)-zampanolide (19) and the (-)-dactylolide (20) macrocycle 
after difficulty with the first generation synthetic plan, which will be described in chapter two. 
 
Figure 1.13: Recent examples of linchpins (in box) in total synthesis of macrolactones. 
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Chapter 2:  Aims and preliminary work 
 
2.1  Aims  
 
The aim of this project is to advance towards the synthesis of (-)-zampanolide (19) and novel 
analogues to in order to undertake structure-activity relationship (SAR) studies. Guided by the 
protein binding studies of (-)-zampanolide (19)1 and the thus-far published analogues,2-4 the 
design of the analogues has been focused on alterations of the side-arm, pendant methyl groups 
and the pyran motif (Figure 2.1). The importance of the side-arm for binding to tubulin has 
been suggested by the different cytotoxicities of 19 and (-)-dactylolide (20), and the interaction 
with protein was confirmed by HRMS and X-ray crystallography studies. A range of side-arm 
alterations was explored prior to this project, including the synthesis of aromatic, alkyl and 
alternative alkenyl amide moieties. The sequential removal of the methyl groups on the 
macrocycle is proposed in order to facilitate the synthesis, which might also reduce steric 
hindrance and improve the affinity of 19 for the microtubule binding site. As for the pyran 
modifications, previous analogue studies by Altmann have shown that the removal of the exo-
methylene has little effect on the cytotoxicity of (-)-20.4 Replacement of the exo-methylene 
with a carbonyl or hydroxyl group at this position might cause conformational change or  
  
Figure 2.1: Proposed sites of modification. 
encourage hydrogen bonding interactions, which could enhance the binding to the protein. In 
addition, monocyclic compounds lacking the pyran ring and with an hydroxy group in place of 
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the pyran ether would certainly result in major conformational change. Nonetheless, if the 
microtubule activity can be sustained, a monocyclic analogue would significantly simplify the 
synthesis. 
 
2.2  Preliminary work  
 
The work of this thesis builds upon the preliminary work done by previous group members 
Samuel Ting and Claudia Gray. Ting’s focus was on exploring synthetic routes to fragments 
making up the macrocyclic core,5 while Gray was working mostly on the synthesis of the 
analogue side-arms.6  
 
2.2.1  Preliminary work on side-arm variants 
 
A preliminary study on the synthesis of simple amides as models of the side-arm of 
zampanolide (19) was undertaken by Claudia Gray prior to the commencement of this project 
(Scheme 2.1).  The one-pot amidation of primary alcohols via oxidation with iodine and in the 
presence of ammonia,  was found to provide a reasonable yield of an aromatic amide 77, but 
the reaction of the saturated equivalent 78 was poor yielding (eq. 1).7 Therefore, a second 
method starting from carboxylic acids was explored, with di-t-butyl dicarbonate (Boc2O) 
activating the acid by anhydride formation, and ammonium carbonate as a nitrogen source.8 
This method provided a better result for the synthesis of alkyl amide 79, and alkenyl amide 80 
could also be prepared in a reasonable yield (eq. 2).  
 
Scheme 2.1: Gray’s synthesis of simple amides as models of the side-arm. 
 39 
 
Claudia Gray also explored the synthesis of (Z,Z)-2,4-hexadienylamide (81)  as side-arm from 
commercially available 82. First, a sequence involving amidation, Sonogashira coupling9 and 
Lindlar hydrogenation was explored (Scheme 2.2). However, the oxidative amidation of 
propargyl alcohol (82) failed to produce the amide 83.  Reordering the sequence led to 
successful Sonogashira coupling of 82 and (Z)-1-bromopropene (84). The subsequent Lindlar 
hydrogenation of 85 caused some over-reduction, which was not prevented by the methods 
available, nor could the mixture of products be separated. Thus the subsequent amidation was 
not attempted. 
Scheme 2.2: Gray’s attempts to synthesize (Z,Z)-2,4-hexadienylamide (81). 
 
In the published total syntheses of zampanolide (19), reagents such as CSA, DIBAL-H, and 
the most successful (S)-TRIP have been used in aza-aldol reactions to construct N-acyl 
hemiaminal functionalities.2,10,11 Gray’s attempt to reproduce the CSA-catalyzed aza-aldol 
reaction with sorbamide (86) as a model amide and n-pentanal (87) as a model aldehyde was 
successful (Scheme 2.3).6 The length of reaction was found to be crucial: a four-hour reaction 
produced the N-acyl hemiaminal 88 in 53% yield, while an overnight reaction only returned 
starting material in the crude reaction mixture. This was presumed to be due to the low stability 
of the product, as it could be sensitive to retro-aza-aldol hydrolysis.12 
Scheme 2.3: Gray’s N-acyl hemiaminal model reaction. 
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2.2.2  Preliminary work on fragment syntheses 
 
Prior to this project, Sam Ting had investigated the synthesis of fragments of the zampanolide 
macrolactone ring. Ting’s original retrosynthetic strategy of (-)-dactylolide (20) incorporated 
the well-established esterification at C1 and ring-closing metathesis at C8. An O-Michael 
addition was planned to synthesize the pyran in 89, after a Nozaki-Hiyama-Kishi reaction to 
connect the western and southern fragments, 90 and 91 (Scheme 2.4).3,13,14  
Scheme 2.4: Ting’s retrosynthetic strategy. 
 
The first synthetic route to build the northern fragment (39) proceeded by way of a Stille cross-
coupling reaction (Scheme 2.5). Synthesis of the vinyl iodide 92, the Stille precursor, was first 
attempted using acrolein (93) as starting material; the Barbier reaction of acrolein (93) 
proceeded with a satisfying 62% yield of 94 obtained, after a series of optimization reactions 
to eliminate the homocoupling by-product 95. However, the following carboalumination15 was 
found to be unfruitful. This was proposed to be due to the quality of available 
trimethylaluminum, but the addition of excess trimethylaluminum was deemed too risky 
because the active aluminum-zirconium species 96 could also react with the terminal alkene.  
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Scheme 2.5: Ting’s first attempted synthesis of fragment 39. 
 
Ting then tried to establish the iodoalkene functional group before installation of the terminal 
alkene.  After protecting glycidol (97) as the triethylsilyl (TES) ether 98, the epoxide was 
opened by TMS-acetylene anion, and both of the silyl groups were then removed to produce 
diol 99 (Scheme 2.6). The ensuing carboalumination-iodination step progressed much more 
smoothly on this new substrate, leading to product 100. The terminal alkene in 92 was 
subsequently installed by a Corey-Chaykovsky reaction, where the tosylated primary alcohol 
derived from 99 was substituted by the ylide prepared from trimethylsulfonium iodide, and 
underwent elimination in the presence of a base to form alkene 92. However, when this vinyl 
iodide 92 was subjected to Stille coupling conditions, none of the desired diene 101 was formed. 
Instead, the product was a mixture of the unwanted Heck product 102, resulting from 
intramolecular reaction of the vinyl iodide with the terminal alkene and the oxidized stannane 
homocoupled product 103.  
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Scheme 2.6: Ting’s second attempted synthesis of fragment 39. 
 
A strategy was planned for the synthesis of the western fragment 90, using the existing 
configuration of diethyl tartrate (104) to provide stereocontrol at the desired chiral centre. The 
plan was to carry out functional group transformations at both ends simultaneously and 
symmetrically, and then cleave the dimer towards the end of this sequence to produce two 
equivalents of the desired fragment 90 (Scheme 2.7). The acetal formation and the reduction 
of the two esters in 105 were successful. However, this route was quickly abandoned, after 
insufficient stereoselectivity was obtained in propargylzinc addition to 105 to produce 106. The 
best ratio of isomers was reported by Ting as 2:1, but he did not clarify the configuration of the 
isomers. 
Scheme 2.7: Ting’s first attempt to synthesize fragment 90. 
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Ting then resorted to using glycidol (97) as a precursor in the synthesis of fragment 90. The 
propargylic alcohol 107 was successfully made, but attempts to produce the vinyl iodide 108 
following the same carboalumination/iodination procedure as before all failed (Scheme 2.8). 
Brief investigation into variations in temperature, solvent and order of addition did not promote 
the desired carboiodination.  
 
Scheme 2.8: Ting’s attempt to synthesize fragment 108 from 97. 
 
Because of the failed carboalumination-based synthesis of the northern fragment 39 and the 
difficulty in producing the NHK precursor 90, this synthetic plan was abandoned. Modification 
of the northern fragment synthesis to proceed from acrolein (93), and employing asymmetric 
alkynylation in place of the NHK reaction led to the first generation retrosynthesis described 
in this thesis.  
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Chapter 3: First generation and fragment syntheses 
 
3.1 Retrosynthetic analysis 
 
Target compounds of this thesis comprise the natural product (-)-zampanolide (19), the related 
compound (-)-20 and analogues described in chapter 2, which include modifications at the side-
arm, pyran region and the appended methyl groups at C5 and C17 on the macrocycle. Both 
natural and modified synthetic fragments will be needed for the target compounds. Due to the 
structural similarity amongst these compounds, a synthetic plan was developed allowing the 
synthesis of the proposed analogues to be carried out in parallel with the total syntheses of 19. 
A first-generation retrosynthetic analysis is shown in Scheme 3.1. Dactylolide (20) can be 
converted to 19 through an aza-aldol reaction with fragment 45. The major retrosynthetic 
disconnections of the macrocycle are ring-closing metathesis at C8-C9 and esterification at C1, 
leading back to fragments 109 and 39, or the des-methyl analogue fragment 110. 
Scheme 3.1: First generation retrosynthetic analysis. 
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A protecting group strategy was developed to facilitate the synthesis, although it was realized 
that revisions might prove necessary. According to this synthetic plan, the hydroxyl group at 
C19 will be deprotected first in order to perform esterification. The hydroxyl groups at C7 and 
C13 can be deprotected and oxidized simultaneously to provide the C13 keto analogue and the 
natural product 19 in anticipation that the difference in electron deficiency at the two carbonyls 
will allow chemoselective Wittig olefination on the pyranone rather than the α,β-unsaturated 
ketone at C7. Finally, the hydroxyl group at C20 can be deprotected and oxidized to produce 
the aldehyde of 20, and in preparation for the N-acyl hemiaminal synthesis to afford 19.  
However, for the analogue with a hydroxyl group on the pyran motif instead of the methylene, 
the protecting group plan will need to be changed so that the hydroxyl group at C13 is 
deprotected last. In case the chemoselective Wittig reaction alluded to above fails, this can also 
serve as a backup plan for the total synthesis. Therefore, the first hydroxyl protection strategy 
chosen to assist the planned synthesis involved TBS at O7, TBS or methoxymethyl (MOM) at 
O13, para-methoxybenzyl (PMB) at O19 and TBDPS at O20 (Scheme 3.1). 
 
Fragment 109 contains a tetrahydropyran moity, which is a privileged scaffold in natural 
products.1-5 Extensive studies have been done to construct tetrahydropyrans, and the most 
commonly used methods are Prins-type cyclization,6,7 iodoetherification,8 O-Michael 
conjugate addition5,9-12 and metal-catalyzed heterocyclization.13-15 To achieve the 
tetrahydropyran with the required substituents in 109, O-Michael addition, iodoetherification 
or palladium-catalyzed cyclization could be suitable for the current strategy, which leads to 
two related variations of the cyclization precursor, 111 and 112 (Scheme 3.2). Both 
 
Scheme 3.2: Retrosynthetic analysis of the pyran fragment 109. 
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tetrahydropyran precursors 111 and 112 can be synthesized via an asymmetric alkyne addition 
of 113 to aldehydes 114 or 115, followed by either alkyne reduction or reductive methylation 
to afford natural or analogue fragments. 
 
The iodoetherification would need to be accompanied by a two-carbon homologation, such as 
by a Heck reaction in order to establish the terminal alkene required for ring-closing metathesis. 
Such Heck reactions involve the activation of a sp3 carbon by palladium (0), which is known 
to give an unstable intermediate prone to elimination and very few examples of related process 
have been published.16,17 A palladium-catalyzed cyclization could be coupled with a 
carbonylation step, producing intermediate 116 (Scheme 3.3). Upon treatment with methanol, 
116 could be converted to an ester in 117, and the ester functionality can be transformed to an 
alkene in two or three steps.18-20 Palladium-catalyzed reactions are very sensitive to the choice 
of ligands and the catalyst loading, and lengthy optimization may be required. Therefore, the 
more reliable O-Michael addition of 112 will be attempted first. If this route proves 
unsuccessful, iodoetherification and palladium-catalyzed cyclization will be explored using the 
precursor 111.  
Scheme 3.3: Mechanism of the palladium-catalyzed cyclization-carbonylation cascade. 
 
3.2 Proposed synthesis of C1-C8 fragment 
 
Synthesis of the natural and modified variants of the C1-C8 fragment (viz. 39 and 110) was 
proposed to start from acrolein (93) and pass through a Barbier reaction followed by TBS-
protection to provide enyne 118, and the subsequent alkyne substitution with methyl 
chloroformate forming ynoate 119 (Scheme 3.4). From this point, the fragment 39 will be 
achieved by reductive methylation, ester reduction, Wittig olefination and saponification. In 
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the synthesis of the analogue fragment 110, the reductive methylation step will divert to a Z-
selective reduction of alkyne in 119, which will be attempted using the Lindlar hydrogenation.  
Scheme 3.4: Plan for fragments C1-C8 (39 and 110) synthesis. 
 
3.2.1  Synthesis of the natural C1-C8 fragment  
 
The Barbier reaction is often compared to the Grignard reaction, but it offers more advantages 
including wider substrate scope, more reliable preparation, more stable intermediate and milder 
reaction condition.21,22 Initial trials were carried out using commercially available zinc powder 
without activation. Following the reported procedure, in addition to the two equivalents each 
of propargyl bromide and zinc dust employed at the outset of the reaction to react with 
propargyl bromide, another 1 equivalent of zinc dust was added immediately before the 
addition of acrolein.21 The first attempt at the Barbier reaction did not achieve a satisfying 
result and a large amount of diol 120 (46%) was obtained alongside the desired product 94  
(22% yield) (Scheme 3.5). A plausible mechanism was proposed to explain the formation of 
120. The excess zinc or an impurity present in the reaction mixture may have activated the 
terminal alkyne in the zinc alkoxide salt of the intermediate 121 to allow deprotonation by the 
excess propargylzinc bromide, or by proton transfer from alkyne to alkoxide. The resulting 
acetylenic anion 122 could then perform a nucleophilic attack on another molecule of acrolein 
(93), upon protonation of 123 producing the observed diol 120. Due to the fact that acrolein 
(93) was the limiting reagent, the deprotonation of the terminal alkyne must be favored 
kinetically over the desired Barbier pathway. A trial with no additional equivalent of zinc dust 
at later stage of the reaction gave a poor yield (30%) of the product 94 and no by-product 120. 
This result was attributed to incomplete reaction, because activation of the carbonyl by the third 
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equivalent of zinc powder was absent. However, the highly volatile acrolein (93, b.p. 51-53 °C) 
cannot be recovered to support this claim. The Barbier product 94 was also found to be volatile, 
so that exposure to a vacuum, such as by prolonged time on rotary evaporator, can cause loss 
of product.   
Scheme 3.5: Proposed mechanism for the formation of 120 in Barbier reaction. 
 
Attention was turned to combining the Barbier reaction with TBS-protection of the resulting 
alcohol 94. Activated zinc powder was also used. An initial attempt at subjecting the crude 
Barbier product to silyl protection did not succeed. Without purifying the alcohol 94, no TBS-
protection can occur. Next, the product of the Barbier reaction 94 was purified by a short silica 
plug. The elute was not reduced to dryness to avoid loss of 94, which was then subjected to 
TBS-protection. With 2 equivalents of activated zinc dust, a reproducible 61~68% yield of 118 
was obtained over the two-steps. The best yield, 81%, was obtained using a third equivalent of 
activated zinc dust and newly purchased propargyl bromide without purification. The by-
product 120 was not observed, which suggested that the formation of the diol 120 was likely 
to be promoted by impurities present in the commercial zinc dust or propargyl bromide. 
 
The carbonyl necessary for olefination was then established by a nucleophilic substitution of 
methyl chloroformate with alkyne 118, and a reductive methylation using Gilman reagent was 
used to produce the tri-substituted alkene 124 (Scheme 3.6). The use of Gilman reagent in 1,4-
addition to α,β-unsaturated carbonyls is well-precedented.23,24 The Gilman reagent was pre-
formed by treating copper (I) iodide with two equivalents of methyllithium at 0 ºC. A deep red 
colour, indicative of methylcopper (I), gradually developed during the addition of the first 
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equivalent of methyllithium, which then disappeared slowly during the addition of the second 
equivalent, resulting in a colourless solution of the Gilman reagent, Me2CuLi.  The mechanism 
describing the regio-selectivity of the Gilman reagent is postulated to go through a bicyclic 
transition state 125, where the lithium interacts with both the carbonyl oxygen and one of the 
methyl groups on Cu to direct the methyl addition to the γ-position; the following Cu-H 
exchange allowed the cis-selectivity (Scheme 3.6). The cis-configuration in product 124 was 
confirmed by a strong nuclear Overhauser effect spectroscopy (NOESY) correlation between 
the methyl protons Hb and the alpha proton Ha, which indicates a through-space interaction 
between these nuclei and their proximity. The alkyne substitution of 118 with methyl 
chloroformate and the subsequent reductive methylation of 119 both proceeded smoothly when 
good quality n-butyllithium, methyllithium and purified copper (I) iodide25 were used, and high 
yields over the two steps were achieved. 
 
Scheme 3.6: Alkyne homologation and subsequent reductive methylation. 
 
Attempts to reduce the ester 124 to the aldehyde 126 with DIBAL-H were unsuccessful. This 
is always a challenging reaction, as it is very sensitive to temperature and the stability of the 
intermediate (127 in this case) (Scheme 3.7). During the addition of DIBAL-H, the higher 
temperature of the droplets introduced to the cold reaction mixture can result in over-reduction. 
This is especially problematic for α,β-unsaturated esters.26 To avoid over-reduction, 1.05 
equivalent of DIBAL-H was added to a solution of ester 124 at -78 ºC slowly against the inner 
wall of the reaction vessel, but only starting material was recovered. The fact that no aldehyde 
or alcohol was observed at any stage of the reaction suggests that the DIBAL-H was of poor 
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quality. Staged addition of DIBAL-H was then carried out, and the reaction was monitored by 
TLC analysis. No reaction was observed with 1.1 and 2.2 equivalents of DIBAL-H, but when 
3.4 equivalents was added, the over-reduced product 128 was produced exclusively and 
isolated in good yield (85%). The amount of DIBAL-H necessary for reaction was later 
optimized to 2.8 equivalents. Therefore, a two-step reduction-oxidation process was 
undertaken to afford aldehyde 126. 
 
Scheme 3.7: Two-step reduction-oxidation process to aldehyde 126. 
 
Three oxidation methods were scanned for converting alcohol 128 to aldehyde 126: Swern 
oxidation was observed to produce reasonable yields, about 50% with recovered starting 
material, but it was not very reliable; Parikh-Doering oxidation only gave a poor yield of 18%; 
employment of freshly prepared 2-iodoxybenzoic acid (IBX)27 gave the best result. Frigerio 
reported that the purities of IBX prepared from iodobenzoic acid using 1.3 and 3.0 equivalents 
of oxone are ≥ 95% and ≥ 99% respectively.27 It was found that the slight difference in the 
quality of IBX produced in these ways provided very different outcomes in the present work. 
The IBX prepared using 1.3 equivalents of oxone only provided up to 27% yield of 126, while 
the sample made using 3.0 equivalents of oxone resulted in an excellent 82% yield of 126 
(Scheme 3.7). The aldehyde 126 was then subjected to a Wittig reaction with ethyl 
(triphenylphosphoranylidene)acetate to produce dienoate 129 (Scheme 3.8). However, the 
Wittig reaction did not go to completion after 22 hours. The product 129 was contaminated by 
aliphatic compounds and starting material, which gave an estimated yield of 129 about 70%. 
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No further purification was carried out, and the Wittig reaction was not optimized, as a better 
route that bypasses this step was found, which will be discussed in chapter four. 
 
Scheme 3.8:  Wittig reaction in the synthesis of the C1-C8 fragment 129. 
 
3.2.2 Synthesis of the des-methyl C1-C8 analogue fragment 
 
According to the planned synthetic route, preparation of the des-methyl analogue fragment 110 
was initiated by reducing 119 using hydrogen gas in the presence of Lindlar’s catalyst (see 
Scheme 3.4). A sacrificial alkene, 2-methylbut-2-ene, was used to avoid over-reduction of the 
alkenes in 130. However, this reaction did not reach completion, and significant amounts of 
over-reduction ccurred at the terminal alkene (Scheme 3.9). The over-reduced product 131 
(present as 10% of the product mixture) was not separable from the desired product 130 by 
standard column chromatographic methods. Addition of extra portion of the sacrificial alkene 
did not make an improvement, and attempts to continue the reaction to completion resulted in 
20 to 50% of over-reduction at the terminal alkene.  
 
Scheme 3.9: Lindlar reduction of ynoate 119. 
 
This mixture of 130 and 131 was first observed as obscured minor and major multiplets with 
the same splitting pattern at 6.38 and 6.33 ppm in the 1H nuclear magnetic resonance (NMR) 
spectrum, which correspond to β-protons. Only one set of the terminal alkene proton signals 
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(5.81, 5.20, 5.07 ppm) was observed (Figure 3.1). In addition, two sets of carbon signals were 
found for the ester and di-substituted alkene, while only one set of the terminal alkene signals 
was present. A close examination of the 1H NMR spectrum with the assistance of correlation 
spectroscopy (COSY) found that both β-protons correlate to a complex multiplet between 2.76 
and 2.94 ppm, which then correlates to the oxymethine proton signal at 4.29 ppm, as expected, 
as well as an obscured upfield multiplet at about 3.73 ppm (minor). The two corresponding 
oxymethine carbon signals were observed at 72.7 and 72.5 ppm in the 13C NMR spectrum, 
respectively. The significant up-field shift of the oxymethine proton in the minor compound 
indicates that the allylic effect is not present. The structure of the over-reduction product 131 
would agree with this observation. Moreover, the oxymethine proton with chemical shift 
around 3.73 ppm also correlates to an alkyl signal at 1.47 ppm, which accounts for two protons 
of the minor compound. In the 13C NMR spectrum, two distinctive alkyl carbons signals of the 
over-reduced product 131 were found at 29.9 and 9.7 ppm. 
Figure 3.1: 1H NMR spectrum of the mixture containing 130 and the over-reduced 131. 
 
The presence of the over-reduced product 131 and its lack of separation from the desired 
product 130 invoked a need to optimize the Lindlar process. In the hope that the propargylic 
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alcohol would be more electron rich than the conjugated ynoate, thus react significantly faster 
than alkene, the ester 119 was reduced to propargylic alcohol 132 by DIBAL-H prior to Lindlar 
reduction (Scheme 3.10, equation a). This reduction provided 132 in a moderate 50% yield. 
The initial attempt at the Lindlar reaction of 132 found that over-reduction occurred. It was 
thought that the sacrificial alkene 2-methylbut-2-ene could be too volatile (b.p. 36~40 °C) to 
last for the entire four hours reaction, therefore, an additional equivalent must be added during 
the reaction. This approach indeed solved the problem, with 75% yield of 133 obtained and no 
over-reduction (equation a). Experiments to shorten the sequence by installing the alcohol 
functional group directly to alkyne 118 and thus avoiding the ester-reduction step were also 
attempted. The addition of the anion of 118 to paraformaldehyde produced a reasonable 68% 
yield of propargylic alcohol 132 (equation b). Attempts to to shorten the sequence even further 
by formylation of alkyne 118 using dimethylformamide (DMF) only achieved a low 28% yield 
of 134 (equation c). In the hope that the yield could be optimized later, 134 was tested in Lindlar 
reduction, but this resulted in a complex mixture of the desired product, the isomerized E-
alkene, over-reduced product at either one of the two alkenes, as well as doubly over-reduced 
product. In an effort to avoid the reduction-oxidation steps in the sequence leading to the natural 
fragment 126, reductive methylation on 134 was attempted, but only starting material was 
recovered. 
 
Scheme 3.10: Lindlar reduction of alkyne substrates 132 and 134. 
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With the allylic alcohol 133 in hand, its oxidation to aldehyde 135 was performed. Thermal 
isomerization of Z-alkenes to the less strained E-configuration can readily occur for 1,2-
disubstituted alkenes at room temperature, catalyzed by the presence of acid. Hence, low 
temperature, basic oxidation methods like Swern reaction are often used to oxidize Z-allylic 
alcohols. Therefore, Swern oxidation was attempted first in order to minimize the formation of 
136, but no reaction was observed (Table 3.1, entry 1). To facilitate this reaction, freshly 
distilled reagents and additional equivalents of dimethylsulfoxide (DMSO) and oxalyl chloride 
were used, but still no reaction occured. A step-wise elevation of temperature up to room 
temperature resulted in a 1:1 mixture of starting material and decomposed products (entry 2). 
A trace amount of the desired aldehyde 135 was also observed, which was too insignificant for 
isolation and purification. The decomposed products were not characterized, but it is well 
known that the standard sulfonium intermediate can go through an alternative pathway to a 
thioacetal 137 at high temperature, instead of the normal oxidation process.  
Table 3.1: Results for the oxidation of 133.  
 
Entry Conditions 
Obtained ratios of starting material and products 
133 135 136 Decomposition 
1 DMSO, (COCl)2,  
NEt3, -78 °C 
1 - - - 
2 DMSO, (COCl)2, 
NEt3, -78 °C to r.t. 
1 - - 1 
3 Commercially 
available MnO2, r.t. 
1 - - - 
4 Prepared MnO2, 
r.t., 3 ha 
3 2 - - 
5 Prepared MnO2,  
r.t., 5 hb 
 2 1 - 
a The reaction was carried out in air; b The starting material was a 3:2 mixture of 133 and 135. 
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Manganese dioxide provides an oxidation method that is selective for α,β-unsaturated alcohols 
and is known to facilitate oxidation of Z-allylic alcohols without isomerization.28,29 A sample 
of commercial manganese dioxide did not promote any reaction, even after it was activated by 
heating at 130 °C for 18 hours (Table 3.1, entry 3). Freshly prepared manganese dioxide30 (10 
equivalents) was then used. As Gritter and Wallace reported that no difference in oxidation 
facility was observed whether under air or nitrogen atmosphere,31 the first trial with manganese 
dioxide was carried out without an inert atmosphere. This reaction converted about 40% of the 
alcohol 133 to aldehyde 135 after 3 hours, before the MnO2 became appearantly inactivated 
(entry 4). Future reactions involving MnO2 were carried out under an atmosphere of nitrogen 
to prevent inactivation. Encouragingly, the aldehyde product from the above MnO2 oxidation 
exclusively retained the Z-configuration of the precursor alcohol 133. This unpurified mixture 
of 3:2 alcohol:aldehyde was treated with another 10 equivalents of MnO2 and an additional 10 
equivalents were added half-way through the reaction. After 5 hours, all starting material was 
consumed, but the product was obtained as a 7:3 mixture of Z:E-alkenes 135 and 136 (entry 5). 
In the 1H NMR spectrum of the inseperable mixture, the signals for the internal alkene protons 
  
Figure 3.2: The alkene region of the 1H NMR for the mixture of 135 and 136. 
are well-defined, and the vicinal coupling constants were measured as 11.1 and 15.5 Hz for the 
major and minor isomers, respectively, which are the typical values for Z- and E-alkenes 
Internal alkene protons 
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(Figure 3.2). Interestingly, although the oxymethine signal at 4.31 ppm is not differentiated 
for the two compounds, the terminal alkene proton signals at 5.82, 5.23 and 5.12 ppm all had 
slight upfield shifts in the minor E-isomer 136. Thus, weak cross-talk must occur between the 
two alkenes in each compound. 13C and 2D NMR experiments were conducted to assist the 
assignment of 135 and 135. The prolonged reaction time was seen to provide a chance for the 
alkene to isomerize. There was literature precedent that the addition of sodium carbonate to 
neutralize any acid and lowering the reaction temperature to 0 °C can avoid the problem of 
isomerization,32 which can be investigated in future.  
 
Parikh-Doering oxidation has not been a commonly used method for the oxidation of Z-allylic 
alcohols, because it is typically carried out at room temperature, which is prone to cause 
thermal isomerization. However, this method was still tested on a mixture of the alcohols 133 
and 138 produced from DIBAL-H reduction of a 1:1 mixture of 130 and 131 (Scheme 3.11). 
To decrease the chance of isomerization, the reaction was quenched before it reached 
completion. Encouragingly, the product consisted of a 1:1 mixture of the two Z-products, 135 
and 139, and no isomerization was observed. Full NMR data were collected for characterization. 
Due to time constraints, Parikh-Doering oxidation on pure Z-allylic alcohol 133 was not 
performed. 
 
Scheme 3.11: Reduction and oxidation sequence on a 1:1 mixture of 130 and 131. 
 
3.3  Synthesis of C16–C20 fragment 
 
According to the synthetic plan, the protection of the hydroxyl groups was sought with a 
TBDPS ether at C20 (see Scheme 2.2), and glycidol (97) was used as the starting material to 
synthesize the C16-C20 fragment 113. To this end, the protection of 97 to afford 140 proceeded 
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in a consistently good yield (80~84%), as did the epoxide ring-opening with TMS-acetylide to 
afford 141 (70~87% yield) (Scheme 3.12). However, the acetylenic silyl deprotection 
produced an inseparable mixture of too products in a 5:2 ratio. While the TMS signal had 
disappeared, two sets of signals were observed in the oxygenated and propargylic regions of 
the 1H NMR spectrum, and both closely resembled signals expected for the desired product 
142. This mixture was proposed to consist of a 5:2 mixture of desired 142 and its regioisomer 
143. To avoid silyl migration, this sequence was adjusted, such that removal of the acetynlenic 
TMS protecting group could be accomplished after protection of the secondary alcohol in 141, 
ideally as a para-methoxybenzyl (PMB) ether. Despite much effort, protection of the secondary 
alcohol with PMB was futile: both the well-established method using PMB-
trichloroacetimidate33 and a recent acid-catalyzed protection method using PMB-alcohol and 
Amberlyst-1534 only returned starting material. The most common method involving 
deprotonation of alcohol 141 with NaH followed by substitution of PMBCl was also attempted 
but, not surprisingly, silyl-migration occurred under the basic conditions. The NMR evidence 
from the crude reaction mixture suggested that the product was mostly starting material 141 
and the silyl-migrated material 144, together with a small amount of C19-silyl,C20-PMB-
protected product (145). Although this outcome is not desirable, it raised awareness that even
 
Scheme 3.12: The first attempt to synthesize C16-C20 fragment 113. 
with a bulky protecting group such as TBDPS on C19, protection of the primary alcohol at C20 
is still possible.  In contrast, protection of the secondary hydroxyl group in the presence of a 
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bulky C20 protecting group was deemed difficult, because of the higher steric hindrance around 
C19.  
 
The previous findings evoked a new approach to this dual-protecting problem: a so-called 
“stepping stone” approach (Scheme 3.13). From the C20-PMB-protected fragment 146, 
transfer of the PMB group on C20 to C19 via a para-methoxyphenyl (PMP) acetal 147 could 
allow the less hindered primary C20 alcohol in 148 to be protected with a silyl group, and thus 
achieves the sought differential protection. A lot of work has previously been done on the 
regioselective opening of benzylidene acetals.35 The most commonly used DIBAL-H reduction 
method is expected to give the primary alcohol, because aluminum prefers to coordinate with 
the less hindered oxygen of the acetal, which then hydrolyzes during work-up to produce the 
primary alcohol.36-39 There are exceptions to the regioselectivity involving DIBAL-H, mainly 
due to unwanted additional chelation with other groups in those substrates, which should not 
occur with acetal 147.40,41 To test this strategy, fragment 146 was required, which could be 
prepared from glycidol (97) following a similar strategy as for the C20-TBDPS-protected 
fragment 141.  
Scheme 3.13: “Stepping stone” approach to C16-C20 fragment 149. 
 
The first attempt to protect glycidol (97) with commercially available p-methoxybenzyl 
chloride (PMBCl) did not provide any reaction, presumed due to the quality of PMBCl. PMBCl 
can be freshly made from p-methoxybenzyl alcohol, following Luzzio and Chen’s sonication 
method.42 They reported that the quality of the prepared PMBCl was sufficient for use in 
reactions, after a simple separation of the aqueous layer, washing with water and drying with 
calcium chloride. However, the PMBCl prepared in that way also did not promote the desired 
protection, and mixtures of multiple degradation products were obtained, which were 
accompanied by disappearance of the epoxide signals in the 1H NMR spectrum. The 
degradation could be resulted from the residual hydrochloric acid present in the prepared 
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PMBCl. An attempt to neutralize the PMBCl by washing it with an aqueous solution of sodium 
bicarbonate resulted in a mixture of about 1:1 PMBCl and PMBOH. The PMBCl was then 
purified by dilution with diethyl ether, washing thoroughly with large amounts of water, drying 
over calcium chloride and purging under high vacuum. The quality of this prepared PMBCl 
was proved sufficient to be used for protection, with a satisfying 76% yield of the PMB ether 
150 achieved (Scheme 3.14, equation 1). Synthesis of the required PMB ether 149 was also 
attempted by substitution of epichlorohydrin (151) with p-methoxybenzyloxide, or by reaction 
of glycidol (97) with freshly prepared PMB-trichloroacetimidate, but neither reaction provided 
satisfying results and insufficient conversions were obtained (equations 2 and 3). 
 
Scheme 3.14: Synthesis of PMB glycidyl ether 150. 
 
The epoxide opening of 150 by trimethylsilylacetylene was promoted by boron trifluoride 
diethyl etherate (BF3·OEt2). During the early trials, the available BF3·OEt2 had been stored 
under atmospheric condition for over ten years, and it was distilled over calcium hydride prior 
to the reaction. However, the majority of the product obtained using this BF3·OEt2 was the 
PMB-deprotected product 151, which could be due to the presence of a strong acid. It is well 
known that BF3·OEt2 decomposes to a strong acid, tetrafluoroboric acid (BF4H) in the presence 
of water, and it may not be removed fully by distillation.43 With newly purchased BF3·OEt2, 
this reaction went smoothly without any deprotection (73~89% yield of 146), even on a gram 
scale (Scheme 3.15, equation a). The following acetylenic trimethylsilyl (TMS) deprotection 
with potassium carbonate and methanol produced 152 in a good yield. The synthesis of the 
enantiomerically pure fragments (S)-146 and (S)-152 from (R)-glycidol was carried out in the 
same manner and proceeded cleanly with good yields (equation b).  
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Scheme 3.15: Synthesis of the precursor to C16-C20 fragment 146 and 152. 
 
Protection of the secondary alcohol in 152 with TBS was attempted. Not only is TBS less bulky 
than TBDPS and similarly orthogonal to the primary PMB protection at the C20 hydroxyl, the 
resulting product 153 would also offer an alternative route to the C1-C8 fragment 129 (Scheme 
3.16). Although the synthesis of the C1-C8 fragment (129) is efficient and high yielding, the 
starting material acrolein (93) possesses many environmental and safety hazards, and can be 
fatal through inhalation, contact and swallowing. In addition, most chemical suppliers have 
discontinued supply of acrolein (93) because of its toxicity and difficulty to transport. 
Therefore, there may be no long-term, reliable supply of acrolein (93).  Once the dual-protected 
C16-C20 fragment 153 is made, it could be adapted for the C3-C8 fragment (129) in the 
following way: the PMB group on C20 could be selectively deprotected, oxidized and 
olefinated via a Wittig reaction to produce enyne 119, a precursor to the C1-C8 fragment 129 
as established earlier (see Scheme 3.4). However, the silyl protection did not proceed, even 
after 5 hours at 100 °C. The search for an alternative route to fragment 129 continues. 
Scheme 3.16: Alternative synthetic plan for the C1-C8 fragment 129. 
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The “stepping-stone’ strategy for O19 protection was explored using 146 (Scheme 3.17). After 
a 14 h reaction with DDQ at 0 ºC, the oxidative acetal formation did not reach completion, and 
the crude reaction mixture consisted of a 2:2:3 ratio of diastereomers of 147: anisaldehyde: 
starting material 146. The presence of anisaldehyde indicates that this reaction had not been 
kept thoroughly dry, so more care in drying the reagents and glassware was required in future. 
A sample of 147 was isolated as a mixture of disterereomers, as expected, but was contaminated 
with 10 mol% of anisaldehyde.  
 
Scheme 3.17: Attempt to PMB-group transfer from O20 to O19. 
 
The 1H NMR spectrum of the mixture containing 147 diastereomers showed two sets of well-
differentiated peaks for the methine Ha and the oxymethylene protons, Hb in 147 (Figure 3.3). 
Two singlets at 5.91 and 5.76 ppm were observed for the Ha acetal protons of the diastereomers  
Figure 3.3: The 1H NMR spectrum of the mixture containing diasteriomeric 147. 
Ha                      Hb { 
{ 
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of 147, while the oxymethylene protons Hb were in an ABM sysem with the oxymethine 
protons, thus vicinal coupling was observed, and the signals appeared as two pairs. One pair of 
signals have higher chemical shifts at 4.34 and 4.39 ppm, and the other pair was found at 3.90 
and 3.88 ppm.  
 
The mixture containing acetal 147 was subjected to treatment with DIBAL-H to test the 
regioselectivity of the reductive ring-opening (Scheme 3.17). An excess of DIBAL-H (2.5 
equivalents) was used to compensate for the presence of anisaldehyde. After an overnight 
reaction at -19 °C, only the acetal starting material 147 was observed by TLC analysis and 1H 
NMR spectroscopy. Other acetal-opening methods are available for future exploration, for 
example, the lithium aluminum hydride/ trichloroaluminum combination,44 procedures 
involving borane40,45 and other boron-containing reagents46,47. However, a more efficient 
approach that required the C19-hydroxyl to be unprotected was found, and thus effort was 
diverted to the new approach. 
 
3.4  Proposed synthesis of C9-C15 fragment 
 
Synthesis of the two variations of the C9-C15 subunit 115 and 116 (see Scheme 3.2) starts 
from (S)-aspartic acid (154) (Scheme 3.18). Firstly, the epoxide 155 can be formed 
stereoselectively via bromine substitution, reduction, epoxidation formation by intramolecular 
bromohydrin substitution and silyl protection. The preference for the oxirane over oxetane 
dictates exclusive formation of the desired epoxide 155. The epoxide 155 can then be opened 
by the vinyl Grignard reagent, and the resulting alcohol would be protected to afford 156. After 
the initial exploration of this method, a similar sequence was described in Altmann’s 
publication of the total synthesis of (-)-zampanolide for production of the TBDPS equivalent 
of 155, which became the C9-C14 fragment upon construction of the pyran through a Prins 
reaction.48 In the present work, the secondary alcohol in 156 was protected with TBS or MOM 
groups for natural and analogue fragments. After selective deprotection of the silyl ether on the 
primary alcohol and oxidation, the substrate for pyran cyclization via iodoetherification or Pd-
mediated cyclization (114) can be produced. Alternatively, the alkene in 156 can be ozonized 
followed by a Horner-Wadsworth-Emmons reaction to establish the α,β-unsaturated ester 
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required for the O-Michael cyclisation, upon deprotection and oxidation producing fragment 
115. Simplified fragments will also be synthesized to be used in model studies and to produce 
truncated analogues. 
 
Scheme 3.18: Proposed synthesis of C9-C15 fragments 114 and 115.  
 
 
3.4.1  Synthesis of the natural C9-C15 fragment 
 
This route had been explored by former colleague Sam Ting, although different protecting 
groups were planned to accommodate the current synthetic strategy. It proceeded with 
reasonable ease. The bromination to produce 157 is carried out via a Sandmeyer-type 
reaction,49 wherein the amine in 154 is converted to diazonium salt 158 upon treatment with 
acidic sodium nitrite solution.  Neighbouring group participation by the carboxylic acid 
facilitates the dissociation of diazonium in a SN2-type fashion, forming an intermediate lactone 
 65 
 
159. Subsequent ring-opening by the bromide occurs, resulting in the double inversion, thus 
the stereochemistry at C17 is retained (Scheme 3.19).  
Scheme 3.19: Bromination of 154 via Sandmeyer reaction. 
 
This reaction should be maintained below -5 °C, because diazonium salts are very unstable. 
Aromatic diazonium salts have been reported to dissociate to produce the corresponding phenol 
in the presence of acid and H2O if temperature arises.
50,51 A related problem was encountered 
when scaling up the reaction from 10 g of S-aspartic acid to 20 g: an unknown by-product was 
formed. Its presence was first noticed as a yield of over 100%. A closer examination revealed 
two peaks at 5.31 and 2.08 ppm in the 1H NMR spectrum, which are typical chemical shifts for 
an oxymethine proton in an ester and hydroxyl group, respectively (Figure 3.4), or 
alternatively dichloromethane and acetone. Neither of these solvents was used during the 
reaction or work-up, but, regardless, the product was further purged under high vacuum. The 
two signals at 5.31 and 2.08 ppm did not disappear, consistent with them not being due to 
dichloromethane and acetone.  The two peaks may suggest the formation of an alcohol by-
product and esterification with the carboxylic acid. However, the mass spectrum showed a 
second major negative molecular ion at 414.8474 m/z as well as the product, and the isotope 
pattern indicated that it contains two bromines, which suggests instead that dimerization of the 
brominated product 157 or polymerization had occured. However, no obvious polymerization 
products with the above characteristics match the molecular weight. Even though it seems a 
minor impurity, its presence interferes with the subsequent reduction reaction, resulting in 
reduced yields and product contaminated by inseparable impurities. A small amount of the 
contaminated sample of 157 was recrystallized from water to produce non-transparent crystals, 
but this did not make an improvement in subsequent reactivity.  
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Figure 3.4: 1H NMR and mass spectra of the unknown by-product from large-scale 
bromination. 
 
The borane reduction of 157 to afford 160 was initially difficult to handle. Following the 
literature work-up,52 the reaction mixture turned into a hard gel upon warming to room 
temperature, even after quenching. This may have resulted from a borane-THF complexation 
or THF polymerization, but neither could be confirmed. Initially the reaction produced 
unsatisfyingly low yields. An attempt to switch the solvent from THF to toluene totally 
quenched the reactivity of borane and starting material was recovered. After more experiments 
the best yield (75%) was achieved with a Rochelle salt quench at 0 ºC, slowly warming up to 
room temperature over an hour and vigorous stirring for a prolonged time (Scheme 3.20). The 
following one-pot epoxide formation and silyl protection to 155 is a very reliable reaction, and 
the epoxide opening with vinylmagnesium bromide also reached good yields when purified 
CuI and newly purchased Grignard reagent were used. According to the current protecting 
group strategy, this secondary alcohol in 156 was protected with TBS to afford bis-silylated 
product 161 with a 72% yield. 
Signals of the desired 
product 157 
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Scheme 3.20: Synthesis of C9-C15 fragment precursor 161.  
 
Deprotection of the TES ether in 161 with HF·Py to 162 was initially quite low yielding despite 
running the reaction overnight (Scheme 3.21). It was speculated that the prolonged reaction 
time promoted double deprotection to the diol 163, and that shorter reaction times could avoid 
all or the majority of TES-deprotection. It was also found that the dryness of acetonitrile is 
essential. When analytical grade acetonitrile was used, both silyl groups were fully deprotected 
and either or both of the alcohols were found to be acetylated, producing inseparable mixtures 
of 164, 165 and 166 in a ratio of 7:2:1, respectively. No direct acetylation source had been 
present. 
Scheme 3.21: Deprotection of TES ether in 161 with HF·Py. 
 
This puzzling phenomenon could be explained by an attack of the alcohol functionalities in 
doubly deprotected 163 on acetonitrile to produce an imine, which is then hydrolyzed in the 
presence of water to produce the acetates 164, 165 and 166 (Scheme 3.22, mechanism I). This 
is only possible if the acetonitrile was protonated by HF in the presence of H2O to become a 
better electrophile. Another possible mechanism was considered based on an observation 
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reported in 1970 by J. R. Norell. In that work, it was shown that hydrogen fluoride can 
fluorinate terminal alkenes at ambient temperatures (25~40°C), and the resulting fluoride reacts 
with acetonitrile in the presence of water to produce N-alkyl acetamides.53 With this 
information, the acetyl may be sourced from the amide in 167 (Mechanism II). However, even 
though acetyl transfer to the secondary alcohol via a six-membered transition state is possible, 
the acetyl transfer to the primary alcohol via an eight-membered ring could be very difficult. 
In addition, to restore the terminal alkene, amine elimination must occur, which is highly 
unlikely under the reaction conditions.  
 
Scheme 3.22: Possible mechanisms for acetylation. 
 
Current PhD student Sophie Geyrhofer confirmed the double deprotection of 161 to afford 163 
occurs in overnight reactions, and successfully produced the TES-deprotected product 162 with 
a 61% yield after a 3 h reaction at 0 ºC. Even with the short reaction time, 20% of the doubly 
deprotected diol 163 was also isolated, thus further optimization of this reaction is required. 
However, the synthetic strategy has been altered, and the TES protection was retained until a 
later stage. 
 
3.4.2  Synthesis of C9-C15 analogue fragments  
 
One aim of this project is to find simplified analogues of zampanolide (19) that can be 
synthesized by shorter sequences than for the natural product. As removal of the exo-methylene 
was found to be beneficial to retain the cytotoxicity,48,54 the use of 5-hexenal (168) as an 
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analogue fragment of C9-C16 was proposed, which avoids the lengthy process required to 
synthesize C9-C15 fragment (115). A good number of literature sources reported that 168 
would be easily accessed by oxidation of the cheap and readily available 5-hexenol (169), and 
various oxidation methods could be used (Scheme 3.23).55-58 
 
Scheme 3.23: Planned preparation of 5-hexenal (168) via oxidation. 
 
Parikh-Doering oxidation was first attempted. By 1H NMR spectroscopy, the crude mixture 
contained almost exclusively the desired aldehyde 168 and pyridinium compound. However, 
during column chromatography, the purified product decomposed. The 1H NMR spectrum 
showed that nearly all aldehyde signals vanished and a new oxymethine signal appeared, which 
suggested that the aldehyde 168 might have polymerized. No effort was put towards the 
characterization of this product. Some fractions containing 168 was collected, but it was always 
contaminated by impurities. Preparation of 5-hexenal (168) was then attempted by using 
pyridinium chlorochromate (PCC). Attempts to purify the crude product with a Celite plug 
resulted in unsatisfying purification, and a silica plug again decomposed the desired 168. 
However, the aldehyde functionality was conserved this time. This product was characterized, 
and identified as the dimerized product 170. It is commonly known that aldehydes can dimerize 
via aldol reactions (Scheme 3.24), where the enol formation can be promoted by the presence 
of acid or base.  
 
Scheme 3.24: Dimerization of 5-hexenal (168) via aldol reaction. 
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The dimerized product 170 was never obtained in pure form, but NMR, HRMS and IR evidence 
all support the assignment of the dimer structure.  Interestingly the 1H NMR spectrum of 170 
shows the signals at 2.45 and 4.07 ppm as triplets (Figure 3.5), which are the protons α- and 
β- to the aldehyde (H2, H3) respectively. The coupling constants indicate that there is no vicinal 
coupling between aldehyde and α-protons or α- and β-protons. According to the Karplus 
equation, vicinal coupling constant is proportional to cos2θ, where θ is the dihedral angel. Thus, 
it can be assumed that free rotation is hindered and the α-proton must be approximately 
perpendicularly oriented to both aldehyde proton and β-proton.   
Figure 3.5: 1H NMR spectrum of the dimerized aldehyde product 170.  
 
To have such geometry, hydrogen bonding between the hydroxy and aldehyde together with 
the steric hindrance of the long chains may be constraining 170 in a rigid six-membered ring 
such that there are ca. 90° angles between H1, H2 and H3. The Newman projection of (2R,3S)-
170 is shown in Figure 3.6 for demonstration. 
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Figure 3.6: Proposed conformation of the dimerized product 170 based on proton coupling. 
 
It was hypothesized that aldehyde 168 could be unstable in contact with the acidic silica or 
upon concentration. Swern oxidation of 5-hexenol (169) produced the cleanest sample of crude 
product 168, which was hoped would allow purification without silica. After washing the 
reaction mixture thoroughly with water, the only contaminant left was triethylamine (Et3N). 
However, the further attempt to remove Et3N by washing with aqueous potassium bisulfate 
(KHSO4) solution caused decomposition, and the aldehyde signal vanished on 
1H NMR 
spectrum. TEMPO/BAIB oxidation was also attempted. Theoretically, upon full conversion, 
the reaction mixture would contain mostly high boiling point species, and the relatively lower 
boiling point compounds would be the desired product 168 (128~129 °C)59 and a low boiling 
solvent such as dichloromethane. Therefore, purification would be possible by distilling the 
reaction mixture to yield a solution of 5-hexenal (168) in dichloromethane. Vacuum distillation 
was initially investigated and yielded a dichloromethane solution of 168 enriched with 
iodobenzene. Atmospheric pressure distillation after dissolving the crude reaction mixture in 
diethyl ether indeed removed iodobenzene, but dimerization still occurred in the solution. 
Therefore, it is concluded that 5-hexenal (168) spontaneously dimerizes in pure form. A 
commercial source was also considered, but 168 is only available via custom synthesis, which 
is too expensive for this project. A careful review of the literature found that this aldehyde 
product 168 was often used without purification,60-63 but this is not an option for this project. 
The intended use of 168 is in a metal-promoted alkynylation reaction and such reactions are 
often very sensitive to impurities. Therefore, this model substrate was abandoned. Similar 
experiments to carry the C9-C15 fragment 162 to the aldehyde 114 were done by current PhD 
student Sophie Geyrhofer (Scheme 3.25). She found that the oxidation of TES-deprotected 
product 162 does not stop at the aldehyde, but demonstrated a high propensity to carry on to 
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the acid 171. Various oxidation conditions were tested, including Dess-Martin periodinane, 
IBX, Swern, and TEMPO/BAIB oxidations. 
 
Scheme 3.25: Geyrhofer’s oxidation of alcohol 162. 
 
From the findings of both the model and real fragments, it was hypothesized that the terminal 
alkene might be interfering with the oxidation, thus the aldehyde should be formed in the 
absence of a terminal alkene. As described before, the fragment required for O-Michael 
addition (115) contains an α,β-unsaturated ester instead of the terminal alkene, thus the 
synthesis of fragment 115 could be explored (see Scheme 3.18). Alternatively, the alkene in 
161 can be ozonized to produce the aldehyde 172, and the C11 silyl ether can be cleaved after 
asymmetric alkynylation and protection of the resulting propargylic alcohol (Scheme 3.26). 
The primary alcohol is then revealed ready for oxidation to produce aldehyde 173. A TES-
protection can be used for the propargylic alcohol, as the primary TES ether can be deprotected 
selectively over the secondary, and TES is partially orthogonal to TBS for later transformations. 
The 173 can be transformed via a Horner-Wadsworth-Emmons reaction to afford the α,β-
unsaturated methyl ester 174, set up for O-Michael addition, or via a Wittig reaction to produce 
the precursor 175 for iodoetherification or Pd-catalyzed cyclization. The terminal alkene 175 
could alternatively be subjected to cross metathesis with methyl acrylate to afford 174 or RCM 
to form 176, precursor to a truncated monocyclic analogue.  
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Scheme 3.26: Alternative synthetic strategy for pyran fragment 174 and 175. 
 
A simple model aldehyde 177 was prepared in two steps via silyl protection of 5-hexenol (169) 
followed by ozonolysis. With only an aqueous work-up after the protection step, a good 95% 
yield of 177 was obtained over the two steps. 
 
Scheme 3.27: Synthesis of model fragment 117. 
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3.5  Experimental data 
General experimental information 
Unless otherwise stated, all reactions were carried out in oven-dried glassware under a positive 
pressure of nitrogen, delivered via a manifold, or argon from a balloon. Dry tetrahydrofuran, 
dichloromethane and toluene were obtained from a PureSolv MD 5 solvent purification system 
(Innovative Technology). Dry dimethylformamide was purchased from Acros and used 
without further purification. DMSO, triethylamine and oxalyl chloride were purified by 
distillation with calcium hydride as drying agent.  Analytical grade solvents were used for 
aqueous work-up and column chromatography (petroleum ether, ethyl acetate, diethyl ether, 
dichloromethane and methanol). Column chromatography was performed on silica gel 60Å 
(Pure Science, 40–63 micron) with the eluent mixtures as stated in the corresponding 
procedures. Thin-layer chromatography was performed on silica-coated plastic plates 
(Macherey-Nagel, POLYGRAM® Sil G/UV254). UV-active compounds were detected under 
UV irradiation (λ = 254 nm), while non-UV-active compounds were visualised with 
anisaldehyde or potassium permanganate staining solutions.  
PMBCl was prepared freshly using the previously reported method.42 All other chemicals were 
purchased from Pure Science, Sigma-Aldrich, AK Scientific, Acros, Merck, British Drug 
House, Burkes Research, Thermo Fisher Scientific, Avocado, Panreac Riedel-de Haën and 
Apollo. Infra-red (IR) spectra were collected from liquid films on a Perkin Elmer Spectrum 
One FT-IR spectrometer or neat sample on an ALPHA FT-IR spectrometer (Bruker) fitted with 
attenuated total reflectance (ATR). The intensities of signals are defined as: br = broad, s = 
strong, m = medium, w = weak. Mass spectra were collected on an Agilent 6530 Accurate-
Mass Q-TOF LC/MS high-resolution mass spectrometer (HRMS). The specific rotations were 
collected on an AUTOPOL II automatic polarimeter (Rudolph Research Analytical), and the 
reported values are an average of 10 measurements and concentrations are reported in g/100 
mL. 
Nuclear magnetic resonance (NMR) spectra were obtained in deuterated chloroform (CDCl3) 
or deuterium oxide (D2O) using Varian Inova instruments operating at 300 or 500 MHz for 
proton and 75 or 125 MHz for carbon. Proton and carbon chemical shifts are reported in parts 
per million (ppm) relative to residual CHCl3 [δ(1H) = 7.26 ppm], H2O [δ(1H) = 4.66 ppm], and 
CDCl3 [δ(13C) = 77.0 ppm], respectively. Signals are defined as: s = singlet, d = doublet, t = 
triplet, q = quartet, quin = quintet, m = multiplet, app. = apparent, obs. = obscured peak, br. = 
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broad.  Coupling constants (J) are reported in Hertz (Hz). Assignments were determined by 
two-dimensional NMR experiments (COSY, NOESY, HSQC and HMBC). 
CuI purification: 
To a boiling aqueous solution of NaI (7.0 g, 47 mmol) in H2O (5 mL, 9 M), CuI (1.00 g, 5.26 
mmol) was added portionwise over 45 min. The solution progressively turned red with each 
addition. The solution was cooled down to r.t., and then 0 °C. H2O was added to precipitate out 
CuI. The precipitate was filtered, washed with H2O, ethanol, EtOAc, Et2O and petroleum ether 
successively. The solid was further dried under high vacuum to yield CuI as a pale-pink powder 
(811 mg). 
Activation of zinc powder: 
To a suspension of zinc powder (3.1 g, 47 mmol) in H2O (10 mL), an aqueous HCl solution 
(0.3 mL, 4 M) was added dropwise with shaking until the release of small gas bubbles was 
observed. The activated zinc powder was filtered, washed sequentially with H2O, MeOH, 
EtOAc, Et2O and petroleum ether, and dried under high vacuum to yield a pale grey powder 
(3.0 g). 
 
Synthesis of C3-C8 fragment 
(Hex-1-en-5-yn-3-yloxy)tert-butyldimethylsilane (118)  
To a suspension of activated zinc powder (982 mg, 15.0 mmol) in THF 
(25 mL), a propargyl bromide solution (1.8 mL, 80 % w/w in toluene, 16 
mmol) was added dropwise. The reaction mixture was stirred at r.t. for 1 h 30 min. After the 
addition of further equivalent of activated zinc powder (410 mg, 6.27 mmol), the reaction was 
cooled down to -78 °C.  A solution of acrolein (93) (0.50 mL, 7.5 mmol) in THF (4.2 mL) was 
added dropwise at -78 °C. The reaction mixture was stirred at -78 °C for 1 h and at r.t. for 2 h. 
The reaction was quenched with sat. aq. NH4Cl (20 mL) and filtered through a Celite pad. The 
filtrate was extracted with Et2O (3×50 mL). The organic layers were combined, dried over 
MgSO4, filtered and concentrated under reduced pressure. The yellow oil obtained was purified 
by column chromatography (silica, 3:1 Pet. ether/EtOAc, Rf = 0.27). The relevant fractions 
were partially concentrated to yield a solution of the desired intermediate alcohol in EtOAc. 
This mixture was combined with imidazole (620 mg, 9.11 mmol) and dissolved in DMF (9.0 
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mL). After cooling down to 0 °C, a solution of TBSCl (1.32 g, 6.27 mmol) in DMF (9.0 mL) 
was added dropwise. The reaction was stirred at r.t. for 14 h, then diluted with Et2O (50 mL), 
washed with H2O (3×50 mL) and brine (50 mL), dried over MgSO4, filtered and concentrated 
under reduced pressure. This crude product was purified by column chromatography (silica, 
10:1 Pet. ether/EtOAc, Rf = 0.80) to yield 118 as a colourless oil (1.28 g, 81% yield).  
1H NMR (500 MHz, CDCl3): δ 5.92 (ddd, J = 16.8, 10.8, 5.6 Hz, 1H, 2-CH), 5.26 (d, J = 17.1 
Hz, 1H, one of 1-CH2), 5.12 (d, J = 10.5 Hz, 1H, one of 1-CH2), 4.27 (app. q, J = 5.6 Hz, 1H, 
3-CH), 2.42 (ddd, J = 16.6, 6.1, 2.9 Hz, 1H, one of 4-CH2), 2.33 (ddd, J = 16.6, 7.1, 2.4 Hz, 
1H, one of 4-CH2), 1.99 ( t, J = 2.6 Hz, 1H, 6-CH), 0.91 (s, 9H, tBu, TBS), 0.10 (s, 3H, Me, 
TBS), 0.07 (s, 3H, Me, TBS).  
13C NMR (125 MHz, CDCl3): δ 139.9 (CH, C2), 114.7 (CH2, C1), 81.3 (C, C5), 72.2 (CH, 
C3), 69.9 (CH, C6), 28.3 (CH2, C4), 25.8 (CH3, tBu, TBS), 18.2 (C, tBu, TBS), -4.6 (CH3, Me, 
TBS), -4.9 (CH3, Me, TBS).  
These data were consistent with those reported previously.64 
 
Methyl 5-tert-butyldimethylsilyloxy-6-hepten-2-ynoate (119)  
To a solution of terminal alkyne 118 (905 mg, 4.30 mmol) in THF (43 
mL) at -78 °C, nBuLi (2.6 mL, 1.8 M in cyclohexane, 4.68 mmol) was 
added dropwise.  The reaction was stirred at -78 °C for 40 min. Methyl 
chloroformate (8.60 mmol, 0.66 mL) was added dropwise. After stirring for 2 h 30 min at -
78°C, the reaction was quenched with sat. aq. NH4Cl (30 mL) and warmed up to r.t. The 
aqueous layer was separated and extracted with Et2O (3 × 30 mL).  The organic layers were 
combined, dried over MgSO4, filtered and concentrated under reduced pressure. This crude 
product was purified by column chromatography (silica, 30:1 Pet. ether/EtOAc, Rf = 0.16) to 
yield the title compound 119 as a pale oil (875 mg, 76%).  
1H NMR (500 MHz, CDCl3): δ 5.87 (ddd, J = 16.7, 10.7, 5.9 Hz,  1H, 6-CH), 5.27 (d, J = 17.1 
Hz, 1H, one of 7-CH2), 5.14 (d, J = 10.5 Hz, 1H, one of 7-CH2), 4.32 (app. q, J = 6.3 Hz, 1H, 
5-CH), 3.76 (s, 3H, CH3, OMe), 2.55 (dd, J = 16.9, 6.3 Hz, 1H, one of 4-CH2), 2.47 (dd, J = 
16.9, 6.3 Hz, 1H, one of 4-CH2), 0.90 (s, 9H, tBu, TBS), 0.10 (s, 3H, Me, TBS), 0.06 (s, 3H, 
Me, TBS). 
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13C NMR (125 MHz, CDCl3): δ 154.1 (C, C1), 139.4 (CH, C6), 115.4 (CH2, C7), 110.0 (C, 
C3), 86.5 (C, C2), 71.5 (CH, C5), 52.6 (CH3, OMe), 28.6 (CH2, C4), 25.7 (CH3, tBu, TBS), 
18.2 (C, tBu, TBS), -4.6 (CH3, Me, TBS), -5.0 (CH3, Me, TBS). 
IR (neat) cm-1: 2954 (m, C–H), 2930 (m, C–H), 2857 (m, C–H), 2241 (m, C≡C), 1716 (s, C=O), 
1248 (s, C–O), 1073 (s, C–H), 930 (s, C–Si), 836 (s, C–Si), 777 (s, C–Si). 
HRMS (ESI) m/z: found 286.1837, calcd for C14H28O3SiN [M+NH4]
+ 286.1833 (Δ = 2.1 ppm). 
 
(2Z)-Methyl 5-(tert-butyldimethylsilyloxy)-3-methyl-2,6-heptadienoate (125)  
To a suspension of CuI (641 mg, 3.37 mmol) in THF (14 mL) at 0 °C, 
MeLi was added dropwise (2.4 mL, 2.8 M in Et2O, 8.4 mmol). After 
stirring at 0 °C for 45 min, a solution of the ynoate 120 (600 mg, 2.24 
mmol) in THF (3.2 mL) was added dropwise at -78 °C. The reaction 
mixture was stirred at -78 °C for 3 h. The reaction was quenched with sat. aq. NH4Cl (30 mL) 
and warmed up to r.t. The aqueous layer was separated and extracted with Et2O (3 × 50 mL). 
The organic layers were combined, dried over MgSO4, filtered and concentrated concentrated 
under reduced pressure. This crude product was purified by column chromatography (silica, 
36:1 Pet. ether/ Et2O, Rf = 0.22) to yield 125 as a yellow oil (620 mg, 97% yield).  
1H NMR (500 MHz, CDCl3): δ 5.86 (ddd, J = 16.4, 10.5, 5.9 Hz, 1H, 6-CH), 5.73 (s, 1H, 2-
CH), 5.20 (d, J = 17.1 Hz, 1H, one of 7-CH2), 5.03 (d, J = 10.3 Hz, 1H, one of 7-CH2), 4.42 
(m, 1H, 5-CH), 3.68 (s, 3H, CH3, OMe), 2.88 (dd, J = 12.2, 4.6 Hz, 1H, one of 4-CH2), 2.71 
(dd, J = 12.6, 7.9 Hz, 1H, one of 4-CH2), 1.95 (s, 3H, 8-CH3), 0.88 (s, 9H, tBu, TBS), 0.01 (s, 
6H, Me, TBS). 
13C NMR (125 MHz, CDCl3): δ 166.7 (C, C1), 158.4 (C, C3), 141.3 (CH, C6), 116.9 (CH, C2), 
113.7 (CH2, C7), 73.6 (CH, C5), 50.8 (CH3, OMe), 41.9 (CH2, C4), 27.5 (CH3, C8), 25.9 (CH3, 
tBu, TBS), 18.1 (C, tBu, TBS), -4.5 (CH3, Me, TBS), -4.9 (CH3, Me, TBS). 
IR (neat) cm-1: 2952 (m, C–H), 2929 (m, C–H), 2857 (m, C–H), 1718 (s, C=O), 1645 (m, C=C), 
1251 (s, C–O), 1196 (s, C–H), 1027 (s, C–H), 834 (s, C–Si), 775 (s, C–Si).  
HRMS (ESI) m/z: found 285.1869, calcd for C15H32O3SiN [M+NH4]
+ 285.1880 (Δ = 3.9 ppm). 
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(2Z)-3-Methyl-5-(tert-butyldimethylsilyloxy)hepta-2,6-dien-1-ol (128)  
To a solution of the ester 125 (306 mg, 1.08 mmol) in CH2Cl2 (10.5 mL, 
0.10 M) at -78 °C, a solution of DIBAl-H (3.5 mL, 1.0 M in THF, 3.5 
mmol) was added dropwise. The reaction was stirred at -78 °C for 30 
min, followed by 0 °C for 30 min and r.t. for 30 min. It was then 
quenched with a sat. aq. solution of Rochelle’s salt (15 mL) and stirred vigorously for 1 h. The 
mixture was extracted with CH2Cl2 (3 × 15 mL). The organic layers were combined and dried 
over MgSO4 and concentrated under reduced pressure. This crude product was purified by 
column chromatography (silica, 5:1 Pet. ether/EtOAc, Rf = 0.41) to yield the product 128 as a 
yellow oil (229 mg, 85% yield).  
1H NMR (500 MHz, CDCl3): δ 5.83 (ddd, J = 17.0, 10.5, 6.6 Hz, 1H, 6-CH), 5.65 (t, J = 7.1 
Hz, 1H, 2-CH), 5.17 (dd, J = 17.3, 1.2 Hz, 1H, one of 7-CH2), 5.06 (dd, J = 10.3, 1.0 Hz, 1H, 
one of 7-CH2), 4.25 (m, 1H, 5-CH), 4.19 (m, 1H, one of 1-CH2), 4.00 (app. dt, J = 12.1, 6.5 
Hz, 1H, one of 1-CH2), 2.51 (dd, J = 13.3, 8.7 Hz, 1H, one of 4-CH2), 2.10 (dd, J = 13.4, 4.6 
Hz, 1H, one of 4-CH2), 1.96 (t, J = 5.4 Hz, 1H, OH), 1.78 (s, 3H, 8-CH3), 0.89 (s, 9H, tBu), 
0.05 (s, 3H, Me), 0.05 (s, 3H, Me). 
13C NMR (125 MHz, CDCl3): δ 141.4 (CH, C6), 136.8 (C, C3), 127.1 (CH, C2), 114.1 (CH2, 
C7), 72.1 (CH, C5), 58.6 (CH2, C1), 41.0 (CH2, C4), 25.9 (CH3, tBu), 23.9 (CH3, C8), 18.3 (C, 
tBu), -4.5 (CH3, Me), -4.7 (CH3, Me). 
IR (film from CH2Cl2) cm
-1: 3410 (br, O–H), 2956 (s, C–H), 2930 (s, C–H), 2886 (s, C–H), 
2857 (s, C–H), 1678 (s, C=C), 1472 (m, C–H), 1253 (s, C–O), 937 (s, C–H), 8345 (s, C–Si), 
776 (s, C–Si).  
HRMS (ESI) m/z: found 279.1756, calcd for C14H28O2SiNa [M+Na]
+ 279.1756 (Δ = 0.0 ppm). 
NOESY(600 MHz, CDCl3):  
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(2Z)-3-Methyl-5-(tert-butyldimethylsilyloxy)hepta-2,6-dienal (126)  
 To a solution of the alcohol 128 (374 mg, 1.46 mmol) in DMSO (2.5 mL, 
0.58 M) at r.t., a solution of IBX (1.23 g, 4.37 mmol) in DMSO (18.8 mL) 
was added dropwise. After stirring at r.t. for 17 h, EtOAc (20 mL) was 
added to the reaction mixture to precipitate out IBX. The mixture was 
filtered through Celite, and the filtrate was concentrated under reduced pressure. This crude 
product was purified by column chromatography (silica, 20:1 Pet. ether/ EtOAc, Rf = 0.38) to 
yield the aldehyde 126 as a colourless oil (306 mg, 82% yield).  
1H NMR (500 MHz, CDCl3): δ 9.90 (d, J = 8.1 Hz, 1H, 1-CH), 5.96 (d, J = 7.7 Hz, 1H, 2-CH), 
5.83 (dddd, J = 17.9, 10.3, 6.4, 2.1 Hz, 1H, 6-CH), 5.22 (d, J = 17.3 Hz, 1H, one of 7-CH2), 
5.11 (d, J = 10.5 Hz, 1H, one of 7-CH2), 4.32 (m, 1H, 5-CH), 2.91 (ddd, J = 13.0, 8.2, 1.5 Hz, 
1H, one of 4-CH2), 2.54 (ddd, J = 13.1, 4.3, 1.3 Hz, 1H, one of 4-CH2), 2.02 (s, 3H, 8-CH3), 
0.86 (s, 9H, tBu), 0.02 (s, 3H, Me), 0.01 (s, 3H, Me). 
13C NMR (125 MHz, CDCl3): δ 191.5 (CH, C1), 159.8 (C, C3), 140.6 (CH, C6), 130.4 (CH, 
C2), 114.9 (CH2, C7), 72.6 (CH, C5), 41.5 (CH2, C4), 26.1 (CH3, C8), 25.8 (CH3, tBu), 18.1 
(C, tBu), -4.5 (CH3, Me), -4.9 (CH3, Me). 
IR (neat) cm-1: 2956 (m, C–H), 2930 (m, C–H), 2857 (m, C–H), 1676 (s, C=O), 1631 (w, C=C), 
1609 (w, C=C), 1073 (s, C–O), 835 (s, C–Si), 775 (s, C–Si). 
HRMS (ESI) m/z: found 255.1776, calcd for C14H27O2Si [M+H]
+ 255.1775 (Δ = 0.4 ppm). 
NOESY (600 MHz, CDCl3):  
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Mixture of (2Z)-methyl 5-(tert-butyldimethylsilyloxy)-2,6-heptadienoate (130) and (2Z)-
methyl 5-(tert-butyldimethylsilyloxy)-2-heptenoate (131) (3:2) 
To a solution of 119 (50 mg, 0.186 mmol) and 
Lindlar’s catalyst (10 mg) in EtOAc (1.3 mL, 0.14 M), 
was added 2-methylbutene (0.13 mL). H2 gas was 
bubbled through the solution for 2 h. The reaction mixture was filtered through a Celite pad, 
and rinsed with CH2Cl2. The filtrate was concentrated under reduced pressure. This crude 
product was purified by column chromatography (silica, 95:5 Pet. ether/EtOAc, Rf = 0.55) to 
yield 130 in a mixture with 40% of 131 (34 mg, 68% combined yield).  
1H NMR (500 MHz, CDCl3) δ 6.39 (dt, J = 11.4, 7.2 Hz, 0.4H, 3-CH-131), 6.33 (dt, J = 11.6, 
7.2 Hz, 0.6H, 3-CH-130), 5.85 (d, J = 11.7 Hz, 1H, 2-CH), 5.80 (ddd, J = 11.7, 10.5, 5.6 Hz, 
0.6H, 6-CH-130), 5.21 (dd, J = 17.1, 1.4 Hz, 0.6H, one of 7-CH2-130), 5.07 (dd, J = 10.4, 1.3 
Hz, 0.6H, one of 7-CH2-130), 4.29 (app. q, J = 5.6 Hz, 0.6H, 5-CH-130), 3.79–3.64 (obs. m, 
0.4H, 5-CH-131), 3.71 (s, 3H, CH3, OMe), 2.95–2.76 (complex m, 2H, 4-CH2), 1.47 (app. quin, 
J = 7.3 Hz, 0.8H, 6-CH2-131), 0.91–0.86 (complex m, 10.2H, CH3, tBu-TBS and 7-CH3-131), 
0.05 (s, 2.4H, CH3, Me, TBS-131), 0.043 (obs. s, 1.8H, CH3, Me, TBS-130), 0.041 (obs. s, 
1.8H, CH3, Me, TBS-130). 
13C NMR (126 MHz, CDCl3) δ 166.7 (C, C1), 147.3 (CH, C3-131), 146.4 (CH, C3-130), 140.7 
(CH, C6-130), 120.5 (CH, C2-130), 120.2 (CH, C2-131), 114.2 (CH2, C7-130), 72.7 (CH, C5-
131), 72.5 (CH, C5-130), 67.9 (CH3, OMe), 51.98 (), 51.95 (), 37.1 (CH2, C4-130), 35.9 (CH2, 
C4-131), 29.9 (CH2, C6-131), 25.83 (CH3, tBu, TBS), 25.77 (CH3, tBu, TBS), 18.2 (C, tBu, 
TBS), 18.1 (C, tBu, TBS), 9.7 (CH3, C7-131), -4.54 (CH3, Me, TBS), -4.56 (CH3, Me, TBS), -
4.6 (CH3, Me, TBS), -4.9 (CH3, Me, TBS). 
 
5-(tert-Butyldimethylsilyloxy)-6-hepten-2-yn-1-ol (132)  
To a solution of ester 119 (100 mg, 0.475 mmol) in THF (1.0 mL, 0.5 
M) at -78 ºC, nBuLi (0.36 mL, 2.0 M in THF, 0.71 mmol) was added 
dropwise. After stirring at -78 ºC for 35 min, paraformaldehyde (29 mg, 
0.95 mmol) was added, and the mixture was warmed to r.t. and stirred for 20 h. The reaction 
was quenched with sat. aq. NH4Cl solution (10 mL), and extracted with Et2O (2 × 10 mL). The 
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organic layers were combined, dried over MgSO4 and concentrated under reduced pressure. 
This crude product was purified by column chromatography (silica, 5:1 Pet. ether/EtOAc, Rf = 
0.35) to yield 132 as a colourless oil (77 mg, 68% yield).  
1H NMR (500 MHz, CDCl3): δ 5.91 (ddd, J = 16.3, 10.4, 5.5 Hz, 1H, 6-CH), 5.25 (d, J = 17.1 
Hz, 1H, one of 7-CH2), 5.11 (d, J = 10.4 Hz, 1H, one of 7-CH2), 4.28–4.22 (complex m, 3H, 
1-CH2 and 5-CH), 2.45 (dd, J = 16.5, 6.3 Hz, 1H, one of 4-CH2), 2.36 (dd, J = 16.5, 6.7 Hz, 
1H, one of 4-CH2), 1.54 (t, J = 5.5 Hz, 1H, OH), 0.91 (s, 9H, tBu, TBS), 0.09 (s, 3H, CH3, Me, 
TBS), 0.07 (s, 3H, CH3, Me, TBS). 
13C NMR (125 MHz, CDCl3) δ 140.0 (CH, C6), 114.6 (C, C7), 83.3 (C, C3), 80.0 (C, C2), 
72.3 (CH, C5), 51.4 (CH2, C1), 28.6 (CH2, C4), 25.8 (CH3, tBu, TBS), 18.3 (C, tBu), -4.6 (CH3, 
Me), -4.9 (CH3, Me).  
HRMS (ESI) m/z: found 258.1884, calcd for C13H28O2SiN [M+NH4]
+ 258.1884 (Δ = 0.0 ppm).  
 
2E-5-(tert-Butyldimethylsilyloxy)hepta-2,6-dien-1-ol (133)  
To a solution of 132 (24 mg, 0.099 mmol) and Lindlar’s catalyst (6 mg) 
in EtOAc (0.9 mL, 0.11 M), was added 2-methylbutene (0.08 mL). H2 
gas was bubbled through the solution for 6 h, with another portion of 2-
methylbutene (0.08 mL) added at 2 h. The reaction mixture was filtered through a Celite pad, 
and rinsed with CH2Cl2. The filtrate was concentrated under reduced pressure to yield 133 as 
a colourless oil (18 mg, 75% yield). 
1H NMR (500 MHz, CDCl3): δ 5.82 (partially obs. ddd, J = 16.9, 10.5, 6.1 Hz, 1H, 6-CH), 
5.77 (partially obs. dt, J = 11.4, 6.9 Hz, 1H, 2-CH), 5.59 (dt, J = 11.0, 7.5 Hz, 1H, 3-CH), 5.17 
(d, J = 17.1 Hz, 1H, one of 7-CH2), 5.07 (d, J = 10.3 Hz, 1H, one of 7-CH2), 4.21–4.07 (complex 
m, 3H, 1-CH2 & 5-CH), 2.37 (dt, J = 13.9, 7.8 Hz, 1H, one of 4-CH2), 2.27 (m, 1H, one of 4-
CH2), 1.62 (t, J = 5.6 Hz, 1H, OH), 0.90 (s, 9H, CH3, tBu, TBS), 0.06 (s, 3H, CH3, Me, TBS), 
0.05 (s, 3H, CH3, Me, TBS).  
13C NMR (125 MHz, CDCl3): δ 141.0 (CH, C6), 130.7 (CH, C2), 128.8 (CH, C3), 114.2 (CH2, 
C7), 73.2 (CH, C5), 58.5 (CH2, C1), 36.3 (CH2, C4), 25.9 (CH3, tBu, TBS), 18.3 (C, tBu, TBS), 
-4.5 (CH3, Me, TBS), -4.7 (CH3, Me, TBS).  
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IR (ATR) cm-1: 3355 (br, O–H), 2931 (m, C–H), 2858 (m, C–H), 1462 (w, C–H), 1252 (m, C–
O), 1026 (s, C–O), 834 (s, C–Si), 775 (s, C–Si).  
HRMS (ESI) m/z: found 243.1777, calcd for C13H27O2Si [M+H]
+ 243.1775 (Δ = 0.8 ppm).  
 
Mixture of (2Z)-5-(tert-butyldimethylsilyloxy)hepta-2,6-dienal (135) and (2E) 5-(tert-
butyldimethylsilyloxy)hepta-2,6-dienal (136) (7:3) 
To a solution of 133 (18 mg, 0.074 mmol) in 
CH2Cl2 (0.7 mL, 0.01 M), freshly prepared MnO2 
(116 mg, 0.74 mmol) was added. After 7 h, the 
reaction mixture was filtered, and the filtrate was 
concentrated to yield a mixture of 3:2 s.m.:desired Z-product. This mixture was dissolved in 
CH2Cl2 (0.5 mL), and MnO2 (147 mg, 0.93 mmol) was added. After 3 h, additional MnO2 (102 
mg, 0.65 mmol) was added, and the reaction was stirred for a further 2 h 30 min. The reaction 
mixture was filtered, and the filtrate was concentrated to yield a colorless oil. This crude 
product was purified by column chromatography (silica, 10:1 Pet. ether/EtOAc, Rf = 0.39) to 
yield a mixture of 7:3 135:136 as a colourless oil (9 mg, 50% combined yield).  
1H NMR (500 MHz, CDCl3) δ 10.03 (d, J = 8.0 Hz, 0.7H, 1-CH-135), 9.50 (d, J = 7.9 Hz, 
0.3H, 1-CH-136), 6.84 (dt, J = 15.8, 7.6 Hz, 0.3H, 3-CH-136), 6.68 (dt, J = 11.3, 8.1 Hz, 0.7H, 
3-CH-135), 6.14 (dd, J = 15.7, 7.9 Hz, 0.3H, 2-CH-136), 6.05 (ddt, J = 11.0, 8.1, 1.4 Hz, 0.7H, 
2-CH-135), 5.82 (dd, J = 17.0, 10.4, 6.1 Hz, 0.7H, 6-CH-135), 5.85–5.77 (obs. m, 0.3H, 6-CH-
136), 5.24 (dt, J = 17.1, 1.3 Hz, 0.7H, one of 7-CH2-135), 5.23 (dt, J = 17.1, 1.3 Hz, 0.3H, one 
of 7-CH2-136), 5.12 (dt, J = 10.3, 1.2 Hz, 0.7H, one of 7-CH2-135), 5.11 (dt, J = 10.4, 1.2 Hz, 
0.3H, one of 7-CH2-136), 4.31 (app. q, J = 5.9 Hz, 1H, 5-CH), 2.88–2.73 (complex m, 1.4H, 
4-CH2-135), 2.54 (app. ddt, J = 7.2, 5.7, 1.4 Hz, 0.6H, 4-CH2-136), 0.89 (s, 2.7H, CH3, tBu, 
TBS-136), 0.89 (s, 6.3H, CH3, tBu, TBS-135), 0.06 (s, 0.9H, CH3, Me, TBS-136), 0.05 (s, 2.1H, 
CH3, Me, TBS-135), 0.04 (s, 3H, CH3, Me, TBS-135 and TBS-136). 
13C NMR (126 MHz, CDCl3) δ 193.9 (C, C1-136), 191.2  (C, C1-135), 154.6 (CH, C3-136), 
148.7 (CH, C3-135), 140.14 (CH, C6-136), 140.09 (CH, C6-135),  134.9 (CH, C2-136), 131.7 
(CH, C2-135), 131.50, 115.1 (CH2, C7-135), 115.0 (CH2, C7-136),  72.4 (CH, C5-135), 72.3 
(CH, C5-136), 41.3 (CH2, C4-136), 36.4 (CH2, C4-135), 25.77 (CH3, tBu, TBS), 25.76 (CH3, 
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tBu, TBS), 18.2 (C, tBu, TBS), -4.4 (CH3, Me, TBS), -4.5 (CH3, Me, TBS), -4.87 (CH3, Me, 
TBS), -4.91 (CH3, Me, TBS). 
 
Synthesis of C16–C20 fragment 
2-(tert-Butyldiphenylsilyloxy)methyloxirane (140)  
To a solution of glycidol (97, 116 mg, 1.56 mmol) and imidazole (138 mg, 2.03 
mmol) in DMF (2.2 mL, 0.71 M) at 0 °C, TBDPSCl (0.47 mL, 1.8 mmol) was 
added dropwise. After stirring at r.t. for 3 h 30 min, the reaction mixture was 
quenched with H2O (10 mL) and diluted with Et2O (15 mL). The organic layer was separated 
and washed sequentially with saturated aqueous NaHCO3 solution (2 × 15 mL), H2O (15 mL), 
brine (15 mL), and then dried over MgSO4, filtered and concentrated under reduced pressure. 
This crude product was purified by column chromatography (silica, 50:1 Pet. ether/EtOAc, Rf 
= 0.18) to yield 140 as a colourless oil (396 mg, 84%).  
1H NMR (500 MHz, CDCl3): δ 7.71–7.67 (complex m, 4H, CH, Ph, TBDPS), 7.46–7.37 
(complex m, 6H, CH, Ph, TBDPS), 3.85 (dd, J = 11.7, 3.2 Hz, 1H, one of 1-CH2), 3.71 (dd, J 
= 11.8, 4.8 Hz, 1H, one of 1-CH2), 3.14 (m, 1H, 2-CH), 2.75 (t, J = 4.6 Hz, 1H, one of 3-CH2), 
2.62 (dd, J = 5.1, 2.7 Hz, 1H, one of 3-CH2), 1.06 (s, 9H, CH3, tBu, TBDPS).  
13C NMR (126 MHz, CDCl3): δ = 135.61 (CH, Ph), 135.55 (CH, Ph), 133.26 (C, Ph), 133.24 
(C, Ph), 129.74 (CH, Ph), 129.73 (CH, Ph), 127.72 (CH, Ph), 127.71 (CH, Ph), 64.3 (CH2, C1), 
52.3 (CH, C2), 44.5 (CH2, C3), 26.7 (CH3, tBu), 19.2 (C, tBu).  
These data matched those reported previously.65 
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1-(tert-Butyldiphenylsilyloxy)-5-trimethylsilyl-4-pentyn-2-ol (141) 
To a solution of ethynyltrimethylsilane (375 mg, 3.82 mmol) in THF (12.7 
mL, 0.30 M) at -78 °C, was added dropwise a solution of nBuLi (2.0 mL, 
1.9 M in cyclohexane, 3.8 mmol). The reaction mixture was stirred at -78 °C 
for 50 min, before BF3·Et2O (0.48 mL, 3.81 mmol) was added dropwise. 
After 10 min stirring, a solution of epoxide 140 (991 mg, 3.17 mmol) in THF (4.0 mL, 0.79 M) 
was added dropwise. The reaction was stirred at -78°C for 2 h 40 min, and then quenched with 
saturated aqueous NH4Cl (15 mL), and extracted with Et2O (3 × 40 mL). The organic layers 
were combined, dried over MgSO4, filtered and concentrated under reduced pressure. This 
crude product was purified by column chromatography (silica, 20:1 Pet. ether/EtOAc, Rf = 
0.23) to yield 141 a pale yellow oil (1.18 g, 91%).  
1H NMR (500 MHz, CDCl3): δ 7.71–7.67 (complex m, 4H, CH, Ph, TBDPS), 7.44 (t, J = 7.2 
Hz, 2H, CH, Ph, TBDPS), 7.41 (t, J = 7.2 Hz, 4H, CH, Ph, TBDPS), 3.88 (m, 1H, 2-CH), 3.76 
(dd, J = 10.1, 4.3 Hz, 1H, one of 1-CH2), 3.69 (dd, J = 10.0, 5.9 Hz, 1H, one of 1-CH2), 2.54 
(dd, J = 16.9, 6.3 Hz, 1H, one of 3-CH2), 2.51 (dd, J = 17.3, 6.7 Hz, 1H, one of 3-CH2), 1.07 
(s, 9H, CH3, tBu, TBDPS), 0.11 (s, 9H, CH3, TMS).  
13C NMR (125 MHz, CDCl3): δ 135.52 (CH, Ph, TBDPS), 135.51 (CH, Ph, TBDPS), 133.05 
(C, Ph, TBDPS), 133.03 (C, Ph, TBDPS), 129.84 (CH, Ph, TBDPS), 129.83 (CH, Ph, TBDPS), 
127.8 (CH, Ph, TBDPS), 102.6 (C, C4), 87.1 (C, C5), 70.2 (CH2, C1), 66.4 (CH, C2), 26.9 
(CH3, tBu, TBDPS), 24.7 (CH2, C3), 19.3 (C, tBu, TBDPS), 0.03 (CH3, TMS).  
These data matched those reported previously.66 
 
(S)-2-(para-Methoxybenzyl)methyloxirane (150) 
To a suspension of NaH (725 mg, 60% w/w in mineral oil, 18.1 mmol) 
in DMF (11.0 mL, 1.6 M) at -70 °C, a solution of (S)-glycidol (97, 
1.0 mL, 1.11 g, 14.8 mmol) in DMF (5.5 mL, 2.7 M) was added 
dropwise. The mixture was stirred for 30 min. PMBCl (2.87 g, 18.3 
mmol, freshly prepared from PMBOH) was added dropwise, followed by TBAI (6 mg, 0.02 
mmol). The reaction was stirred for 25 min at -70 °C before warming to r.t., and stirred for 5 h 
25 min. Reaction was quenched with H2O (40 mL), and then extracted with Et2O (3 × 50 mL). 
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The organic layers were combined, dried over MgSO4 and concentrated under reduced pressure. 
The crude product was purified by column chromatography (silica, 10:1 Pet. ether/EtOAc, Rf 
= 0.14) to yield 150 as a colourless oil (2.60 g, 89%).  
1H NMR (500 MHz, CDCl3): δ 7.28 (d, J = 9.3 Hz, 2H, 6-CH), 6.89 (d, J = 8.5 Hz, 2H, 7-CH), 
4.55 (d, J = 11.5 Hz, 1H, one of CH2, 4-CH2), 4.49 (d, J = 11.5 Hz, 1H, one of 4-CH2), 3.81 (s, 
3H, 9-CH3), 3.73 (dd, J = 11.4, 3.1 Hz, 1H, one of 2-CH2), 3.42 (dd, J = 11.5, 5.9 Hz, 1H, one 
of 2-CH2), 3.18 (ddt, J = 5.9, 4.1, 2.9 Hz, 1H, 1-CH), 2.80 (dd, J = 5.0, 4.3 Hz, 1H, one of 3-
CH2), 2.61 (dd, J = 5.1, 2.7 Hz, 1H, one of 3-CH2).  
13C NMR (125 MHz, CDCl3): δ 159.3 (C, C8), 129.9 (C, C5), 129.4 (CH, C6), 113.8 (CH, C7), 
73.0 (CH2, C4), 70.5 (CH2, C1), 55.3 (CH3, C9), 50.9 (CH, C2), 44.4 (CH2, C3).  
Specific rotation: [𝑎]𝐷
25 = -1.04 (c = 1.34, CH2Cl2). Lit.: [𝑎]𝐷
24 = -5.98 (c = 0.98, CHCl3).
54 
These NMR data matched those reported previously.54  
 
(S)-1-(para-Methoxybenzyl)oxy-5-trimethylsilyl-4-pentyn-2-ol (146) 
To a solution of ethynyltrimethylsilane (0.87 mL, 609 mg, 
6.20 mmol) in THF (20.0 mL, 0.31 M) at -78 °C, nBuLi (3.2 
mL, 1.9 M in cyclohexane, 6.18 mmol) was added dropwise. 
This solution was stirred for 50 min. BF3·Et2O (0.78 mL, 
6.18 mmol) was added dropwise. After 10 min, a solution of 
151 (1.01 g, 5.20 mmol) in THF (5.0 mL, 1.0 M) was added dropwise. The reaction was stirred 
for 3 h 15 min at -78 °C. The reaction was quenched with sat. aq. NH4Cl solution, and then 
extracted with EtOAc (3 × 30 mL). The organic layers were combined, dried over MgSO4 and 
concentrated under reduced pressure. The crude product was purified by column 
chromatography (silica, 5:1 Pet. ether/EtOAc, Rf = 0.38) to yield 146 as a pale yellow oil (1.08 
g, 72%).  
1H NMR (500 MHz, CDCl3): δ 7.27 (d, J = 8.7 Hz, 2H, 8-CH), 6.89 (d, J = 8.8 Hz, 2H, 9-CH), 
4.51 (s, 2H, 6-CH2), 3.98–3.91 (m, 1H, 2-CH), 3.81 (s, 3H, 11-CH3), 3.58 (dd, J = 9.6, 3.9 Hz, 
1H, one of 1-CH2), 3.47 (dd, J = 9.8, 6.5 Hz, 1H, one of 1-CH2), 2.51 (dd, J = 16.8, 6.0 Hz, 1H, 
one of 3-CH2), 2.46 (dd, J = 16.8, 6.8 Hz, 1H, one of 3-CH2), 2.42 (d, J = 4.1 Hz, 1H, OH), 
0.14 (s, 9H, CH3, TMS). 
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13C NMR (125 MHz, CDCl3): δ 159.3 (C, C10), 129.9 (C, C7), 129.4 (CH, C8), 113.8 (CH, 
C9), 102.5 (C, C4), 87.3 (C, C5), 73.1 (CH2, C6), 72.4 (CH2, C1), 68.8 (CH, C2), 55.3 (CH3, 
C11), 25.0 (CH2, C3), 0.03 (CH3, TMS). 
IR (neat) cm-1: 3433 (br, OH), 2956 (m, C–H), 2921 (m, C–H), 2836 (m, C–H), 2179 (m, C≡C), 
1612 (m, Ar C–C), 1247 (s, C–O), 1073 (br, C–O), 1033 (s, C–O), 839 (s, C–Si), 739 (m, C–
H). 
HRMS (ESI) m/z: found 293.1571, calcd for C16H25O3Si [M+H]
+ 293.1567 (Δ = 1.4 ppm). 
Specific rotation: [𝑎]𝐷
22 = +13.9 (c = 1.14, CH2Cl2).  
Only 1H NMR data was reported previously, and the above 1H NMR data matched those 
reported previously.67 
 
(S)-1-(para-Methoxybenzyl)oxy-4-pentyn-2-ol (152) 
To a solution of 146 (114 mg, 0.390 mmol) in MeOH (2.6 mL, 
0.15 M) at r.t., K2CO3 (26 mg, 1.95 mmol) was added. After 4 h 
30 min of stirring, reaction was diluted with H2O and extracted 
with Et2O (3 × 40 mL). The organic layers were combined, dried 
over MgSO4 and concentrated under reduced pressure. The crude 
product was purified by column chromatography (silica, 5:1 Pet. ether/EtOAc, followed by 1:1 
Pet. ether/EtOAc, Rf = 0.10 in 5:1 Pet. ether/EtOAc) to yield 152 as a colourless oil (64 mg, 
74%).  
1H NMR (500 MHz, CDCl3): δ 7.27 (d, J = 8.1 Hz, 2H, 8-CH), 6.89 (d, J = 8.3 Hz, 2H, 9-CH), 
4.51 (s, 2H, 6-CH2), 3.97 (m, 1H, 2-CH), 3.81 (s, 3H, 11-CH3), 3.59 (dd, J = 9.5, 3.7 Hz, 1H, 
one of 1-CH2), 3.48 (dd, J = 9.4, 6.7 Hz, 1H, one of 1-CH2), 2.51 (br. d, J = 6.2 Hz, 2H, 3-
CH2), 2.47 (d, J = 4.9 Hz, 1H, OH), 2.03 (br. s,  1H, 5-CH). 
13C NMR (125 MHz, CDCl3): δ 159.3 (C, C10), 129.9 (C, C7), 129.4 (CH, C8), 113.9 (CH, 
C9), 80.2 (C, C4), 73.1 (CH2, C6), 72.5 (CH2, C1), 70.6 (CH, C5), 68.7 (CH, C2), 55.3 (CH3, 
C11), 23.5 (CH2, C3). 
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IR (neat) cm-1: 3436 (br, OH), 3289 (m, C–H), 2911 (m, C–H), 2863 (m, C–H), 2180 (w, C≡C), 
1612 (m, Ar C–C), 1245 (s, C–O), 1078 (m, C–O), 1031 (s, C–O), 817 (m, C–H), 638 (m, C–
H). 
HRMS (ESI) m/z: found 243.1000, calcd for C13H16O3Na [M+Na]
+ 243.0992 (Δ = 3.3 ppm). 
Specific rotation: [𝑎]𝐷
23 = +6.32 (c = 0.64, CH2Cl2).  
 
Fragment C9-C15 
(S)-Bromosuccinic acid (157) 
A solution of (S)-sspartic acid (154, 10.0 g, 75.1 mmol) and potassium 
bromide (40.7 g, 342 mmol) in sulfuric acid (195 mL, 2.5 M in H2O) was 
cooled down to -10 °C. A solution of sodium nitrite (9.25 g, 134 mmol) in 
water (17.8 mL, 7.54 M) was added slowly over 50 min, at such a rate to keep the temperature 
between -10 and -5 °C. The fumes generated in the reaction were neutralized in a gas trap 
containing NaOH aqueous solution before releasing in the fumehood. The reaction was stirred 
at -10 °C for 2 h, and white precipitate was observed. The reaction mixture was warmed to r.t. 
and extracted with EtOAc (3 × 100 mL). The organic layers were combined, dried over MgSO4 
and concentrated under reduced pressure. The product obtained was further dried under high 
vacuum to yield 157 as a white powder (12.5 g, 84% yield).  
1H NMR (500 MHz, D2O): δ 4.53 (dd, J = 7.9, 6.5 Hz, 1H, 2-CH), 3.11 (dd, J = 17.5, 7.8 Hz, 
1H, one of 3-CH2), 2.99 (dd, J = 17.5, 6.5 Hz, 1H, one of 3-CH2).  
13C NMR (125 MHz, D2O): δ 173.8 (C, C4), 172.9 (C, C1), 39.3(CH2, C3), 39.0 (CH, C2).  
IR (neat): 3009 (br, O–H), 2646 (br, C–H), 1702 (s, C=O), 1420 (s, C–H), 1306 (m, C–H), 
1185 (s, C–O), 934 (s, O–H), 648 (s, C–Br) cm-1.  
HRMS (ESI) m/z: found 194.9292, calcd for C4H4O4Br
79 [M-H]- 194.9298 (Δ = 3.1 ppm).   
M.p.: 169.4 – 170.8 °C (Lit. 166 – 167 °C).  
Specific rotation: [𝑎]𝐷
27 = -41.8 (c = 1.11, H2O).  
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These NMR data are consistent with those reported in MeOH-d4, and the IR and m.p. 
matched those reported previously.68 
 
(S)-2-Bromobutane-1,4-diol (160) 
To a solution of (S)-bromosuccinic acid (157, 3.83 g, 19.4 mmol) in THF 
(23.0 mL, 0.84 M) at 0 °C, BH3•Me2S (29.1 mL, 2.0 M in THF, 58.2 mmol) 
was added drop-wise over 1 h 15 min. This reaction was stirred at 0 °C for 
1 h, and then slowly warmed to r.t. over 20 min. A saturated aqueous solution of K2CO3 (10 
mL) was added dropwise, at a rate that allowed the vigorous gas release to settle after each 
addition. This mixture was filtered through Celite and the filtrate was concentrated. The crude 
product was purified by column chromatography (silica, 50:1 EtOAc:MeOH, Rf =  0.44) to 
yield 160 as a  colourless clear oil (2.47 g, 75% yield). 
1H NMR (500 MHz, CDCl3): δ 4.37 (app. dt, J = 12.9, 5.6 Hz, 1H, 2-CH), 3.95–3.80 (complex 
m, 4H, 1-CH2 & 4-CH2), 2.68 (br., 2H, OH), 2.21–2.07 (m, 2H, 3-CH2).   
13C NMR (125 MHz, CDCl3): δ 67.1 (CH2, C4), 60.1 (CH2, C1), 55.2 (CH, C2), 37.7 (CH2, 
C3).  
IR (neat) cm-1: 3315 (br, O–H), 2932 (w, C–H), 2885 (w, C–H), 1420 (m, C–H), 1377 (w, C–
H), 1051 (s, C–O), 1022 (s, C–O), 639 (m, C–Br), 533 (m, C–Br).  
Specific rotation: [𝑎]𝐷
25 = -32.8 (c = 1.00, CH2Cl2).  
These data matched those reported previously.54,52 
 
(R)-Triethyl-3-(oxiranyl)ethoxysilane (155) 
To a suspension of NaH (1.77 g, 60% w/w in mineral oil, 44.3 mmol) in 
THF (20 mL) at -15 °C under N2 atm.,  a solution of  (S)-2-bromobutane-
1,4-diol (160, 2.47 g, 14.6 mmol) in THF (20 mL, 0.71 M) was added dropwise over 45 min. 
After stirring at temperatures between -9 and -15 °C for 30 min, chlorotriethylsilane (2.25 mL, 
17.5 mmol) was added dropwise via a syringe, and THF (1.0 mL) was used to rinse the syringe. 
The reaction mixture was allowed to warm to r.t. over 10 min. After stirring at r.t. for 1 h, the 
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reaction was slowly quenched with sat. aq. NH4Cl solution (30 mL), and a minimum amount 
of H2O was added to dissolve any precipitate. The mixture was extracted with EtOAc (3 × 50 
mL). The organic layers were combined, dried over MgSO4 and concentrated under reduced 
pressure. The crude product was purified by column chromatography (silica, 5:1 Pet. 
ether:EtOAc, Rf =  0.69) to yield 155 as a  colourless clear oil (2.08 g, 70% yield).  
1H NMR (500 MHz, CDCl3): δ 3.78 (t, J = 6.0 Hz, 2H, 1-CH2), 3.06 (m, 1H, 3-CH), 2.79 (app. 
t, J = 4.6 Hz, 1H, one of 4-CH2), 2.52 (dd, J = 5.1, 2.7 Hz, 1H, one of 4-CH2),  1.81 (dtd, J = 
13.9, 7.0, 5.0 Hz, 1H, one of 2-CH2),  1.71 (app. dq, J = 13.9, 5.9 Hz, 1H, one of 2-CH2),  0.97 
(t, J = 8.1 Hz, 9H, CH3, TES), 0.61 (q, J = 8.1 Hz, 6H, CH2, TES).   
13C NMR (125 MHz, CDCl3): δ 59.7 (CH2, C1), 50.0 (CH, C3), 47.2 (CH2, C4), 35.9 (CH2, 
C2), 6.7 (CH3, TES), 4.4 (CH2, TES).  
IR (neat) cm-1: 2954 (m, C–H), 2913 (m, C–H), 2876 (m, C–H), 1459 (m, C–H), 1414 (m, C–
H), 1238 (m, epoxide), 1096 (s, C–O), 1039 (s, C–O), 765 (m, epoxide), 727 (s, O–Si).  
HRMS (ESI) m/z: found 241.1025, calcd for C10H22O2SiK [M+K]
+ 241.1021 (Δ = 1.7 ppm).  
Specific rotation: [𝑎]𝐷
25 = +1.35 (c = 1.06, CH2Cl2).  
 
(S)-Triethyl-(3-hydroxy)hex-5-enoxysilane (156) 
A mixture of purified CuI (147 mg, 0.772 mmol) and vinyl magnesium 
bromide (15.4 mL, 1.0 M in THF, 15.4 mmol) was stirred at -78 °C for 
10 min, then a solution of 155 (1.56 g, 7.71 mmol) in THF was added 
dropwise. This reaction was stirred for 2 h, and slowly warmed to -50 °C. A sat. aq. NH4Cl 
solution (30 mL) was added to quench the reaction, followed by H2O (10 mL) and aqueous 
ammonia solution (5 mL, 35% w/w), and the mixture was stirred at r.t. for a further 10 min. 
The mixture was extracted with EtOAc (2 × 30 mL). The organic layers were combined, dried 
over MgSO4 and concentrated under reduced pressure. This crude product was purified by 
column chromatography (SiO2, 2:1 Pet. ether:EtOAc, Rf = 0.66) to yield 156 as a clear oil (1.67 
g, 94% yield).  
1H NMR (500 MHz, CDCl3): δ 5.85 (ddt, J = 15.6, 8.8, 8.5 Hz, 1H, 5-CH), 5.11 (d, J = 15.6 
Hz, 1H, one of 6-CH2), 5.08 (d, J = 9.4 Hz, 1H, one of 6-CH2), 3.94–3.87 (complex m, 2H, 3-
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CH and one of 1-CH2), 3.87–3.78 (m, 1H, one of 1-CH2), 3.47 (d, J = 1.7 Hz, OH), 2.33–2.18 
(m, 2H, 4-CH2), 1.68 (app. q, J = 5.4 Hz, 2H, 2-CH2), 0.96 (t, J = 7.9 Hz, 9H, CH3, TES), 0.62 
(q, J = 7.9 Hz, 6H, CH2, TES). 
13C NMR (125 MHz, CDCl3): δ 135.0 (CH, C5), 117.3 (CH2, C6), 71.3 (CH, C1), 62.3 (CH2, 
C3), 42.0 (CH2, C4), 37.7 (CH2, C2), 6.7 (CH3, TES), 4.2 (CH2, TES).  
IR (neat) cm-1: 3440 (br, O–H), 3077 (w, C–H), 2954 (s, C–H), 2912 (s, C–H), 2876 (s, C–H), 
1641 (w, C=C), 1414 (m, C–H), 1239 (m, C–H), 1085 (s, C–O), 743 (s, O–Si). 
HRMS (ESI) m/z: found 231.1770, calcd for C12H27O2Si [M+H]
+ 231.1775 (Δ = 2.2 ppm). 
Specific rotation: [𝑎]𝐷
20 = -9.03 (c = 1.20, CH2Cl2). 
 
(S)-1-Triethylsilyloxy-3-(t-butyldimethylsilyloxy)hex-5-ene (161) 
To a solution of imidazole (629 mg, 9.24 mmol) and 156 (1.07 g, 4.64 
mmol) in DMF (9.3 mL, 0.50 M) at 0 ºC, a solution of TBSCl (1.09 g, 
7.23 mmol) in DMF (8.5 mL, 0.9 M) was added dropwise. The reaction 
temperature was brought up to r.t. and stirred for 21 h. The reaction mixture was then diluted 
with EtOAc (30 mL) and washed with H2O (30 mL). The aqueous layer was extracted with 
EtOAc (2 × 30 mL). The organic layers were combined, washed with H2O (30 mL) and brine 
(2 × 30 mL), dried over MgSO4 and concentrated under reduced pressure. The crude product 
was purified by column chromatography (SiO2, 20:1 Pet. ether:EtOAc, Rf = 0.56) to yield 161 
as a clear oil (1.16 g, 72% yield). 
1H NMR (500 MHz, CDCl3): δ 5.88–5.76 (m, 1H, 5-CH), 5.04 (d, J = 16.6 Hz, 1H, one of 6-
CH2), 5.03 (d, J = 11.0 Hz, 1H, one of 6-CH2), 3.87 (tt, J = 12.5, 6.4 Hz, 1H, 3-CH), 3.72–3.61 
(m, 2H, 1-CH2), 2.32–2.15 (m, 2H, 4-CH2), 1.73–1.60 (m, 2H, 2-CH2), 0.96 (t, J = 7.9 Hz, 9H, 
CH3, TES), 0.89 (s, 9H, CH3, TBS), 0.60 (q, J = 7.8 Hz, 6H, CH3, TES), 0.05 (s, 3H, CH3, 
TBS), 0.04 (s, 3H, CH3, TBS). 
13C NMR (125 MHz, CDCl3): δ 135.1 (CH, C5), 116.8 (CH2, C6), 69.0 (CH, C3), 59.6 (CH2, 
C1), 42.2 (CH2, C4), 39.8 (CH2, C2), 25.9 (CH3, tBu, TBS), 18.1 (C, tBu, TBS), 6.8 (CH3, 
TES), 4.4 (CH2, TES), -4.7 (CH3, Me, TBS), -5.3 (CH3, Me, TBS). 
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IR (neat) cm-1: 3077 (w, C–H), 2954 (s, C–H), 2877 (s, C–H), 1641 (w, C=C), 1471 (m, C–H), 
1415 (m, C–H), 1253 (m, C–H), 1089 (s, C–O), 834 (s, O–Si), 773 (s, O–Si), 725 (s, O–Si). 
HRMS (ESI) m/z: found 345.2643, calcd for C18H41O2Si2 [M+H]
+ 345.2640 (Δ = 0.9 ppm). 
Specific rotation: [𝑎]𝐷
22 = +12.0 (c = 0.87, CH2Cl2). 
 
2-(But-3′-enyl)-3-hydroxyoct-7-enal (170, Characterized from a mixture with unidentified 
by-product)  
 
1H NMR (500 MHz, CDCl3): δ 9.78 (d, J = 1.2 Hz, 1H, 1-CH), 5.85–5.72 (complex m, 2H, 7-
CH & 3′-CH), 5.07–4.92 (complex m, 4H, 8-CH2 & 4′-CH2), 4.07 (t, J = 6.6 Hz, 1H, 3-CH), 
2.45 (t, J = 7.3 Hz, 1H, 2-CH), 2.14–2.04 (complex m, 4H, 6-CH2 & 2′-CH2), 1.74 (partially 
obs. dt, J = 7.3, 7.0 Hz, 2H, 1′-CH2), 1.64 (app. quin, J = 7.2 Hz, 2H, 4-CH2), 1.64 (app. quin, 
J = 7.6 Hz, 2H, 5-CH2).  
13C NMR (125 MHz, CDCl3): δ 202.5 (CH, C1), 138.3 (C, C7), 137.5 (C, C3′), 115.6 (CH2, 
C8), 114.8 (CH2, C4′), 64.2 (CH, C3), 43.1 (CH, C2), 33.06 (CH2, C6), 33.00 (CH2, C2′), 28.1 
(CH2, C4), 25.2 (CH2, C5), 21.2 (CH2, C1′). 
IR (neat) cm-1: 3437 (br, O–H), 3077 (w, C–H), 2933 (s, C–H), 2862 (m, C–H), 1735 (s, C=O), 
1440 (s, C-H), 1244 (s, C–O), 1170 (s, C–O), 909 (s, C–H). 
HRMS (ESI) m/z: found 197.1536, calcd for C12H21O2 [M+H]
+ 197.1536 (Δ = 0.0 ppm). 
 
5-(t-Butyldimethylsilyloxy)pentanal (177) 
To a solution of 5-hexenol (169, 508 mg, 5.08 mmol) and imidazole (419 mg, 
6.16 mmol) in DMF (5.0 mL, 1.0 M) at 0 ºC, a solution of TBSCl (937 mg, 
6.22 mmol) in DMF (5.0 mL, 1.2 M) was added dropwise. The reaction was stirred at 0 ºC for 
10 min, then warmed to r.t. and stirred for 16 h. The reaction mixture was diluted with EtOAc 
(30 mL) and washed with H2O (30 mL). The aqueous layer was extracted with EtOAc (2 × 30 
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mL). The organic layers were combined, dried over MgSO4 and concentrated under reduced 
pressure. The crude mixture was filtered through a silica plug (5:1 Pet. Ether:EtOAc). The 
filtrate was concentrated to yield the TBS ether. The product was dissolved in CH2Cl2 (25 mL), 
and cooled down to -78 ºC. Ozone gas was passed through the reaction until the solution turned 
pale blue. Triphenylphosphine (1.56 g, 5.74 mmol) was added, and the blue colour disappeared. 
The reaction was allowed to warm to room temperature and stirred overnight. The solvent was 
removed and the oil obtained was purified by column chromatography (SiO2, 10:1 Pet. 
ether:EtOAc, Rf = 0.38) to yield 177 a clear colourless oil (1.05 g, 95% yield). 
1H NMR (500 MHz, CDCl3): δ 9.76 (t, J = 1.6 Hz, 1H, 1-CH), 3.62 (t, J = 6.2 Hz, 2H, 5-CH2), 
2.45 (td, J = 7.3, 1.6 Hz, 2H, 2-CH2), 1.69 (quin, J = 7.5 Hz, 2H, 3-CH2), 1.61–1.49 (m, 2H, 4-
CH2), 0.88 (s, 9H, CH3, tBu, TBS), 0.04 (s, 6H, tBu, TBS). 
13C NMR (126 MHz, CDCl3): δ 202.7 (CH, C1), 62.6 (CH2, C5), 43.6 (CH2, C2), 32.1 (CH2, 
C4), 25.9 (CH3, tBu, TBS), 18.6 (C, tBu, TBS), 18.3 (CH2, C3), -5.4 (CH3, Me, TBS). 
These data matched those reported previously.69 
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Chapter 4: Second generation synthesis and Bestmann ylide linchpin 
 
4.1  Second generation retrosynthetic analysis 
 
The difficulty with protecting C19 in the C16-C20 fragment (141, 146), and the problem of 
oxidizing the hydroxy group at C15 to an aldehyde led to the development of a new reaction 
plan. The second generation strategy relied on a linchpin strategy to construct the dienoate, 
which involves the use of Bestmann ylide.1 The fragments to be used in the linchpin reaction, 
C3-C8 aldehyde (126) and the C16-C20 alcohol (viz. 141 and 146) were already prepared 
(Scheme 4.1). The strategy for side-arm attachment, ring-closing and pyran formation stayed 
the same, namely aza-aldol reaction, metathesis and alkynylation followed by O-Michael 
reaction. In previous zampanolide (19) and dactylolide (20) syntheses, the dienoate moiety is 
commonly synthesized by a sequence of a Wittig-type reaction to construct the C2-C3 alkene 
and esterification between a carboxylic acid at C1 and an alcohol at C19.2-6 The proposed 
linchpin approach is more efficient, as it not only reduces the number of steps, but also
 
Scheme 4.1: Second generation retrosynthetic analysis. 
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removes the need for protection at C19. The scope of this three-component Bestmann ylide 
reaction more generally in the synthesis of α,β,γ,δ-unsaturated esters was also studied. 
 
4.2  Bestmann ylide 
 
(Triphenylphosphoranylidene)ketene, Ph3P=C=C=O, also known as Bestmann ylide (178) is 
capable of, inter alia, three-component reactions to form α,β-unsaturated esters from alcohols 
and aldehydes.1 First reported in 1966, it initially attracted attention due to its unique structure, 
namely the 145.5° angle of the C=C=P moiety and the unusually short C=C bond (1.210 Å).7,8 
Bestmann ylide (178) has surprising stability, and can be stored under inert atmosphere at room 
temperature for months. This stability is attributed to resonance stabilization (Figure 4.1). Two 
zwitterionic resonance structures of the uncharged phosphorane (I) exist. The phosphonium 
ylide (II) can have bent conformatioin which better represents the Wittig-type reactivity and is 
the source of the 145.5° angle of the C=C=P moiety (insert, Figure 4.1), while the charge-
segregated alkyne (III) can explain the unusually short C=C bond. 
 
Figure 4.1: Resonance structures of Bestmann ylide (178).  
 
Its utility was subsequently explored with pioneering work by Bestmann and co-workers,9-11 
lending the name Bestmann ylide to this versatile and readily obtainable reagent.1,12,13 Studies 
revealed that the ylide can react with alcohols, amines and thiols to form α-phosphoranylidene 
esters, amides and thioesters, providing diverse isolable Wittig reagents that can be used in 
subsequent transformations (Scheme 4.2, equation 1).9-12 The use of a β-ketoamide in this type 
of reaction has also been explored (equation 2).14 Furthermore, if the α-phosphoranylidene ester 
or amide is formed in the presence of an aldehyde, ketone or ester, an additional in situ Wittig 
reaction step can occur.15-21 In a similar way, intramolecular couplings with Bestmann ylide 
(178) have enabled direct lactone (equation 3)22 and lactam synthesis,16-18 including the 
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preparation of macrolactones.19,21 Such Bestmann ylide cascade reactions can allow good 
compatibility with other reaction conditions, forming longer cascades. An extension of this 
methodology by the Taylor group to γ-hydroxyenone substrates allows preparation of α-
alkylidene-γ-butyrolactones through tandem acylation and Michael addition, followed by a 
Wittig reaction (equation 4).23,24 Burke and Risi performed a one-pot hydroformylation–
macrocyclization cascade, where the aldehyde resulting from enantioselective 
hydroformylation reacted with Bestmann ylide (178) to complete this macrolactone ring 
(equation 5). The intermolecular Bestmann ylide cascade leads to amides, esters and thioesters 
through three-component couplings.17,19 In the examples above, the 178 is a bifunctional two-
carbon linchpin containing two sites: one for nucleophilic attack and the other for subsequent 
 
Scheme 4.2: Examples of the Bestmann ylide (178) in synthesis. 
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Wittig reaction. Unlike the linchpins discussed in section 1.7, Bestmann ylide (178) partakes 
in cascades that proceed in a one-pot manner, which optimizes the efficiency of the synthetic 
linchpin. Although the utility of Bestmann ylide (178) in the synthesis of acyclic α,β-
unsaturated esters and dienamides has already been reported,16,19,25 its application to the 
synthesis of α,β,γ,δ-unsaturated esters (i.e. dienoates) remains uncharted. Because Wittig 
reactions are known to readily occur with α,β-unsaturated aldehydes, this Bestmann ylide 
cascade should proceed with ease.  
 
As reported by Schobert, Bestmann ylide (178) can be prepared by deprotonation of methyl 
(triphenylphosphoranylidene)acetate (179) with the strong non-nucleophilic base sodium 
bis(trimethylsilyl)amide (NaHMDS).13 The phosphorane 179 is commercially available, but 
can also be prepared following a sequence starting from bromoacetic acid (180) (Scheme 
4.3).26 The acid 180 was methylated to methyl bromoacetate (181) after activation with oxylyl 
chloride, which can readily convert to the desired 179 via a phosphonium bromide salt. The 
four steps only reached a combined yield of 33%, while the substitution and ylidene formation 
steps have an good yield of 87~88%. Both bromoacetic acid (180) and methyl bromoacetate 
(181) are commercially available; the small cost difference between them encouraged the 
preparation of 179 from 181. The phosphorane 179 was subjected to deprotonation by 
NaHMDS. Schobert prepared NaHMDS from sodium amide and bis(trimethylsilyl)amine in 
situ prior to the addition of 179. However, because of the toxicity and potentially explosive 
nature of sodium amide, NaHMDS solution was purchased from a commercial source (Sigma- 
Aldrich). Schobert reported Bestmann ylide (178) as a “very pale yellow, flaky powder”, but 
with careful recrystallization, creamy white needle-shaped crystals were obtained. The better  
 
Scheme 4.3: Preparation of Bestmann ylide (178). 
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crystal quality was compensated by the yields of 41 to 58% of 178 obtained, which are lower 
than Schobert’s yield (Scheme 4.3).  Interestingly, an attempt to prepare 178 from ethyl 
(triphenylphosphoranylidene)acetate under the same reaction conditions only returned starting 
material. This could be a result of the extra steric hindrance from the ethyl group, or reduced 
acidity of the ylidene proton. 
 
The different appearance may explain the slightly lower melting point measured in this work, 
164~169 °C, compared to the quoted value 173 °C,13 although it could also be merely the 
discrepancy between melting point apparatus. This sample of Bestmann ylide (178) obtained 
was also characterized by IR, 31P NMR and 13C NMR spectroscopy, and showed broad 
agreement with literature (Table 4.1). 1H NMR spectroscopy cannot provide useful 
information on the identification of 178 due to the paucity of characteristic hydrogens in the 
molecule, and the ESI-HRMS technique only decomposed the compound. The 13C NMR data 
obtained did not completely match those reported: the α and β-carbon signals, assigned by 
Schobert at -10.5 ppm (J = 185.4 Hz) and 145.6 ppm (J = 43.0 Hz), respectively, were not 
observed, while excess aromatic signals were displayed. The absence of the α and β-carbon 
signals could be a result of weak peak intensities for those carbonyl and ylide carbons. The 
excess aromatic signals could be from residue ylidene starting material 179. However, the 
overall agreement of the data suggested that 178 was made. 
Table 4.1: Comparison of the measured Bestmann ylide (178) data with literature. 
Spectroscopic 
method 
Prepared  Lit.13 
IR (C=P) 2097 cm−1 2090 cm−1  
31P NMR 5.5 ppm 6.0 ppm 
m.p. 164~169 °C  173°C 
13C NMR 
134.99 (d, J = 3.3 Hz), 133.31 (d, 
J = 10.8 Hz), 132.07 (d, J = 10.0 
Hz), 130.39 (d, J = 13.0 Hz), 
128.48 (d, J = 12.2 Hz), 119.3 (d, 
J = 88.1 Hz). 
145.6 (d, J = 43.0 Hz), 132.3 (s), 
132.2 (s), 129.6 (d, J = 98.5 Hz), 
128.8 (d, J = 12.9 Hz), -10.5 (d, J 
= 185.4 Hz) 
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As discussed in Schobert’s paper, 178 can be stored for a few months under inert atmosphere. 
This was corroborated in this work. No change in the quality of 178 was observed for up to six 
months after preparation. However, longer storage led to gradual decrease in the reactivity. 
Althought no visible change of appearance, IR of the partially decomposed product showed 
reduced intensity of the characteristic band at 2097 cm−1. 
 
4.3  Scope of the Bestmann ylide cascade in the synthesis of α,β,γ,δ-unsaturated esters 
 
The study of the reactions between Bestmann ylide, alcohols and α,β-unsaturated aldehydes 
began with investigation of the coupling between the linchpin 178, E-hex-2-en-1-ol (182) and 
E-cinnamaldehyde (183) (Table 4.2, entry 1).  Typically, Bestmann ylide reactions are 
performed at elevated temperature in either high boiling or ether solvents, such as toluene, 1,4-
dioxane or THF.17-20,23-25 To investigate the necessity for high temperature, the first reaction in 
this study was initiated at room temperature (19 °C) in toluene and then progressively warmed 
to reflux (110 °C) while monitoring progress by TLC.  It was noted that the Bestmann ylide 
reagent (178) was insoluble up to 80 °C and no reaction was observed until the reaction mixture 
was heated at reflux. Under these conditions, incomplete consumption of both starting 
materials was seen after 18 h and the poor conversion was attributed to the instability of 
Bestmann ylide (178) over long periods at elevated temperatures and in the presence of any 
adventitious nucleophilic source.  In response to these observations, the reaction was attempted 
in THF, a solvent in which the Bestmann ylide readily dissolved, even at room temperature.  
Upon heating at reflux, this reaction provided better conversion, although the isolated yield of 
184 was only marginally improved (entry 2).  The poor yields could be due to excessive 
handling to monitor the reaction. Gratifyingly, the reaction of oct-2-en-1-ol (185) with 
cinnamaldehyde (183) was efficient and high yielding, and after a reaction time of just 1.5 
hours in high yield (93%) of 186 was obtained (entry 3).  Reaction of Z-allylic alcohol 187 was 
run in parallel (entry 4), and likewise produced full conversion and excellent amounts of the 
product 188 (91% yield), although a longer reaction time was required to achieve this. The Z-
geometry of the allylic alcohol was retained in 187, as expected.  After this, the secondary 
allylic alcohol 189 was investigated and a reasonable yield of the product was obtained when 
the reaction was carried out in THF (entry 5).  A comparative reaction in toluene was also 
performed and found to a deliver a better yield of the product 190 after the same length of time  
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Table 4.2: Coupling reactions of model alcohols and aldehydes with Bestmann ylide (178)a 
 
Entry Alcohol Aldehyde 
Conditions: 
solvent, 
temperature, 
reaction length 
Product 
Yieldb 
(conversion)c 
1 
 
 
182 
 
183 
Toluene, r.t. to 
110 °C 
18 hd 
184 
53% (60%) 
2 182 183e THF, 68 °C 
2 hf 
184 55% (94%) 
3  
185 
183 THF, 65 °C 
1.5 h 
186 
93% (100%) 
4  
187 
183 THF, 68 °C 
6 hg 
188 
91% (100%) 
5 
 
189 
183 THF, 65 °C 
4.5 h 
190 
61% (100%) 
6 189 183 Toluene, 110 °C 
5.5 h 
190 71% (94%) 
7 
 
191 
183 THF, 65 °C 
22 h 
192 
77% (85%) 
8 191 183 Toluene, 110 °C 
23 h 
192 29% (100%) 
9 191 183 Toluene, 110 °C 
9.5 hg 
192 53% (100%) 
10 191 
193 
Toluene, 110 °C 
3 h 
194 
67% (90%) 
11 191 193 Toluene, 110 °C 
4.5 hg 
194 66% (100%) 
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a Unless otherwise stated, reactions were performed on a 0.1 mmol scale using approximately 1:1:1 ratio of 
alcohol/Bestmann ylide/aldehyde.  b Isolated yields.  c Conversion was calculated based on comparison of peak 
integrations for the limiting reagent (aldehyde) and product in 1H NMR spectra of the crude product mixture after 
workup.  d Reaction was carried out on 0.8 mmol scale.  e 0.57 equiv. of aldehyde 145 were used.  f Reaction was 
carried out on 0.2 mmol scale.  g Reaction was carried out on 0.3 mmol scale.  
(entry 6).  The saturated secondary alcohol menthol (191), with additional steric encumbrance 
and stereogenic centres, provided a good yield of the product 192 in THF, despite incomplete 
conversion after 22 h (entry 7). Disappointingly, full conversion but a poor isolated yield of 
the product was achieved in toluene after reaction for 23 hours (entry 8).  Decreasing the 
reaction time provided better results (entry 9), indicating that the product may decompose upon 
prolonged periods at the elevated reflux temperature of toluene. It should be noted that this 
latter reaction was performed on a larger scale (0.3 mmol rather than 0.1 mmol).  The Bestmann 
ylide reaction with menthol (191) and octa-2,4-dienal (193) delivered the trienoate product 194 
in good yields at both 0.1 and 0.3 mmol scales (entry 10 and 11).  Taken together, these results 
indicate that primary alcohol substrates react effectively in THF, while more hindered 
secondary alcohols require either longer reaction time or the higher temperature available with 
toluene. There is also a need for balancing conversion rate and decomposition by adjusting 
reaction time. 
 
The 1H NMR spectra of the products all showed characteristic signals for the dienoate β-proton 
with chemical shift between 7.4 and 7.5 ppm (Figure 4.2). Most of them overlap with phenyl 
signals, apart from in the trienoate 194, where the β-proton was observed as a doublet of 
doublets with coupling constants of 15.4 and 11.2 Hz. For all the dienoate products, the trans-
configuration was confirmed by the coupling constant of the α-protons at about 6.0 ppm (J = 
14.9~15.6 Hz). The α-protons are always well resolved, thus these signals were used to quantify 
the conversion rates by comparison with the singlet due to the aldehyde proton of the starting 
material. The γ- and δ-protons of the dienoates formed from cinnamaldehyde (183) are 
expected to provide signals with doublet of doublets and doublet respectively, but the multiplet 
observed are heavily distorted. The γ- and δ-protons are in a ABM spin system (Pople’s notion), 
such that the very small difference in their chemical shifts in relation to the coupling constants 
can result in second order spin couplings, which significantly diverts the intensities of the 
multiplets from Pascal’s triangle.27 The assignments of γ- and δ-protons were confirmed by 2D 
NMR. 
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Figure 4.2: Typical multiplets seen for α-, β-, γ- and δ-protons (for 190 as an example). 
 
In the 1H NMR spectra of products generated from primary alcohols (viz. products 184, 186, 
188), a small signal at 8.15 ppm (dd, J = 11~12 and 15~16 Hz) was always observed, which 
integrated up to 10% of the major product (Figure 4.3). Product 184 obtained after much 
handling had the highest percentage of this by-product. This multiplet was also observed in the 
1H NMR spectra of products formed from secondary alcohols, but was barely above the noise 
level. Analyzing the correlation spectroscopy (COSY) NMR spectrum of 184, this signal has 
a correlation to signal at 6.75 ppm (td, J = 11.5, 1.5 Hz), which also correlates to a doublet at 
5.74 ppm with a J-value of 11.0 Hz. This system is very similar to the major product, but the 
11.0 Hz coupling constant of the doublet at 5.74 ppm is much lower than the 15~16 Hz 
observed for the major E,E-products. Weak signals at alkene, aromatic and oxymethine regions 
were also observed in the 13C NMR, and showed appropriate HSQC correlations to minor 1H 
NMR signals. This minor species could be the Z,E-isomer of the desired (major) E,E-dienoate. 
Attempts to separate the two structural isomers by column chromatography were unfruitful and 
insufficient data was collected for full characterization. Due to the low occurrence of the minor 
isomer in products generated from secondary alcohols, as required for zampanolide (19) 
synthesis, further separation was not attempted.  
β                               γ,δ                                             α 
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Figure 4.3: Partial 1H NMR spectrum of E,E-dienoate 184 with signals attributed to Z,E-
isomer indicated. 
 
A singlet peak at 3.78 ppm was also noticed, and the compound was isolated and identified as 
the methoxy protons of the corresponding methyl ester 195 (Scheme 4.4). This could be due 
to the presence of methyl phosphoranylidene 179 in the Bestmann ylide (178) prepared, and its 
Wittig reaction with the aldehydes. However, the varying quantity obtained from different 
reactions indicated that it could instead be a decomposition product resulting from contact of 
the desired dienoate products with a source of methanol, and transesterification. The source of 
methanol was unknown at the time, but residual methanol after the preparation of Bestmann 
ylide (178) was suspected. Thus, the 178 prepared was left under high vacuum for prolonged 
time. 
 
Scheme 4.4: Decomposition of the desired dienoate in the presence of methanol. 
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4.4  Applying the Bestmann ylide linchpin to macrocycle fragments 
 
After the promising results with simple alcohols, the racemic TBDPS-protected C16–C20 
fragment of zampanolide, 141,28,29 was subjected to the Bestmann ylide linchpin reaction with 
cinnamaldehyde (183) in THF and toluene (Table 4.3, entries 1 and 2). In an effort to avoid 
degradation, the reactions were terminated prior to full conversion, leading to the dienoate 
product 196 in modest yields and with good recovery of starting material.  Unfortunately, it 
was found that the product was not pure. Apart from the already identified methyl ester 
degradation product 195, the purified product contains the desired 196 and a by-product in a 
ratio between 3:2 and 5:2. Similarly, the reaction of alcohol 141 with hept-2-enal (197) 
afforded the dienoate 198 in equally poor yield and purity (Table 4.3, entries 3).  
Table 4.3: Coupling reactions of C16-C20 alcohol fragment 141 and model aldehydes with 
Bestmann ylide (178)a 
 
Entry aldehyde 
Conditions: solvent, 
temperature, 
reaction length 
Product 
Yieldb 
(conversion)c 
1 183 
THF, 68 °C 
3.5 h 
 
 
196  
<36% (43%) 
2 183 
Toluene, 110 °C 
2 h 
196 <49% (73%) 
3  
197 
Toluene, 110 °C 
1 h 
 
198 
<41% (50%) 
a Reactions were performed on a 0.1 mmol scale using approximately 1:1:1 ratio of alcohol/Bestmann 
ylide/aldehyde.  b Isolated yields.  c Conversion was calculated based on comparison of peak integrations for the 
limiting reagent (aldehyde) and product in 1H NMR spectra of the crude product mixture after workup. 
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Comparing the 1H NMR spectra obtained from the crude reaction mixture and the post-column 
purification species of 196, the methyl ester decomposition product 195 was only present after 
purification, which suggested post-reaction decomposition. The source of this decomposition 
was identified as methanol used to dissolve the product prior to TLC analysis, thus it was 
switched to dichloromethane, and the situation improved. Separation of the methyl ester 195 
from the desired product 196 was not achieved with EtOAc/petroleum ether or Et2O/petroleum 
ether elution, but use of CH2Cl2/petroleum ether as eluent afforded satisfactory separation. 
However, the product was still a mixture of two compounds. Examination of the 1H NMR 
spectrum revealed great structural similarity between the two products, wherein, apart from the 
non-resolvable phenyl region, each of the protons in the major compound have a corresponding 
minor signal with similar peak shape and chemical shift (Figure 4.4). Assisted by 2D NMR 
data, the oxymethine protons were identified as the apparent quintet signals at 5.16 and 4.10 
ppm for the major and minor compounds, respectively. The chemical shift of 5.16 ppm is 
within the expected range of the ester oxymethine in the desired product 196, while the 
chemical shift of 4.10 ppm would indicate the absence of the ester functionality. The 
 
Figure 4.4: 1H NMR spectrum of the mixture containing 196. 
oxymethylene protons in the minor compound (4.24 and 4.20 ppm) exhibited higher chemical 
shifts than the equivalent ones in the major compound (3.91 and 3.82 ppm), showing a pair of 
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signals at, which suggested that the stronger electron withdrawing group was connected to the 
methylene in the minor compound. 
 
Based on these observations, the mixture might consist of the desired product 196 and its silyl-
migrated isomer 199 (Figure 4.5). To confirm this, correlation between H2′ and C1 in the 
major and H1′ and C1 in the minor product is needed. However, normal heteronuclear multiple-
bond correlation (HMBC) spectroscopy did not detect this three-bond correlation. The classic 
HMBC is set to detect correlations optimized at about 8 Hz, but three- or four-bond coupling 
constants can range between 2 and 25 Hz.30 A carbon-proton coupling across an ester 
functionality (typically 3~4 Hz) can be beyond the detection limit due to incomplete relaxation. 
Ideally, an HMBC spectrum would show minimal signals from both one-bond carbon-proton 
and multiple-bond proton-proton correlations, and be able to detect up to five-bond carbon-
proton correlations.30,31 Great effort has been put into the improvement of HMBC techniques, 
and several advancements have been reported.32-35 A modified HMBC experiment, namely, 
constant time inverse-detection gradient accordion rescaled (CIGAR)  HMBC spectroscopy36 
is one of the most recent development, where the dual-stage low-pass J-filter removes a broad 
range of one-bond proton-carbon couplings, and the complete suppression of proton-proton 
coupling detection maximises the resolution of the desired multi-bond proton-carbon 
correlations.36 This CIGAR-HMBC method was applied to the mixture and allowed detection 
of the three-bond correlations between H2′ and C1 in 196 and H1′ and C1 in 199. 
 
Figure 4.5: CIGAR-HMBC correlations used to confirm the position of the ester functionality 
in product 196 and 199. 
 
Silyl groups are known to migrate under basic conditions, and lack of an exogenous base in 
the simple composition of the reaction mixture suggested that the ylide was serving as the base. 
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This level of basicity is not expected for Bestmann ylide (178) itself, but the migration could 
also be facilitated by various basic intermediates generated in the cascade. The three 
component cascade reaction involving 178 is thought to proceed via the phosphoranylidene 
intermediate 200 (Scheme 4.5),4,5,9-12 which is isolable in reactions lacking the aldehyde 
component. There are two possible pathways to form the intermediate 200: Pathway I shows 
the case where the hydroxyl would perform the nucleophilic attack directly at the electrophilic 
 
Scheme 4.5: Proposed mechanistic pathways of the ylide–alcohol coupling. 
carbon of Bestmann ylide (178) to produce 201, followed by proton transfer, either inter- or 
intramolecularly, to afford phosphoranylidene 200; Pathway II involves the deprotonation of 
the secondary alcohol by 178 first, which produces a stronger alkoxide nucleophile 202 and a 
better carbonyl electrophile 203 for the subsequent nucleophilic attack. The generation of 
alkoxide 202 in Pathway II could facilitate the observed silyl migration, and the intermediate 
201 in pathway I is potentially basic enough to deprotonate the alcohol starting material to 
allow the silyl protecting group to migrate. Hydroxyls are not very acidic, with pKa typically 
around 30 in DMSO. Strong bases such as hydrides, alkaline metals and alkoxides are usually 
required to deprotonate an alcohol. However, the elevated reaction temperature could have 
encouraged the deprotonation, and full deprotonation of the alcohol may not be necessary for 
the silyl to migrate. 
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With C3-C8 fragment 126 in hand, a reaction with 178 was performed in toluene using the 
TBDPS-protected alcohol 141.  A mixture of four isomeric compounds was observed by 1H 
and 13C NMR spectroscopy, two diastereomers of 204 and two diastereomers of the silyl 
migrated product 205 (Scheme 4.6). The diastereomers were not differentiable by 1H NMR 
spectroscopy, but four sets of signals were observed in the 13C NMR spectrum. The assignment 
was supported by the obtained 2D NMR data including CIGAR-HMBC. With the problem of 
silyl migration seen in all reaction of alcohol 141, an alternative protection group was required. 
 
 Scheme 4.6: Coupling of macrocycle fragments 141 with 126. 
 
A three-component reaction with the PMB-protected variant 146 was then attempted with 
cinnamaldehyde 183. The trial performed in THF did not reach completion after 8 h, and a 
moderate 42% yield of 206 was achieved, while using toluene as the solvent produced a good 
70% yield after 4 h. (Scheme 4.7). The product 206 was obtained with good purity. Employing 
the alcohol 146 in the reaction with macrocycle fragment 126 led to gratifying yields of 
products 207, as a mixture of diastereomers.  While the reaction of 146 with aldehyde 126 in 
THF took 11 h to go to completion (62% isolated yield of 207), the equivalent reaction in 
toluene required only 5 h (68% yield). Alcohol 152 was used to test the compatibility of an 
unprotected alkyne in this linchpin reaction for synthetic ease. To our delight, reaction of 
aldehyde 126 with alcohol 152 in toluene provided the desired product 208 in a comparable 
yield (66%) after 5 h. The coupling of enantiopure fragment S-152 with 126 was later carried 
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out, but only 26% of 19S-208 was obtained with recovered starting material (33%). This is 
thought to be due to decomposition of the Bestmann ylide (178) after months in storage. 
 
Scheme 4.7: Coupling of 146 or 152 with model 183 and macrocycle fragments 126. 
 
The E-configuration of C2-C3 alkene in the E,Z-dienoates 207 and 208 was confirmed by the 
coupling constant of around 15 Hz between the α- and β-protons, as well as the strong through-
space correlation of the α-proton to the γ-proton observed by rotating frame Overhauser effect 
spectroscopy (ROESY) (Figure 4.5). Very weak ROESY correlation between α- and β-protons 
was observed, which is more likely to be due to noise from through-bond interaction. The Z-
configuration of the γ,δ-alkene was retained as expected, based on strong ROESY correlation 
of the γ-proton with the singlet attributed to the allylic methyl protons. Correlations between 
the β-proton and the allylic methylene protons were also clearly seen. The pairs of 
diastereomers are differentiable in the 13C NMR spectra, with doubled signals between 1.0 and 
4.8 Hz apart. The differentiated diastereomeric signals are from carbons around the two 
stereocentres, C19 and C7, with more differentiation around the C7 centre. The two peaks 
attributed to C7 in the diastereomers differ by 4.8 Hz, and signals for C6 and C8 are also 
differentiated. On the other hand, the two signals for C19 only differ by 1.9 Hz and only one 
peak each was observed for C18 and C20. 
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Figure 4.5: ROESY correlations of the diene region in 207 and 208. 
 
In summary, the scope of the efficient three-component reaction between Bestmann ylide (178), 
an alcohol and an unsaturated aldehyde to deliver α,β,γ,δ-unsaturated esters was studied for 
simple alcohols and aldehydes.  This methodology enabled the facile synthesis of E,Z-dienoate 
products 207 and 208, which represent two-thirds of the dactylolide/zampanolide macrocycle. 
Terminal alkene 208 is poised to undergo alkynylation at C16 and metathesis at C8. 
 
4.5  Experimental data 
General experimental information 
Unless otherwise stated, all reactions were carried out in oven-dried glassware under a positive 
pressure of nitrogen, delivered via a manifold. Dry tetrahydrofuran and toluene were obtained 
from a PureSolv MD 5 solvent purification system (Innovative Technology). Analytical grade 
solvents were used for aqueous work-up and column chromatography (petroleum ether, n-
hexane, diethyl ether and dichloromethane). Column chromatography was performed on silica 
gel 60Å (Pure Science, 40–63 micron) with the eluent mixtures as stated in the corresponding 
procedures. Thin-layer chromatography was performed on silica-coated plastic plates 
(Macherey-Nagel, POLYGRAM® Sil G/UV254). UV-active compounds were detected under 
UV irradiation (λ = 254 nm), while non-UV-active compounds were visualised with 
anisaldehyde or potassium permanganate staining solutions.  
All other chemicals were purchased from Pure Science, Sigma-Aldrich, Panreac and 
Bedoukian Research. Infra-red (IR) spectra were collected on an ALPHA FT-IR spectrometer 
(Bruker) fitted with attenuated total reflectance (ATR). The intensities of signals are defined 
as: br = broad, s = strong, m = medium, w = weak. Mass spectra were collected on an Agilent 
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6530 Accurate-Mass Q-TOF LC/MS high-resolution mass spectrometer (HRMS). The specific 
rotations were collected on an AUTOPOL II automatic polarimeter (Rudolph Research 
Analytical), and the reported values are an average of 10 measurements and concentrations are 
reported in g/100 mL. 
Nuclear magnetic resonance (NMR) spectra were obtained in deuterated chloroform (CDCl3) 
using Varian Inova instruments operating at 500 or 600 MHz for proton, 125 or 150 MHz for 
carbon, and 120 MHz for phosphorus. Proton and carbon chemical shifts are reported in parts 
per million (ppm) relative to residual CHCl3 [δ(1H) = 7.26 ppm] and CDCl3 [δ(13C) = 77.0 
ppm], respectively. Signals are defined as: s = singlet, d = doublet, t = triplet, q = quartet, quin 
= quintet, sext = sextet, sept = septet, m = multiplet, app. = apparent, obs. = obscured peak.  
Coupling constants (J) are reported in Hertz (Hz). Assignments were determined by two-
dimensional NMR experiments (COSY, HSQC, HMBC, ROESY and CIGAR-HMBC). 
 
Methyl (triphenylphosphoranylidene)acetate (179) 
 To a solution of triphenylphosphine (7.08 g, 27.0 mmol) in toluene (40 
mL, 0.67 M), a solution of methyl bromoacetate (181, 4.04 g, 26.4 
mmol) in toluene (8.0 mL, 3.3 M) was added. The reaction turned 
cloudy upon the addition, and was stirred at r.t. for 19 h. The solid was collected by filtration 
to yield a white powder. The powder was dissolved in CH2Cl2 (100 mL), and an aqueous NaOH 
solution (60 mL, 0.43 M) was added. The mixture was shook vigorously for 1 min, and the 
aqueous layer was separated and extracted with CH2Cl2 (3 × 50 mL). The organic layers were 
combined and dried over MgSO4, and the solvent was removed under reduced pressure to yield 
the phosphoranylidene 179 as a white powder (7.59 g, 87%). 
1H NMR (500 MHz, CDCl3): δ 7.66 (dt, J = 16.9, 8.7 Hz, 6H, 5-CH), 7.59 – 7.51 (m, 3H, 6-
CH), 7.50 – 7.41 (m, 6H, 4-CH), 3.52 (s, 3H, CH3, Me), 2.90 (s, 1H, 2-CH). 
13C NMR (125 MHz, CDCl3): δ 133.0 (d, J = 10.0 Hz, CH, Ph), 131.9 (d, J = 2.8 Hz, CH, 
Ph), 128.7 (d, J = 12.7 Hz, CH, Ph), 50.0 (d, J = 4.9 Hz, CH3, Me), 29.7 (d, J = 131.6 Hz, 
CH, C2). 
31P NMR (120 MHz, CDCl3): δ 17.6. 
M.p.: 163.6 – 164.8 °C (Lit. 162 – 163 °C).37  
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The signals for C1 and C3 were missing from the 13C NMR data, but 31P NMR and m.p. data 
agree with those reported previously.37 
 
(Triphenylphosphoranylidene)ketene (178)  
 To a solution of methyl (triphenylphosphoranylidene)acetate (179, 3.00 g, 
8.97 mmol) in toluene (30 mL, 0.30 M), a solution of NaHMDS (17 mL, 0.6 
M in toluene, 10 mmol) was added. The reaction was heated at 65 ºC for 20 h. 
While still hot, the reaction mixture was filtered through a thin pad of Celite, and the filtrate 
was concentrated under reduced pressure until white precipitate started to form. After the 
precipitate was re-dissolved with heating, the solution was cooled down to 4 ºC and left to 
recrystallize overnight. The precipitate was collected by filtration to yield the ylide 178 as 
cream white needle-shaped crystals (1.43 g, 53%). 
13C NMR (125 MHz, CDCl3): δ 135.0 (d, J = 3.3 Hz), 133.3 (d, J = 10.8 Hz), 132.1 (d, J = 
10.0 Hz), 130.4 (d, J = 13.0 Hz), 128.5 (d, J = 12.2 Hz), 119.3 (d, J = 88.1 Hz). 
31P NMR (120 MHz, CDCl3): δ 5.5. 
IR (ATR): 2910 (w, C–H), 2093 (s, C=P), 1620 (s, C=O), 1435 (s, C–H), 1347 (s, C–H), 
1104 (s, C–O), 743 (s, C–P), 717 (s, C–P), 514 (s, C–H). 
M.p.: 163.7 – 168.6 °C (Lit. 173 °C). 
The signals for C1 and C2 were missing from the 13C NMR data, but 31P NMR, IR and m.p. 
data broadly agree with those reported previously.13 
 
General procedure for Bestmann ylide linchpin reaction: 
To a mixture of alcohol (1 eq., 0.1-0.3 M) and Bestmann ylide (1 eq.) in solvent (toluene or 
tetrahydrofuran) heated at reflux, a solution of aldehyde (1 eq., 1.0 M) was added. The reaction 
was heated at reflux until full consumption of starting material aldehyde was observed by TLC. 
After cooling to r.t., the reaction was concentrated and purified by silica column 
chromatography to afford the product as a colourless or pale yellow oil. 
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(2′E,2E,4E)-Hex-2′-enyl 5-phenylpenta-2,4-dienoate (184) 
Formed in 53% yield, 76% BRSM. No detection of (2ʹE,2Z,4E)-isomer when reaction was 
carried out to completion with minimum handling.   
 
TLC: Rf = 0.23 (20:1 Pet. ether: Et2O).  
1H NMR (500 MHz, CDCl3): δ 7.48–7.43 (complex m, 3H, 3-CH & 7-CH), 7.36 (app. t, J = 
7.6 Hz, 2H, 8-CH), 7.30 (t, J = 6.9 Hz, 1H, 9-CH), 6.82–6.93 (complex m, 2H, 4-CH & 5-CH), 
6.01 (d, J = 15.6 Hz, 1H, 2-CH), 5.81 (dt, J = 15.4, 6.6 Hz, 1H, 3′-CH), 5.62 (dt, J = 15.4, 6.2 
Hz, 1H, 2′-CH), 4.63 (d, J = 6.6 Hz, 2H, 1′-CH2), 2.14 (app. q, J = 7.1 Hz, 2H, 4′-CH2), 1.43 
(app. sext, J = 7.4 Hz, 2H, 5′-CH2), 0.92 (t, J = 7.3 Hz, 3H, 6′-CH3). 
13C NMR (125 MHz, CDCl3): δ 166.8 (C, C=O), 144.7 (CH, C3), 140.4 (CH, C5), 136.3 (CH, 
C3′), 136.0 (C, C6), 129.0 (CH, C9), 128.8 (CH, C8), 127.2 (CH, C7), 126.2 (CH, C4), 124.0 
(CH, C2′), 121.2 (CH, C2), 65.2 (CH2, C1′), 34.3 (CH2, C4′), 22.0 (CH2, C5′), 13.6 (CH3, C6′). 
IR (neat) cm-1: 2958 (m, C–H), 2929 (m, C–H), 1706 (s, C=O), 1625 (s, C=C), 1449 (m, C–
H), 1236 (s, C–O), 1172 (s, C–O), 997 (m, C–H), 689 (m, C–H). 
HRMS (ESI) m/z: found 257.1529, calcd for C17H21O2 [M+H]
+ 257.1536 (Δ = 2.7 ppm).  
 
(2′E,2E,4E)-Oct-2′-enyl 5-phenylpenta-2,4-dienoate (186)  
Formed in 93% yield, contains 1% of the (2′E,2Z,4E)-isomer as determined by integration of 
the post-chromatography 1H NMR spectrum. Key spectral resonances were used to determine 
the ratio of minor to major isomers as 1:99: 6.01 (d, J = 15.4 Hz, 0.99H, 2-CH-major), 8.14 
(dd, J = 15.5, 12.0 Hz, 0.01H, 3-CH-minor). NMR data are of the major isomer signals obtained 
from the spectrum of the purified mixture. 
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TLC: Rf = 0.08 (40:1 Pet. ether: Et2O).  
1H NMR (500 MHz, CDCl3): δ 7.57–7.50 (complex m, 3H, 3-CH & 7-CH), 7.35 (t, J = 7.3 Hz, 
2H, 8-CH), 7.31 (t, J = 7.3 Hz, 1H, 9-CH), 6.93–6.82 (complex m, 2H, 4-CH & 5-CH), 6.01 
(d, J = 15.4 Hz, 1H, 2-CH), 5.81 (dt, J = 15.0, 7.0 Hz, 1H, 3′-CH), 5.62 (dt, J = 15.1, 6.6 Hz, 
1H, 2′-CH), 4.62 (d, J = 6.3 Hz, 2H, 1′-CH2), 2.07 (app. q, J = 7.1 Hz, 2H, 4′-CH2), 1.40 (app. 
quin J = 7.3 Hz, 2H, 5′-CH2), 1.34–1.24 (complex m, 4H, 6′-CH2 & 7′-CH2), 0.90 (t, J = 6.8 
Hz, 3H, 8′-CH3). 
13C NMR (125 MHz, CDCl3): δ 166.8 (C, C1), 144.7 (CH, C3), 140.4 (CH, C4 or C5), 136.6 
(CH, C3′), 136.0 (C, C6), 129.0 (CH, C9), 128.8 (CH, C8), 127.2 (CH, C7), 126.2 (CH, C4 or 
C5), 123.8 (CH, C2′), 121.2 (CH, C2), 65.3 (CH2, C1′), 32.3 (CH2, C4′), 31.4 (CH2, C6′), 28.6 
(CH2, C5′), 22.5 (CH2, C7′), 14.0 (CH3, C8′). 
IR (neat) cm-1: 2956 (m, C–H), 2955 (m, C–H), 1709 (s, br, C=O), 1625 (s, C=C), 1235 (s, C–
O), 1129 (s, C–O), 969 (s, C–H), 691 (m, C–H). 
HRMS (ESI) m/z: found 307.1666, calcd for C19H24O2Na [M+Na]
+ 307.1669 (Δ = 0.9 ppm). 
 
(2′Z,2E,4E)-Hex-2′-enyl 5-phenylpenta-2,4-dienoate (188) 
Formed in 91% yield, contains 7% of the (2′E,2Z,4E)-isomer as determined by integration of 
the post-chromatography 1H NMR spectrum. Key spectral resonances were used to determine 
the ratio of major and minor isomers as 93:7: 6.03 (d, J = 14.9 Hz, 0.93H, 2-CH-major), 8.15 
(dd, J = 15.7, 11.4 Hz, 0.07H, 3-CH-minor). NMR data are of the major isomer signals obtained 
from the spectrum of the purified mixture. 
 
TLC: Rf = 0.25 (20:1 Pet. ether: Et2O).  
1H NMR (500 MHz, CDCl3): δ 7.49–7.44 (complex m, 3H, 3-CH & 7-CH), 7.36 (app. t, J = 
7.6 Hz, 2H, 8-CH), 7.30 (t, J = 6.9 Hz, 1H, 9-CH), 6.98–6.83 (complex m, 2H, 4-CH & 5-CH), 
6.03 (d, J = 14.9 Hz, 1H, 2-CH), 5.69 (dt, J = 11.0, 7.5 Hz, 1H, 2′-CH), 5.63 (dt, J = 11.8, 6.4 
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Hz, 1H, 3′-CH), 4.76 (d, J = 7.2 Hz, 2H, 1′-CH), 2.14 (app. q, J = 7.2 Hz, 2H, 4′-CH), 1.45 
(app. sext, J = 7.2 Hz, 2H, 5′-CH), 0.95 (t, J = 7.3 Hz, 3H, 6′-CH). 
13C NMR (125 MHz, CDCl3): δ 167.0 (C, C1), 144.7 (CH, C3), 140.5 (CH, C4 or C5), 136.0 
(C, C6), 135.2 (CH, C2′), 129.0 (CH, C9), 128.8 (CH, C8), 127.2 (CH, C7), 126.2 (CH, C4 or 
C5), 123.6 (CH, C3′), 121.1 (CH, C2), 60.4 (CH2, C1′), 29.6 (CH2, C4′), 22.6 (CH2, C5′), 13.7 
(CH3, C6′). 
IR (neat) cm-1: 2959 (m, C–H), 2930 (m, C–H), 1707 (s, C=O), 1624 (s, C=C), 1449 (m, C–
H), 1234 (s, C–O), 997 (s, C–H), 690 (m, C–H). 
HRMS (ESI) m/z: found 257.1527, calcd for C17H21O2 [M+H]
+ 257.1536 (Δ = 3.5 ppm).  
 
(2E,4E)-Oct-1′-en-3′-yl 5-phenylpenta-2,4-dienoate (190) 
Formed in 61% yield in THF or 71% in toluene, contains 3% of the (2′E,2Z,4E)-isomer as 
determined by integration of the post-chromatography 1H NMR spectrum. Key spectral 
resonances were used to determine the ratio of major and minor as 97:3: 6.02 (d, J = 14.9 Hz, 
0.H, 2-CH-major), 8.17 (dd, J = 15.6, 11.4 Hz, 0.03H, 3-CH-minor). NMR data are of the major 
isomer signals obtained from the spectrum of the purified mixture. 
 
TLC: Rf = 0.16 (40:1 Pet. ether: Et2O).  
1H NMR (500 MHz, CDCl3): δ 7.47 (d, J = 7.8 Hz, 2H, 7-CH), 7.46 (dd, J = 14.9, 8.8 Hz, 1H, 
3-CH), 7.36 (app. t, J = 7.6 Hz, 2H, 8-CH), 7.31 (t, J = 7.2 Hz, 1H, 9-CH), 6.95–6.84 (complex 
m, 2H, 4-CH & 5-CH), 6.02 (d, J = 14.9 Hz, 1H, 2-CH), 5.83 (ddd, J = 17.1, 10.6, 6.2 Hz, 1H, 
7′-CH), 5.34 (app. q, J = 6.6 Hz, 1H, 1′-CH), 5.27 (dd, J = 17.3, 1.2 Hz, 1H, one of 8′-CH2), 
5.18 (dd, J = 10.5, 1.0 Hz, 1H, one of 8′-CH2), 1.74–1.59 (complex m, 2H, 2′-CH2), 1.39–1.26 
(complex m, 6H, 3′-CH2 & 4′-CH2 & 5′-CH2), 0.89 (t, J = 6.1Hz, 3H, 6′-CH3). 
13C NMR (125 MHz, CDCl3): δ 166.3 (C, C1), 144.6 (CH, C3), 140.4 (CH, C4 or C5), 136.7 
(CH, C7′), 136.0 (C, C6), 129.0 (CH, C9), 128.8 (CH, C8), 127.2 (CH, C7), 126.2 (CH, C4 or 
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C5), 121.5 (CH, C2), 116.4 (CH2, C8′), 74.7 (CH, C1′), 34.3 (CH2, C2′), 31.6 and 24.8 and 
22.5 (CH2, C3′ and C4′ and C5′), 14.0 (CH3, C6′). 
IR (neat) cm-1: 2930 (m, C–H), 2859 (m, C–H), 1706 (s, C=O), 1625 (s, C=C), 1235 (s, C–O), 
1130 (s, C–O), 996 (s, C–H), 688 (m, C–H). 
HRMS (ESI) m/z: found 307.1667, calcd for C19H24O2Na [M+Na]
+ 307.1669 (Δ = 0.65 ppm). 
 
(1′R,2′S,5′R,2E,4E)-2′-iso-Propyl-5′-methylcyclohex-1′-yl 5-phenylpenta-2,4-dienoate 
(192) 
Formed in 77% yield in THF or 53% in toluene. No detection of (2′E,2Z,4E)-isomer.   
 
TLC: Rf = 0.14 (40:1 Pet. ether: Et2O).  
1H NMR (500 MHz, CDCl3): δ 7.46 (d, J = 7.8 Hz, 2H, 7-CH), 7.43 (partially obs. ddd, J = 
15.3, 9.2, 1.0 Hz, 1H, 3-CH), 7.36 (app. t, J = 7.6 Hz, 2H, 8-CH), 7.30 (tt, J = 7.3, 2.4 Hz, 1H, 
9-CH), 6.93–6.83 (complex m, 2H, 4-CH & 5-CH), 5.99 (d, J = 15.4 Hz, 1H, 2-CH), 4.79 (td, 
J = 10.9, 4.4 Hz, 1H, 1′-CH), 2.05 (dddd, J = 11.9, 4.4, 3.0, 2.0 Hz, 1H, one of 6′-CH2), 1.91 
(septd, J = 7.0, 2.7 Hz, 1H, 7′-CH), 1.74–1.66 (complex m, 2H, one of 3′-CH2 & one of 4′-
CH2), 1.53 (m, 1H, 5′-CH), 1.43 (tt, J = 11.7, 2.9 Hz, 1H, 2′-CH), 1.09 (qd, J = 13.2, 3.3 Hz, 
1H, one of 4′-CH2), 1.02 (q, J = 11.5 Hz, 1H, one of 6′-CH2), 0.92 (d, J = 6.6 Hz, 3H, 10′-CH3), 
0.91 (d, J = 7.1 Hz, 3H, 8′-CH3), 0.94–0.84 (partially obs. m, 1H, one of 3′-CH2), 0.78 (d, J = 
7.1 Hz, 3H, 9′-CH3). 
13C NMR (125 MHz, CDCl3): δ 166.6 (C, C1), 144.3 (CH, C3), 140.2 (CH, C4 or C5), 136.1 
(C, C6), 129.0 (CH, C9), 128.8 (CH, C8), 127.1 (CH, C7), 126.3 (CH, C4 or C5), 121.9 (CH, 
C2), 74.1 (CH, C1′), 47.2 (CH, C2′), 41.0 (CH2, C6′), 34.3 (CH2, C3′), 31.4 (CH, C5′), 26.3 
(CH, C7′), 23.6 (CH2, C4′), 22.0 (CH3, C10′), 20.8 (CH3, C8′), 16.5 (CH3, C9′). 
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IR (neat) cm-1: 2953 (m, C–H), 2925 (m, C–H), 2868 (m, C–H), 1702 (s, C=O), 1625 (s, C=C), 
1237 (s, C–Si), 1131 (s, C–O), 995 (s, C–H), 754 (s, C–Si), 689 (s, C–Si). 
HRMS (ESI) m/z: found 335.1969, calcd for C21H28O2Na [M+Na]
+ 335.1982 (Δ = 3.9 ppm). 
Specific rotation: [α]D22 = -60 (c = 0.40, CH2Cl2). 
This compound has been reported previously.38 There is close correlation between the IR and 
13C NMR data entered above and those in the earlier report.  However, the 1H NMR data quoted 
previously do not match those obtained. The identity of the sample prepared in this work was 
supported by NMR and HRMS data, and all NMR assignments were made on the basis of 
thorough 2D NMR experiments (COSY and HSQC).  Therefore, it was suspected that the 90 
MHz instrument used in the earlier work did not allow accurate identification of the 1H NMR 
signals, and the earlier report does not indicate either HRMS or elemental analytical results. 
 
(1′R,2′S,5′R,2E,4E,6E)- 2′-iso-Propyl-5′-methylcyclohex-1′-yl deca-2,4,6-trienoate (194)  
Formed in 67% yield. No detection of (2′E,2Z,4E)-isomer.   
 
TLC: Rf = 0.14 (40:1 Pet. ether: Et2O).  
1H NMR (500 MHz, CDCl3): δ 7.28 (dd, J = 15.4, 11.2 Hz, 1H, 3-CH), 6.53 (dd, J = 14.9, 
10.7 Hz, 1H, 5-CH), 6.21 (dd, J = 14.9, 11.2 Hz, 1H, 4-CH), 6.13 (dd, J = 15.1, 10.7 Hz, 1H, 
6-CH), 5.92 (dt, J = 14.9, 7.2 Hz, 1H, 7-CH), 5.83 (d, J = 15.4 Hz, 1H, 2-CH), 4.75 (app. td, 
J = 10.9, 4.4 Hz, 1H, 1′-CH), 2.12 (app. q, J = 7.3 Hz, 2H, 8-CH2), 2.02 (br d, J = 12.2 Hz, 
1H, one of 6′-CH2), 1.88 (septd, J = 6.8, 2.3 Hz, 1H, 7′-CH), 1.65–1.71 (complex m, 2H, one 
of 3′-CH2 & one of 4′-CH), 1.50 (partially obs. m, 1H, 5′-CH2), 1.44 (m, 2H, 9-CH2), 1.40 
(partially obs. m, 1H, 2′-CH), 1.07 (app. qd, J = 12.9, 2.9 Hz, 1H, one of 4′-CH2), 0.99 (app. 
q, J = 11.5 Hz, 1H, one of 6′-CH2), 0.91 (t, J = 7.3 Hz, 3H, 10-CH3), 0.90 (d, J = 6.1 Hz, 3H, 
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10′-CH3), 0.89 (d, J = 6.8 Hz, 3H, 8′-CH3), 0.87 (partially obs. m, 1H, one of 3′-CH2), 0.76 
(d, J = 7.1 Hz, 3H, 9′-CH3). 
13C NMR (125 MHz, CDCl3): δ 166.8 (C, C1), 144.6 (CH, C3), 141.0 (CH, C5), 140.2 (CH, 
C7), 130.0 (CH, C6), 127.8 (CH, C4), 120.5 (CH, C2), 73.9 (CH, C1′), 47.2 (CH, C2′), 41.0 
(CH2, C6′), 35.0 (CH2, C8), 34.3 (CH2, C3′), 31.4 (CH, C5′), 26.3 (CH, C7′), 23.6 (CH2, C4′), 
22.2 (CH2, C9), 22.0 (CH3, C10′), 20.7 (CH3, C8′), 16.4 (CH2, C9′), 13.7 (CH3, C10). 
IR (neat) cm-1: 2955 (s, C–H), 2930 (s, C–H), 2869 (s, C–H), 1694 (s, C=O), 1615 (s, C=C), 
1456 (m, C–H), 1342 (m, C–H), 1133 (s, C–O), 1007 (s, C–H). 
HRMS (ESI) m/z: found 305.2486, caled for C20H33O2 [M+H]
+ 305.2475 (Δ = 3.6 ppm).  
Specific rotation: [α]D22 = -26 (c = 0.42, CH2Cl2). 
 
Mixture of (2E,4E)-[1′-(tert-butyldiphenylsilyloxy)-5′-trimethylsilyl]pent-4′-yn-2′-yl 5-
phenylpenta-2,4-dienoate (196) and the silyl migrated product (2E,4E)-[2′-(tert-
butyldiphenylsilyloxy)-5′-trimethylsilyl]pent-4′-yn-1′-yl 5-phenylpenta-2,4-dienoate (199) 
(3:2) 
The isomers were formed in a combined 36% yield in THF or 49% in toluene.   
 
TLC: Rf = 0.14 (36:1 Pet. ether: Et2O).  
1H NMR (500 MHz, CDCl3): δ 7.75–7.67 (complex m, 4H, CH, Ph), 7.55–7.30 (complex m, 
11H, CH, Ph), 7.47 (obs. m, 0.6H, 3-CH-196), 7.32 (obs. m, 0.4H, 3-CH-199), 6.94–6.79 
(complex m, 2H, 4-CH & 5-CH), 5.99 (d, J = 15.3 Hz, 0.6H, 2-CH-196), 5.83 (d, J = 15.6 Hz, 
0.4H, 2-CH-199), 5.16 (app. quin, J = 5.6 Hz, 0.6H, 2′-CH-196), 4.23 (dd, J = 11.4, 4.4 Hz, 
0.4H, one of 1′-CH2-199), 4.20 (dd, J = 11.2, 5.9 Hz, 0.4H, one of 1′-CH2-199), 4.10 (app. quin, 
J = 5.3 Hz, 0.4H, 2′-CH-199), 3.91 (dd, J = 11.2, 5.0 Hz, 0.6H, one of 1′-CH2-196), 3.86 (dd, 
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J = 10.9, 4.1 Hz, 0.6H, one of 1′-CH2-196), 2.77 (dd, J = 16.7, 7.0 Hz, 0.6H, one of 3′-CH2-
196), 2.67 (dd, J = 16.7, 5.9 Hz, 0.6H, one of 3′-CH2-196), 2.47 (dd, J = 17.0, 6.5 Hz, 0.4H, 
one of 3′-CH2-199), 2.43 (dd, J = 17.0, 5.1 Hz, 0.4H, one of 3′-CH2-199), 1.08 (s, 2.7H, CH3, 
tBu-199), 1.06 (s, 5.4H, CH3, tBu-196), 0.14 (s, 2.7H, CH3, Me-199), 0.13 (s, 5.4H, CH3, Me-
196). 
13C NMR (125 MHz, CDCl3): δ 166.6 (C, C1-199), 166.1 (C, C1-196), 145.0 (CH, C3-196), 
144.8 (CH, C3-199), 140.6 (CH, C5/4-196), 140.5 (CH, C5/4-199), 136.0 (CH, Ph), 135.9 (CH, 
C6), 135.8 (CH, Ph), 135.54 (CH, Ph), 135.52 (CH, Ph), 133.7 (C, Ph), 133.5 (C, Ph), 133.3 
(C, Ph), 129.8 (CH, Ph), 129.7 (CH, Ph), 129.08 (CH, C7-196), 129.06 (CH, C7-199), 128.8 
(CH, C9), 127.70 (CH, Ph), 127.68 (CH, Ph), 127.65 (CH, Ph), 127.59 (CH, Ph), 127.21 (CH, 
C8-196), 127.18 (CH, C8-199), 126.22 (CH, C4/5-196), 126.18 (CH, C4/5-199), 121.1 (CH, 
C2-196), 120.8 (CH, C2-199), 102.6 (C, C4′-199), 102.1 (C, C4′-196), 87.2 (C, C5′-199), 86.9 
(C, C5′-196), 72.1 (CH, C2′-196), 69.6 (CH, C2′-199), 66.9 (CH2, C1′-199), 63.7 (CH2, C1′-
196), 26.9 (CH3, tBu-199), 26.7 (CH3, tBu-196), 25.8 (CH2, C3′-199), 21.9 (CH2, C3′-196), 
19.4 (C, tBu-199), 19.3 (C, tBu-199), -0.01 (CH3, Me).  
IR (neat) cm-1: 3071 (w, C–H), 2958 (m, C–H), 2857 (m, C–H), 2178 (m, C≡C), 1710 (s, 
C=O), 1625 (s, C=C), 1235 (s, Si–C), 1112 (s, C–O), 997 (s, C–H), 840 (s, Si–C), 700 (s, Si–
C), 504 (s, Si–C). 
HRMS (ESI) m/z: found 605.2314, calcd for C35H42O3Si2K [M+K]
+ 605.2304 (Δ = 1.7 ppm). 
The three-bond C-H correlations across the esters in both compounds were confirmed by 
CIGAR-HMBC NMR. 
 
Mixture of (2E,4E)-[1′-(tert-butyldiphenylsilyloxy)-5′-trimethylsilyl]pent-4′-yn-2′-yl 
nona-2,4-dienoate (198) and the silyl migrated product, (2E,4E)-[2′-(tert-
butyldiphenylsilyloxy)-5′-trimethylsilyl]pent-4′-yn-1′-yl nona-2,4-dienoate (2:1) 
The isomers were formed in a combined 41% yield.   
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TLC: Rf = 0.12 (36:1 Pet. ether: Et2O).  
1H NMR (500 MHz, CDCl3): δ 7.74–7.61 (complex m, 4H, CH, Ph), 7.47–7.32 (complex m, 
6H, CH, Ph), 7.28 (dd, J = 14.7, 10.5 Hz, 0.67H, 3-CH-198), 7.15 (dd, J = 15.4, 9.8 Hz, 0.33H, 
3-CH-minor), 6.23–6.06 (complex m, 2H, 4-CH & 5-CH), 5.78 (d, J = 15.4 Hz, 0.67H, 2-CH-
198), 5.64 (d, J = 15.1, 0.33H, 2-CH-minor), 5.12 (app. quin, J = 5.6 Hz, 0.67H, 2′-CH-198), 
4.19 (dd, J = 10.0, 4.2 Hz, 0.33H, one of 1′-CH2-minor), 4.19 (dd, J = 10.9, 4.8 Hz, 0.33H, 
one of 1′-CH2-minor), 4.07 (app. dt, J = 10.7, 5.4 Hz, 0.33H, 2′-CH-minor), 3.89 (dd, J= 11.0, 
4.8 Hz, 0.67H, one of 1′-CH2-198), 3.84 (dd, J= 10.5, 4.2 Hz, 0.67H, one of 1′-CH2-198), 2.74 
(dd, J= 16.6, 7.3 Hz, 0.67H, one of 3′-CH2-198), 2.64 (dd, J= 16.9, 6.7 Hz, 0.67H, one of 3′-
CH2-198), 2.47 – 2.37 (complex m, 0.66H, 3′-CH2-minor), 2.18 (dt, J= 13.4, 6.8 Hz, 2H, 6-
CH2), 1.46–1.39 (complex m, 2H, 7-CH2), 1.06 (s, 2.97H, CH3, tBu-minor), 1.05 (s, 6.03H, 
CH3, tBu-198), 0.95–0.89 (complex m, 2H, 8-CH2), 0.89–0.80 (complex m, 3H, 9-CH2), 0.13 
(s, 2.97H, CH3, Me-minor), 1.03 (s, 6.03H, CH3, Me-198). 
13C NMR (125 MHz, CDCl3): δ 166.9 (C, C1-minor), 166.4 (C, C1-198), 145.6 (CH, C3-198), 
145.4 (CH, C3-minor), 145.0 (CH, C4-198), 144.9 (CH, C4-minor), 136.0 (CH, Ph), 135.8 
(CH, C5), 135.61 (CH, Ph), 135.55 (CH, Ph), 135.53 (CH, Ph), 135.51 (CH, Ph), 133.3 (C, Ph), 
129.8 (CH, Ph), 129.7 (CH, Ph), 128.8 (CH, C9), 127.70 (CH, Ph), 127.70 (CH, Ph), 127.68 
(CH, Ph), 127.66 (CH, Ph), 127.62 (CH, CH, C5), 127.58 (CH, Ph), 118.9 (CH, C2-198), 118.7 
(CH, C2-minor), 102.1 (C, C4′), 86.8 (C, C5′), 71.9 (CH, C2′-198), 69.6 (CH, C2′-minor), 
66.8 (CH2, C1′-minor), 63.7 (CH2, C1′-198), 32.70 (CH2, C6-198), 32.68 (CH2, C6-minor), 
30.94 (CH2, C7-minor), 30.8 (CH2, C7-198),  26.9 (CH3, tBu-minor), 26.7 (CH3, tBu-198), 
22.6 (CH2, C8), 22.2 (CH2, C3′), 19.4 (C, tBu-minor), 19.3 (C, tBu-minor), 13.9 (CH3, C9), -
0.02 (CH3, TMS-minor), -0.03 (CH3, TMS-198). 
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IR (neat) cm-1: 2957 (m, C–H), 2928 (s, C–H), 2857 (m, C–H), 2179 (w, C≡C), 1717 (s, C=O), 
1643 (m, C=C), 1249 (s, Si–C), 1137 (s, C–O), 999 (s, C–H), 842 (s, Si–C), 702 (s, Si–C), 506 
(s, Si–C). 
HRMS (ESI) m/z: found 547.3033, calcd for C33H47O3Si2 [M+H]
+ 547.3058 (Δ = 4.6 ppm). 
 
 
Mixture of (2E,4Z)-1′-(tert-butyldiphenylsilyloxy)-5′-(trimethylsilyl)pent-4′-yn-2′-yl 7-
(tert-butyldimethylsilyloxy)-5-methylnona-2,4,8-trienoate (204) and the silyl migrated 
product, (2E,4Z)-2′-(tert-butyldiphenylsilyloxy)-5′-(trimethylsilyl)pent-4′-yn-1′-yl 7-(tert-
butyldimethylsilyloxy)-5-methylnona-2,4,8-trienoate (205) (2:1) 
The isomers were formed in a combined 69% yield.   
 
TLC: Rf = 0.21 (40:1 Pet. ether: Et2O).  
1H NMR (500 MHz, CDCl3): δ 7.75–7.64 (complex m, 4H, CH, Ph), 7.57 (partially obs. ddd, 
J = 15.3, 11.6, 3.9 Hz, 0.67H, 3-CH-204), 7.51 (partially obs. ddd, J = 15.4, 11.7, 3.9 Hz, 0.33H, 
3-CH-205), 7.46–7.34 (complex m, 6H, CH, Ph), 6.09 (d, J = 11.7 Hz, 0.67H, 4-CH-204), 6.04 
(d, J = 11.7 Hz, 0.33H, 4-CH-205), 5.85–5.74 (complex m, 1.67H, 8-CH & 2-CH-204), 5.64 
(d, J = 15.1 Hz, 0.33H, 2-CH-205), 5.22–5.10 (complex m, 1.67H, 2′-CH-204 & one of 9-CH2), 
5.07–5.00 (complex m, 1H, one of 9-CH2), 4.25 (dt, J = 6.6, 5.9 Hz, 1H, 7-CH), 4.18 (dd, J = 
5.1, 1.5 Hz, 0.66H, 1′-CH2-205), 4.09–4.04 (complex m, 0.33H, 2′-CH), 3.89 (ddd, J = 11.0, 
4.6, 2.4 Hz, 0.67H, one of 1′-CH2-204), 3.84 (ddd, J = 11.0, 4.4, 1.7 Hz, 0.67H, one of 1′-CH2-
204), 2.75 (ddd, J = 16.9, 7.1, 1.5 Hz, 0.67H, one of 3′-CH2-204), 2.64 (obs. ddd, J = 16.9, 5.9, 
4.2 Hz, 0.67H, one of 3′-CH2-204), 2.60–2.52 (complex m, 1H, one of 6-CH2), 2.44–2.39 
(complex m, 0.66H, 3′-CH2-205), 2.36 (dd, J = 13.4, 5.4 Hz, 1H, one of 6-CH2), 1.93 (s, 2.0H, 
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10-CH3-204), 1.92 (s, 1.0H, 10-CH3-205), 1.07 (s, 3.0H, CH3, tBu, TBDPS-205), 1.05 (s, 6.0H, 
CH3, tBu, TBDPS-204), 0.86 (s, 3.0H, CH3, tBu, TBS-205), 0.86 (s, 6.0H, CH3, tBu, TBS-204), 
0.13 (s, 3.0H, CH3, TMS-205), 0.12 (s, 6.0H, CH3, TMS-204), 0.01 (s, 6H, CH3, Me).  
13C NMR (125 MHz, CDCl3): δ 167.15 and 167.14 (C, C1-205), 166.68 and 166.65 (C, C1-
204), 146.54 and 146.51 and 146.46 (C, C5), 141.50 and 141.48 (CH, C3-204), 141.30 and 
141.29 (CH, C3-205), 140.90 and 140.88 and 140.84 (CH, C8), 135.9 (CH, Ph), 135.82 (CH, 
Ph), 135.81 (CH, Ph), 135.61 (CH, Ph), 135.58 (CH, Ph), 135.54 (CH, Ph), 135.52 (CH, Ph), 
135.51 (CH, Ph), 135.50 (CH, Ph), 133.62 (C, Ph), 133.57 (C, Ph), 133.4 (C, Ph), 133.3 (C, 
Ph), 129.8 (CH, Ph), 129.68 (CH, Ph), 129.66 (CH, Ph), 129.65 (CH, Ph), 129.59 (CH, Ph), 
129.32 (CH, Ph), 127.69 (CH, Ph), 127.67 (CH, Ph), 127.64 (CH, Ph), 127.62 (CH, Ph), 127.58 
(CH, Ph), 126.11 and 126.06 and 126.04 (CH, C4), 119.02 and 118.96 (CH, C2-204), 118.76 
and 118.75 (CH, C2-205), 114.2 (CH2, C9), 102.74 and 102.72 (C, C4′-205), 102.23 and 
102.21 (C, C4′-204), 87.01 (C, C5′-205), 86.77 and 86.76 (C, C5′-204), 72.86 (CH, C7-205), 
72.84 (CH, C7-204), 71.87 and 71.83 (CH, C2′-204), 69.53 (CH, C2′-205), 66.58 and 66.54 
(CH2, C1′-205), 63.72 and 63.69 (CH2, C1′-204), 41.7 (CH2, C6), 26.9 (CH3, tBu), 26.74 (CH3, 
tBu), 26.72 (CH3, tBu), 25.82 (CH3, C10-204), 25.68 (CH3, C10-205), 25.66 and 25.65 (CH2, 
C3′-205), 21.9 (CH2, C3′-204), 19.4 (C, tBu), 19.3 (C, tBu), 18.1 (C, tBu), 1.02 (CH3, Me), 
0.01 (CH3, Me), 0.00 (CH3, Me), -0.03 (CH3, Me).  
IR (Et2O film) cm
-1: 3072 (w, C–H), 2959 (s, C–H), 2858 (s, C–H), 2179 (m, C≡C), 1716 (m, 
C=O), 1637 (m, C=C), 1251 (m, C–Si), 1114 (s, Si–O), 776 (m, Si–Me), 702 (s, Si–C). 
HRMS (ESI) m/z: found 689.3838, calcd for C40H62O4Si3 [M+H]
+ 689.3872 (Δ = 4.8 ppm). 
The three-bond C-H correlations across the esters in both compounds were confirmed by 
CIGAR-HMBC NMR. 
 
(2E,4E)-[1′-(para-Methoxybenzyloxy)-5′-trimethylsilyl]pent-4′-yn-2′-yl 5-phenylpenta-
2,4-dienoate (206) 
Formed in 42% yield in THF or 70% in toluene. 
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TLC: Rf = 0.28 (80% CH2Cl2 in n-hexane).  
1H NMR (500 MHz, CDCl3): δ 7.51–7.44 (complex m, 3H, 3-CH & 8-CH), 7.37 (app. t, J = 
7.1 Hz, 2H, 7-CH), 7.33 (m, 1H, 9-CH), 7.28 (br d, J = 8.8 Hz, 2H, 9′-CH), 6.95–6.84 (complex 
m, 4H, 8′-CH & 4-CH & 5-CH), 6.02 (d, J = 15.4 Hz, 1H, 2-CH), 5.20 (app. dt, J = 10.5, 5.7 
Hz, 1H, 2′-CH), 4.55 (d, J = 11.5 Hz, 1H, one of 11′-CH2), 4.50 (d, J = 11.7 Hz, 1H, one of 
11′-CH2), 3.80 (s, 3H, 6′-CH3), 3.72–3.67 (m, 2H, 1′-CH2), 2.68 (dd, J = 17.1, 7.1 Hz, 1H, one 
of 3′-CH2), 2.63 (dd, J = 16.9, 5.9 Hz, 1H, one of 3′-CH2), 0.14 (s, 9H, CH3, TMS). 
13C NMR (125 MHz, CDCl3): δ 166.2 (C, C1), 159.2 (C, C7′), 145.2 (CH, C3), 140.7 (CH, 
C5), 136.0 (C, C6), 130.1 (C, C10′), 129.3 (CH, C9′), 129.1 (CH, C7), 128.8 (CH, C9), 127.2 
(CH, C8), 126.2 (CH, C4), 121.0 (CH, C2), 113.8 (CH, C8′), 101.9 (C, C4′), 87.1 (C, C5′), 73.0 
(CH2, C11′), 70.7 (CH, C2′), 69.4 (CH2, C1′), 55.2 (CH3, C6′), 22.3 (CH2, C3′), 0.00 (CH3, 
TMS).  
IR (neat) cm-1: 3028 (w, C–H), 2957 (m, C–H), 2901 (m, C–H), 2178 (m, C≡C), 1709 (s, 
C=O), 1625 (s, C=C), 1512 (m, C–O), 1245 (s, C–O), 1128 (s, C–O), 840 (s, C–Si), 757 (s, C–
Si). 
HRMS (ESI) m/z: found 449.2146, calcd for C27H33O4Si [M+H]
+ 449.2143 (Δ = 0.67 ppm). 
 
(2E,4Z)-1′-(para-Methoxybenzyloxy)-5′-(trimethylsilyloxy)pent-4′-yn-2′-yl 7-(tert-
butyldimethylsilyloxy)-5-methylnona-2,4,8-trienoate (207) 
Formed in 68% yield as a single regioisomer, and with 1:1 d.r. based on composition of 
racemic starting materials. 
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TLC: Rf = 0.30 (80% CH2Cl2 in n-hexane). 
1H NMR (500 MHz, CDCl3): δ 7.57 (dd, J = 14.9, 11.8 Hz, 1H, 3-CH), 7.26 (d, J = 8.3 Hz, 
2H, 9′-CH), 6.87 (d, J = 8.3 Hz, 2H, 8′-CH), 6.07 (d, J = 11.5 Hz, 1H, 4-CH), 5.80 (obs. ddd, 
J = 16.8, 10.6, 5.7 Hz, 1H, 8-CH), 5.80 (obs. d, J = 15.2 Hz, 1H, 2-CH), 5.23–5.11 (obs. m, 
1H, 2′-CH), 5.18 (obs. d, J = 17.2 Hz, 1H, one of 9-CH2), 5.05 (d, J = 10.3 Hz, 1H, one of 9-
CH2), 4.53 (d, J = 11.5 Hz, 1H, one of 11′-CH2), 4.48 (d, J = 11.5 Hz, 1H, one of 11′-CH2), 
4.25 (app. q, J = 6.2 Hz, 1H, 7-CH), 3.80 (s, 3H, 6′-CH3), 3.67 (app. d, J = 4.9 Hz, 2H, 1′-CH2), 
2.69–2.54 (complex m, 3H, 3′-CH2 & one of 6-CH2), 2.36 (ddd, J = 13.0, 6.5, 5.5 Hz, 1H, one 
of 6-CH2), 1.92 (s, 3H, 10-CH3), 0.87 (s, 9H, CH3, tBu), 0.13 (s, 9H, CH3, TMS), 0.01 (s, 6H, 
CH3, Me). 
13C NMR (125 MHz, CDCl3): δ 166.71 and 166.69 (C, C1), 159.2 (C, C7′), 146.58 and 146.56 
(C, C5), 141.70 and 141.67 (CH, C3), 140.9 (CH, C8), 130.1 (C, C10′), 129.3 (CH, C9′), 126.09 
and 129.07 (CH, C4), 118.89 and 118.87 (CH, C2), 114.2 (CH2, C9), 113.8 (CH, C8′), 102.0 
(C, C4′), 86.92 and 86.90 (C, C5′), 73.00 and 72.99 (CH2, C11′), 72.86 and 72.82 (CH, C7), 
70.48 and 70.47 (CH, C2′), 69.45 and 69.41 (CH2, C1′), 55.2 (CH3, C6′), 41.7 (CH2, C6), 25.83 
and 25.82 (CH3, tBu), 25.64 and 25.62 (CH3, C10), 22.32 and 22.29 (CH2, C3′), 18.1 (C, tBu), 
0.00 and -0.01 (CH3, TMS), -4.54 and -4.88 (CH3, TBS).  
IR (neat) cm-1: 2956 (s, C–H), 2857 (m, C–H), 2180 (w, C≡C), 1714 (s, C=O), 1636 (m, C=C), 
1513 (m, C=C), 1249 (s, C–O), 1033 (m, C-H), 837 (s, C–Si), 775 (m, C–Si), 760 (m, C–Si). 
HRMS (ESI) m/z: found 571.3276, calcd for C32H51O5Si2 [M+H]
+ 571.3270 (Δ = 1.1 ppm). 
 
(2E,4Z)-1′-(para-Methoxybenzyloxy)pent-4′-yn-2′-yl 7-(tert-butyldimethylsilyloxy)-5-
methylnona-2,4,8-trienoate (208) 
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Formed in 66% yield as a single regioisomer, and with 1:1 d.r. based on composition of racemic 
starting materials. 
 
TLC: Rf = 0.32 (80% CH2Cl2 in n-hexane). 
1H NMR (500 MHz, CDCl3): δ 7.58 (dd, J = 14.9, 11.7 Hz, 1H, 3-CH), 7.26 (d, J = 8.6 Hz, 
2H, 9′-CH), 6.87 (d, J = 8.6 Hz, 2H, 8′-CH), 6.07 (d, J = 11.5 Hz, 1H, 4-CH), 5.80 (obs. ddd, 
J = 17.1, 10.5, 5.9 Hz, 1H, 8-CH), 5.80 (obs. d, J = 14.9 Hz, 1H, 2-CH), 5.23–5.14 (obs. m, 
1H, 2′-CH), 5.18 (obs. d, J = 16.9 Hz, 1H, one of 9-CH2), 5.05 (d, J = 10.3 Hz, 1H, one of 9-
CH2), 4.53 (d, J = 11.5 Hz, 1H, one of 11′-CH2), 4.48 (d, J = 11.5 Hz, 1H, one of 11′-CH2), 
4.25 (app. q, J = 5.6 Hz, 1H, 7-CH), 3.80 (s, 3H, 6′-CH3), 3.71–3.62 (m, 2H, 1′-CH2), 2.65 
(ddd, J = 16.9, 6.6, 2.7 Hz, 1H, one of 3′-CH2), 2.58 (ddd, J = 16.9, 5.4, 2.5 Hz, 1H, one of 3′-
CH2), 2.61–2.54 (obs. m, 1H, one of 6-CH2), 2.36 (app. dt, J = 13.1, 4.9 Hz, 1H, one of 6-CH2), 
1.97 (m, 1H, 5′-CH), 1.92 (s, 3H, 10-CH3), 0.86 (s, 9H, CH3, tBu), 0.01 (s, 3H, CH3, Me), 0.00 
(s, 3H, CH3, Me). 
13C NMR (125 MHz, CDCl3): δ 166.7 (C, C1), 159.2 (C, C7′), 146.81 and 146.78 (C, C5), 
141.92 and 141.89 (CH, C3), 140.95 and 140.93 (CH, C8), 130.1 (C, C10′), 129.31 and 129.30 
(CH, C9′), 126.07 and 126.05 (CH, C4), 118.71 and 118.68 (CH, C2), 114.2 (CH2, C9), 113.8 
(CH, C8′), 79.6 (C, C4′), 73.0 (CH2, C11′), 72.81 and 72.77 (CH, C7), 70.33 and 70.30 (CH, 
C5′), 70.18 and 70.13 (CH, C2′), 69.3 (CH2, C1′), 55.2 (CH3, C6′), 41.8 (CH2, C6), 25.8 (CH3, 
tBu), 25.66 and 25.65 (CH3, C10), 20.97 and 20.95 (CH2, C3′), 18.1 (C, tBu), -4.54 and -4.88 
(CH3, TBS).   
IR (neat) cm-1: 3308 (w, C–H), 2930 (m, C–H), 2857 (s, C–H), 2214 (w, C≡C), 1712 (s, C=O), 
1635 (m, C=C), 1612 (m, C=C), 1514 (s, C–H), 1248 (s, C–O), 1033 (m, C–O), 836 (s, C–Si), 
776 (s, C–Si). 
HRMS (ESI) m/z: found 499.2868, calcd for C29H43O5Si [M+H]
+ 499.2874 (Δ = 1.2 ppm). 
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(2E,4Z,2′S)-1′-(para-Methoxybenzyloxy)pent-4′-yn-2′-yl 7-(tert-butyldimethylsilyloxy)-5-
methylnona-2,4,8-trienoate (2′S-208)  
Formed in 26% yield as a single regioisomer, and with 1:1 d.r. based on composition of starting 
materials. 
 
All spectroscopic data matched those of the racemate 208. 
Specific rotation: [𝑎]𝐷
21 = -2.11 (c = 0.18, CH2Cl2).  
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Chapter 5: Exploration of late-stage connections  
 
5.1 Formation of N-acyl hemiaminal  
 
As discussed in section 1.4.3, linear N-acyl hemiaminal structures are rare in natural product. 
Apart from zampanolide (19), natural products in the pederin family are often used to 
demonstrate the occurrence of the N-acyl hemiaminal functionality (examples shown in Figure 
5.1). However, construction of the N-acyl hemiaminal in members of the pederin family has 
been achieved primarily by amide synthesis from carboxylic acids and amines.1,2 In the total 
syntheses of 19, aza-aldol reactions have been more commonly used (see section 1.4.3). Since 
very few aza-aldol reactions conducted in this fashion were previously published,3,4,5 the total 
synthesis of 19 provided a good basis for exploration of the methodology to form N-acyl 
hemiaminal via aza-adol reaction, especially in complex natural product synthesis.  
 
Figure 5.1: Examples of the pederin family. 
 
In the present study, the attachment of the amides to the macrocyclic core was attempted by a 
boron-catalyzed aza-aldol reaction. A non-stereoselective boron-catalyzed aza-aldol reaction 
for N-acyl hemiaminal formation was reported by Kiren, Shangguan and William in 2007.6 In 
their experiments, a number of chlorodicyclohexylborane (Cy2BCl)-mediated direct additions 
of amides to aldehydes were conducted, and moderate to good yields were obtained after a 30 
min reaction followed by quenching with a mixture of MeOH, phosphate buffer (pH = 7.40) 
and H2O2 (Scheme 5.1).  
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Scheme 5.1: Kiren’s aza-aldol reactions.6 
 
Adaption of this type of reaction to use a chiral boron reagent to achieve stereoselectivity was 
investigated, in particular chlorodiisopinocampheylborane (DIP-chloride). Although DIP-
chloride has never been used in aza-aldol reaction, it is well-established to mediate asymmetric 
adol reaction.7 Both (+)-DIP-chloride and (-)-DIP-chloride were to be tested. (-)-DIP-chloride 
was purchased, but the high cost encouraged us to also explore the synthesis of DIP-chloride. 
DIP-chloride can be prepared from the readily available starting material α-pinene following a 
few well-precedented methods.8-10 Reider’s convenient method was attempted first (Scheme 
5.2). In this procedure, -BHCl3 and borane are proposed to form, generated from boron 
trichloride and excess borohydride in situ. The borane or a related entity then reacts with two 
equivalents of α-pinene to produce the intermediate 209, which is chlorinated, probably by 
either -BHCl3 or BCl3, to produce DIP-chloride as a solution in 1,2-dimethoxyethane (DME).
10  
 
Scheme 5.2: Reider’s preparation of (+)-DIP-Cl and proposed mechanism. 
In this way, (+)-DIP-chloride was prepared from (-)-α-pinene. The activity of the home-made 
(+)-DIP-chloride was tested in the reduction of acetophenone, and full conversion was achieved 
after 5 hours at -23 °C followed by 1 hour at 0 °C. However, the enantioselectivity of the 
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reagent was not assessed at this time, and the presence of any remaining active borane species 
in the mixture could reduce the aldehyde starting material in the aza-adol reaction. 
 
The planned DIP-chloride-promoted aza-aldol reaction was first tested in model studies 
involving simple aldehydes (Scheme 5.3), where DIP-chloride, amide and Et3N were pre-
mixed prior to the addition of the aldehyde. With the amine models sorbamide (210) and 
cyclohexylamide (211) and aldehyde models 2-methylbutyraldehyde (212) and n-pentanal 
(213), various reaction conditions were modified, including temperature (0 to 40 °C), time (30 
min to overnight) and solvent (THF or DME).  
Scheme 5.3: Aza-aldol reaction with DIP-Cl to N-acyl hemiaminal. 
 
Model reactions with sorbamide (210) and n-pentanal (213) were carried out in THF, but 
starting material remained after reacting for up to 60 h at toom temperature (Scheme 5.3). It 
was noted that sorbamide (210) has very low solubility in THF. Sonication, heating and 
changing the solvent to DME all failed to produce the required N-acyl hemiaminal. Attention 
was then turned to models similar to Kiren’s, cyclohexanecarboxamide (211) and 2-
methylbutyraldehyde (212). In Kiren's procedure, a 30 min reaction at 0 °C was sufficient to 
carry most of the reactions to completion.6 However, in this study, TLC analysis at 30 min 
showed the presence of both starting materials, and in the 1H NMR spectrum of the aliquot 
removed and quenched after 30 min, the signature hemiaminal signal (doublet of doublets at 
around 5.0 ppm) was not observed. Furthermore, aliquots removed at 15 min intervals during 
the first hour and then hourly for 3 hours displayed no observable change from the reaction 
mixture at t = 0 min. With commercial (-)-DIP-Cl and an overnight reaction time, aldehyde 
signal nearly all disappeared and two interesting doublets at around 5.0 ppm with coupling 
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constants 4.2 and 5.1 Hz were observed (Figure 5.2). Unfortunately, this material was lost 
during column chromatography, and the eluent after flushing the column with ethyl acetate 
contains mostly isopinocampheol.  
 
Figure 5.2: 1H NMR spectrum (500 MHz) of the crude mixture from a model aza-aldol 
reaction of 211 with 212. 
 
Although the compound with interesting-looking 1H NMR signals was lost during column 
chromatography, further exploration of this reaction was undertaken on substrates 211 and 212. 
Interestingly, conducting the work-up with distilled water produced a different result to that 
obtained with hydrogen peroxide and pH7 buffer. Theoretically, the purpose of hydrogen 
peroxide is only to facilitate the purification by oxidatively hydrolyzing the boronate ester 
intermediate to produce boric acid and isopinocampheol. While the result of the hydrogen 
peroxide work-up was not encouraging, with the water-only work-up, a dd at 5.18 ppm in the 
1H NMR spectrum of the crude mixture with coupling constants of 6.2 and 6.8 Hz was observed. 
This signal is comparable with the oxymethine signal reported for 1-hydroxyl-1-
cyclohexylmethyl hexamide (dd at 5.06 ppm, J = 7.8, 7.5 Hz).6 After column chromatography, 
a small amount of a promising-looking product was obtained in impure form (<5~9% yield).  
The signal at 5.18 ppm appeared as a triplet with J value of 6.1 Hz, and correlated to the signals 
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at 6.01 and 3.56 ppm, which could be the amide proton and the hydrogen bonded alcohol, 
respectively (Figure 5.3). An aldehyde signal with identical chemical shift (9.74 ppm) to that 
of aldehyde 212 was observed, which was not present in the 1H NMR spectrum of the crude 
reaction mixture before purification. This suggests decomposition of the product on silica, 
which contradicts Kiren’s results. The minor signals near the multiplet at 3.56 ppm could be 
resulted from other stereoisomers in the mixture. However, full characterization was never 
achieved, due to decomposition and the low quantity of material hampering efforts to purify it.  
 
Figure 5.3: 1H NMR spectrum (500 MHz) of the promising product from model N-aldol 
reaction of 211 with 212. 
 
A proposal of a hydrogen bonding network in oxygenated N-acyl hemiaminals, including 
zampanolide (19) was reported by Porco and Troast (Figure 5.4).11 Based on their calculation, 
this system could contribute to the stability of zampanolide (19).11 Porco and Troast also 
reported that simple N-acyl hemiaminals decomposed on the acidic silica gel, and suggested 
using neutral aluminum oxide for chromatography as a substitute purification method.11   
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Figure 5.4: Porco’s proposed hydrogen bonding network. 
 
New model substrates were planned to better mimic the structure in (-)-zampanolide (19). A 
couple of aldehyde substrates were proposed that would enable the hydrogen bonding network 
in product. One is the α-acetoxy aldehyde (214), which would lead to a similar O-acylated α-
hydroxy-N-acyl hemiaminal (215) system to that in zampanolide (19) (Scheme 5.4, eq. 1). 
However, aldehydes are often accessed by reduction of esters or oxidation of alcohols, so the  
 
Scheme 5.4: Model aldehydes 214 and 216 that enable double hydrogen bonding. 
presence of the acetate group would require selective reduction, selective acetylation or other 
convoluted approaches. Another model is the α-hydroxy aldehyde (216), which would produce 
α-hydroxy-N-acyl hemiaminal 217 upon aza-aldol reaction (eq. 2). The α-hydroxy aldehyde 
model 216 is easier to synthesize, and the product is also capable of forming a hydrogen 
bonding network, but it would produce a five-membered ring instead of the seven membered 
ring in the zampanolide system. Both the secondary amide NH and hydroxyl OH in 217 consist 
of hydrogen bonding donor and acceptor, so an equilibrium was expected, which could improve 
the stability. Thus, α-hydroxy aldehyde 216 would be tested first. 
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A suitable aldehyde substrate would ideally meet the following criteria: convenient to prepare; 
stable and easy to handle; easy to be detected by TLC analysis. (S)-2-Hydroxy-3-
phenylpropanal (218) was chosen for this purpose, which was expected to be stable, UV-active, 
and available through a three-step preparation from the cheap amino acid (L)-phenylalanine 
(219) (Scheme 5.5). The first two steps, hydroxylation and methylation proceeded smoothly 
with moderate yields. The Sandmeyer-type reaction used to convert the amine to an alcohol 
was related to that previously discussed during the synthesis of the C9-C15 natural fragment 
in chapter 3, although that was carried out in the presence of bromine at below -5 ºC to achieve 
bromination.  In this case, the increased temperature (0 ºC) led to the production of the 
hydroxylated product 220. The subsequent reduction of methyl ester 220 was incomplete and 
produced a mixture of inseparable compounds.  
 
Scheme 5.5: Synthesis of the model aldehyde 218. 
 
The 1H NMR spectrum of the inseparable mixture showed a very complicated oxygenated C–
H region between 3.5 and 5.5 ppm, with abundant signals. The desired aldehyde signal was 
also observed, but far weaker than the combined signals in the oxygenated region. This problem 
was believed to be the result of dimerization of 218 to afford various hemiacetals, which can 
proceed through two different pathways, resulting in both five- and six-membered heterocycles, 
221 and 222, respectively (Scheme 5.6). The existence of multiple stereocenters in this mixture, 
together with different ring sizes, made the mixture impossible to purify and properly 
characterize, therefore another model substrate was explored. 
 139 
 
 
Scheme 5.6: Proposed dimerization of model aldehyde 218. 
 
Protection of the α-hydroxy group as either an ester or a carbonate was then proposed, as both 
could serve as a hydrogen bond acceptor in stabilisation of the N-acyl hemiaminal.  Compared 
to acetyl protection, a carbonate would be more stable in the reduction of the substrate to afford 
the aldehyde, and can be easily accessed using the already synthesized intermediate 220. 
Therefore, tert-butyl carbonate (Boc)-protection was attempted on 220, and the corresponding 
aldehyde 223 was produced by DIBAL-H reduction of 224 (Scheme 5.7). The low yield (38%) 
of this reduction is a result of incomplete reduction, which indicated poor quality of DIBAL-
H. Only 1H NMR and HRMS data were collected to support the characterization of 223. 
Scheme 5.7: Synthesis of model aldehyde 223.  
 
A boron reagent-promoted aza-aldol reaction was then tested with substrates 223 and 
sorbamide (210) using commercial (-)-DIP-chloride. Dichloromethane was used as the solvent 
to achieve good solubility of the aldehyde and amide (Scheme 5.8). Unfortunately, this reaction 
failed to proceed. After monitoring the reaction for 60 hours, TLC analysis still indicated the 
presence of the aldehyde, and the crude product mixture contained only the starting materials 
and pinene-like compounds. This failure might be caused by the bulkiness of the Boc group, 
which could sterically hinder the reaction.  
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Scheme 5.8: Aza-aldol reaction of aldehyde 223 and sorbamide (210). 
 
The synthesis of the α-acetoxy aldehyde 224 was also investigated, as the relatively small size 
of the acetyl protecting group would hopefully not cause steric inhibition of the aza-aldol 
reaction. This acetylated substrate 224 cannot be synthesized via the same route as before, 
because of the difficulty in differentiating the acetoxy from the methyl ester to be reduced. An 
oxidative addition of acetic acid to 3-phenylpropanal (225) was reported to produce the desired 
α-acetyloxy aldehyde 224 using tetrabutylammonium iodide (TBAI) and tert-butyl 
hydroperoxide (TBHP)  (Scheme 5.9).12 The combination of TBAI and TBHP has been found 
to be useful in a variety of bond forming reactions.13 The mechanism of the reaction is believed 
to go through a radical intermediate, promoted by the active species hypoiodite ([R4N]
+[IO]−) 
or iodite ([R4N]
+[IO2]
− generated by oxidation of TBAI by TBHP.13 However, when this 
reaction was performed in this work, the product obtained was not the desired 224. 
 
Scheme 5.9: Proposed substrate 224 for model study of aza-aldol reaction. 
 
The 1H NMR spectrum of the purified product obtained from this attempted α-oxidation 
showed a 1:4:10 ratio between aldehyde, phenyl and benzylic signals, which suggested 
dimerization of starting material 225 (Figure 5.5). However, the signal at 3.59 ppm was 
thought to be too high field to be the oxymethine signal in the dimerization product 226 via an 
aldol reaction. In addition, the peak at 3.59 ppm correlated to a carbon signal at 34.4 ppm, and 
thus was not oxygenated. Due to time constraints, the assignment of the unknown by-product 
and the synthesis of model aldehyde 224 were not pursued further. However, further 
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investigation of the reaction could be attempted and, if unsuccessful, other procedures for 
oxidative α-acetoxylation of aldehydes are also available.14,15  
Figure 5.5: 1H NMR spectrum of the product obtained from the attempted oxidative addition. 
 
After the initial exploration, Ghosh's attempt to use boron reagent-promoted aza-aldol reaction 
in (-)-zampanolide (19) synthesis was published.16 In the reported work, achiral boron reagent, 
dicyclohexylboron chloride (Cy2BCl) was used. A couple of Cy2BCl-promoted model 
reactions were successfully carried out (Scheme 5.10), but when applying this method to the 
addition of (Z,E)-hex-2,4-dienamide (45) to (-)-dactylolide (20), decomposition was observed. 
Thus, the viability of using R2BCl in the synthesis of the natural product and analogues is 
questionable. 
 
Scheme 5.10: Ghosh’s Cy2BCl-catalyzed aza-aldol model reactions.  
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5.2  Model study of C20 oxidation 
 
The conversion of the C20-hydroxyl to an aldehyde (228) was done exclusively with Dess-
Martin periodinane (DMP) in past dactylolide (20) and zampanolide (19) syntheses.17-24 
Product 206 from the model Bestmann ylide cascade was used to test this oxidation of alcohol 
at C20. The PMB group was deprotected selectively with the well-established oxidative 
deprotection method of DDQ and H2O (Scheme 5.11).
25 The best yield of 227 (95%) was 
achieved when the reaction mixture was directly subjected to column chromatography without 
aqueous work-up. The oxidation of 227 did not go smoothly, so a number of oxidation methods 
were tested. The precedented DMP and the related oxidant IBX resulted in complicated 
mixtures, which showed multiple signals in the aldehyde region of the 1H NMR spectrum, and 
potentially also contained starting material and structurally similar compounds. At least eight 
multiplets with various intensities were observed in the oxymethine region (4.8 to 5.4 ppm). 
Attempts to separate the major aldehyde product by column chromatography failed. Apart from 
the similar polarity amongst the products, some components also streaked on the TLC plate, 
typical of carboxylic acids, but DMP and IBX are not known for over-oxidation of alcohols. 
Swern and Parikh-Doering methods did not promote any oxidation and starting material was 
recovered. The last method attempted was TEMPO/BAIB oxidation, which is quite different 
from all the above methods. It proceeds via a catalytic cycle, whereby TEMPO goes through a 
redox sequence assisted by BAIB in order to oxidize the alcohols to aldehydes.26 Unfortunately, 
TEMPO/BAIB oxidation produced the over-oxidized carboxylic acid 229 quantitatively. After 
column chromatography, significant line-broadening was observed by 1H NMR spectroscopy 
of 229, which may be a sign of decomposition. Therefore, some characterization data for acid 
229 were obtained using the crude product prior to purification. The desired molecular ion [M-
H]- was found in large abundance using mass spectrometry, and the broad hydroxy stretch was 
observed by IR spectroscopy with the carboxylic acid C=O stretch at 1709 cm-1 also evident. 
In the 1H NMR spectrum, apart from the disappearance of the oxymethylene signal, very little 
change was evident in chemical shift and multiplicity. Aldehyde-like compounds were never 
observed, either by NMR spectroscopy or by TLC analysis during the reaction. The results of 
these oxidation methods are not very well understood. The hydroxyl group in our substrate 227 
may be participating in hydrogen bonding with the ester carbonyl. This interaction may be 
disturbed in the precursor of dactylolide by the steric hindrance of the ring, but strong enough 
in the model substrate to interfere with the oxidative reagents. Although the oxidation results 
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are very discouraging, we are still confident of this late-stage oxidation in the real system, 
because of the abundant precedence in the literature. 
Scheme 5.11: Model oxidation of alcohol at C20. 
 
5.3 Asymmetric alkynylation of aldehydes for C15-C16 connection 
 
Alkynylation of carbonyls has often been used in total syntheses to construct the versatile 
propargylic alcohol motif, for which metalated alkynylides are commonly used as the 
nucleophiles. Lithium and magnesium alkynylides are readily formed by treating terminal 
alkynes with BuLi and alkyl Grignard reagents, respectively, but they are harsh nucleophilic 
bases and have high reactivity towards a large variety of functional groups, thus are unsuited 
for reaction with complicated substrates. The formation of zinc alkynides by treating terminal 
alkynes with Et2Zn has been known since the mid-1960’s,27 and the use of zinc alkynides in 
the addition to carbonyls was subsequently explored in the past few decades. Although these 
reactions are slow, the mild reaction conditions and compatibility with a range of functional 
groups are favored in organic synthesis. With the assistant of chiral catalysts, asymmetric 
alkynylations can be achieved. A number of methods involving dialkylzinc were developed, 
including Trost’s ProPhenol/Me2Zn and the BINOL/Ti(IV)/Et2Zn methods.28  
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As discussed in section 1.7, Trost’s ProPhenol-catalyzed alkynylation can achieve excellent 
yields and ee’s between propiolate, aromatic and the sensitive α,β-unsaturated aldehydes (see 
Scheme 1.22).29 The success with propiolate was attributed to the interaction of the Lewis basic 
carbonyl with ProPhenol-bound zinc. The addition of triphenylphosphine oxide (TPPO) was 
found to compensate for the absence of a Lewis basic moiety in the alkyne substrates, which 
further expand the scope to aliphatic alkynes. However, with aliphatic alkynes and enolizable 
aldehydes such as 230 and 231, increased catalytic loading and prolonged pre-mixing before 
the addition of the aldehyde are required to achieve a moderate yield (69%) and 
enantioselectivity (67% ee) (Scheme 5.12).29,30  
 
Scheme 5.12: Prophenol-catalysed alkynylation of aliphatic alkyne 230 and aldehyde 231. 
 
In the Et2Zn/Ti(IV)/BINOL system published by Pu, the alkynylzinc was formed by heating 
alkyne and diethylzinc in toluene at reflux for 5 hours (Scheme 5.13).31 At the same time, a 
very similar procedure was published by Chan, whereby treating an alkyne with dimethylzinc 
at room temperature in THF for 18 hours afforded the alkynylzinc species.32 The 
Ti(IV)/BINOL-catalyzed alkyne addition to aldehydes achieved good yields and 
stereoselectivity  in both cases. The reflux condition in Pu’s method limits its compatibility 
with low boiling point and heat sensitive substrates, so Pu and You explored ways to carry out 
the alkynylzinc formation at room temperature while maintaining high stereoselectivity. 
Additives such as hexamethylphosphoramide, N-methylimidazole and dicyclohexylamine 
were found to be efficient, and the scope of this method was further extended to aliphatic 
alkynes and aldehydes at the same time.33-35 Although these above methods are efficient and 
enantioselective, the use of the highly pyrophoric dialkylzinc introduces environmental and 
safety hazards, and requires extravagant care to exclude any moisture. Therefore, the formation 
of Et2Zn in situ was explored by Pu’s group. It was found that with the assistance of Ti(OiPr)4 
and BINOL, the alkynylzinc complex can be formed from iodoethane, zinc powder and alkyne 
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in THF at room temperature, which can then react with aromatic aldehydes in diethylether with 
high enantioselectivity (Scheme 5.13).36 Optimization of this facile alkynylation method by Pu 
led to conditions involving 4 equivalents of alkyne, 6 equivalents of zinc powder, 12 
equivalents of iodoethane and stoichiometric amount of Ti(OiPr)4, thus it is not economical or 
environmentally friendly. With complex substrates such as those required for zampanolide (19) 
synthesis, further optimization to reduce the amount of reagents, especially the alkyne and 
Ti(OiPr)4 required, would be prudent.  
 
Scheme 5.13: Pu’s development of Ti (IV)/BINOL-catalyzed asymmetric alkynylation. 
 
Another efficient way to produce zinc alkynylides was discovered by Carreira.37 With a 
catalytic amount of zinc triflate and amine base, the zinc alkynylides can readily form from 
aliphatic, aromatic, mono-silylated and allylic alkynes. The nucleophilic attack of Zinc 
alkynylides was reported with nitrones, but examples of aldehyde, ketone and imine were also 
given.37 Further investigation established the use of N-methylephedrine as an effective director 
for asymmetric alkynylation to aldehydes,38 and that the inert atmosphere and exclusion of 
moisture is not necessary for this method.39 Differing from the methods above, aliphatic 
aldehydes provide better yields than aromatic aldehydes under Carreira’s conditions, because 
Cannizaro reactions can occur with aromatic aldehydes.38 Despite this, Carreira’s Zn(OTf)2/N-
methylephedrine protocol has become the most commonly used asymmetric alkynylation 
method in natural product synthesis, and good yields and stereoselectivity are often achieved 
for complicated natural product fragments.40-43 For example, it was used for a late-stage 
connection in the synthesis of (+)-10-epi-latrunculol, whereby the product was prepared with 
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the desired configuration in 95% yield (Scheme 5.14).43 It was noted during the optimization 
process that it is essential to thoroughly dry zinc triflate prior to use, which contradicts 
Carreira’s finding that the presence of moisture and oxygen did not interfere with the 
alkynylation.39  
 
Scheme 5.14: Asymmetric alkynylation in the synthesis of (+)-10-epi-latrunculol A. 
 
Unfortunately, ephedrine-derived compounds are strictly controlled substances in New 
Zealand and, even with a lengthy and costly application process, access is most likely not 
granted.44 An alternative method using zinc alkynylide generated by zinc triflate was reported 
by Xiong, which involves the use of a different chiral ligand (1S,2S)-232 derived from (1S,2S)-
2-amino-1-(4-nitrophenyl)-1,3-propanediol (233) (Scheme 5.15). Unlike ephedrine-
derivatives, the precursor (+) and (-)-233 are commercially accessible and available in New 
Zealand. Therefore, this method was tested in the present study. During the literature research, 
discrepancy was found with methods involving the use of zinc triflate. Apart from the dryness 
of zinc triflate as mentioned before, the particle size and surface morphology can also affect 
the outcome of this alkynylation, but insufficient studies have been conducted to fully 
understand this phenomenon.45  
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Scheme 5.15: Xiong’s Zn(OTf)2 method using chiral ligand 232. 
 
Indium (III) has also been used successfully to facilitate asymmetric alkynylation, owing to its 
dual activating properties for aldehydes and alkynes. Shibasaki has developed a facile 
asymmetric alkynylation method involving In(III)/BINOL (Scheme 5.16).46 Good yields and 
selectivity are obtained, apart from the pairing of an enolizable aldehyde with an aliphatic 
alkyne. Shibasaki also tested the reaction of benzaldehyde and phenylacetylene in air and found 
no loss of yield or stereoselectivity.  
 
Scheme 5.16: Shibasaki’s In(III)/BINOL alkynylation method. 
 
In this study, the alkynylation was tested with model substrate 234 first, which was synthesized 
via Steglich esterification of alcohol 153 and cinnamic acid (Scheme 5.17). A few of the 
literature procedures for asymmetric aldehyde alkynylation were tested, including Carreira’s 
non-stereoselective Zn(OTf)2/EtNiPr2 method
37 with either lab-made or commercial zinc 
triflate, Xiong’s Zn(OTf)2 method with the accessible chiral ligand 23247 and Trost’s 
alkynylation using chiral ligand ProPhenol29.  
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Scheme 5.17: Synthesis of model substrate 234 for alkynylation. 
 
Carreira’s three articles describing the alkynylation methods contain three sets of reaction 
conditions.37-39 The non-stereoselective method was first reported for alkyne additions mainly 
to nitrones with one example of an aldehyde substrate. This method used a catalytic amount of 
Zn(OTf)2 (10 mol%) and iPr2EtN (25 mol%) in dichloromethane.
37 The subsequently 
developed asymmetric alkynylation to aldehydes also used catalytic amount of reagents (20 
mol%  Zn(OTf)2, 22 mol% (+)-N-methylephedrine, 50 mol% Et3N), but was carried out in 
toluene at 60 ºC.38  Later, it was found that the reaction can be performed at room temperature 
in toluene, although its effectiveness was compromised by requiring stoichiometric amounts of 
Zn(OTf)2 (1.1 equiv.), (+)-N-methylephedrine (1.2 equiv.) and Et3N (1.2 equiv.).
39 Due to the 
poor availability of (+)-N-methylephedrine, the non-stereoselective method was tested first, 
with catalytic and stoichiometric amounts of reagents on simple substrates phenylacetylene 
(235) and hexanal (236) as reported previously, using zinc triflate made by treating activated 
zinc powder with triflic acid (Scheme 5.18).48 No reaction was observed. Because 
discrepancies were present in reports of alkynylation reactions regarding the dryness and 
particle size of zinc triflate, the prepared zinc triflate was ground and dried under high vacuum 
at 140 ºC overnight, but this did not make any improvement.39,45  
 
Scheme 5.18: Non-stereoselective alkynylation reactions using lab-made Zn(OTf)2.  
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Commercially available zinc triflate was then used in the alkynylation of 235 to 236 (Scheme 
5.19). The initial experiment with a catalytic amount of zinc triflate and DIPEA in 
dichloromethane did not produce any product, only starting material was observed by TLC 
analysis and 1H NMR spectroscopy after 6 hours at room temperature. Therefore, this mixture 
was concentrated, re-dissolved in toluene, and additional stoichiometric amounts of zinc triflate 
and triethylamine were added. After 15 hours at 60 ºC, a small amount of the desired propargyl 
alcohol 237 was isolated (5% yield). The propargylic functionality showed a characteristic 
proton signal at 4.6 ppm and a carbon signal at 63.0 ppm, which are in agreement with literature 
values. The major products were the polymerized compounds derived from hexanal (236), 
which is likely to be caused by the concentration process to remove dichloromethane.  
 
Scheme 5.19: Non-stereoselective alkynylation reactions using commercially available 
Zn(OTf)2.  
 
At the same time, the chiral ligand (1R,2R)-232 was prepared via two steps, N-methylation and 
silyl protection (Scheme 5.20).47 Because the required configuration in this project is opposite 
to that of Xiong’s report using (1S,2S)-232, (1R,2R)-232 was prepared. The methylation of 
amines with aqueous formaldehyde and formic acid is a well-established method.49 During the 
reaction, the amine of (1R,2R)-233  was transformed to an imine or iminium with formaldehyde, 
which was then reduced by formic acid to form each of the two methyl groups, producing 
carbon dioxide as the by-product.50 This step produced the dimethylated amine 238 in an 
excellent 94% yield. The following selective mono-silyl protection only reached a moderate 
61% yield of (1R,2R)-232. Only 3% of the diprotected product 239 was isolated, and the rest 
of the mass was thought to be unreacted starting material. A species with higher polarity was 
observed by TLC analysis, but was not recovered.  
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Scheme 5.20: Two-step preparation of chiral ligand (1R,2R)-232. 
 
The asymmetric alkynylation using Xiong’s chiral ligand (1R,2R)-232 was attempted on the 
model substrates 234 and 177 (Scheme 5.21), despite the poor result obtained with the non-
stereoselective alkynylation performed with similar reagents. It has been report that the amino 
alcohol ligand (1R,2R)-232 may be essential for the reactivity as well as the stereoselectivity.51 
With stoichiometric amount of reagents, this reaction was first performed at room temperature. 
After 14 h, no reaction was observed, thus the reaction mixture was heated up to 60 ºC. 
However, starting material remained after four days at 60 ºC. Further investigation is required. 
 
Scheme 5.21: Attempted Xiong’s asymmetric alkynylation on model substrates 234 and 177. 
 
Trost’s alkynylation involving the use of ProPhenol was then attempted with substrates 234 
and 177 (Scheme 5.22). Due to difficulty in obtaining dimethylzinc, diethylzinc was used 
instead. Longer premixing of alkyne with diethylzinc, TPPO and (R,R)-ProPhenol was applied 
to compensate for the potentially lower activity of diethylzinc. This air-sensitive reaction was 
initially carried out as a bench-top reaction under nitrogen atmosphere. All glassware was dried 
under high vacuum with heating, and the non-volatile reagents were dried under high vacuum. 
No reaction was observed, possibly due to the presence of adventitious water or air. Therefore, 
this reaction was next carried out in a glovebox. The alkyne 234 was premixed for 64 h, and 
the resulting alkynylzinc was allowed to react with the aldehyde 177 for 24 h. To our delight, 
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the desired product 240 was obtained in high yield (76%) after a single column chromatography 
operation.   
Scheme 5.22: Trost’s alkynylation of substrates 234 and 177. 
 
The product 240 was expected to exist as diastereomers. Kinetic resolution in the alkynylation 
could conceivably result in a single diastereomer, but the high isolated yield indicated that both 
stereoisomers of 234 have reacted, as is likely. The signals in the 1H and 13C NMR spectra 
showed no differentiation (Figure 5.6), and the configuration at the newly formed propargylic 
alcohol was yet to be determined. 
Figure 5.6: 1H NMR spectrum of propargylic alcohol 240. 
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Using chiral derivatizing agents is a convenient NMR-based method to determine the absolute 
configuration of alcohols.45 A commonly used chiral derivatizing agent is α-methoxy-α-
trifluoromethylphenylacetic acid (MTPA), also known as Mosher’s acid, which reacts with the 
alcohol to produce its corresponding trifluoromethylphenylmethoxyacetate via 
esterification.46,47 As the Mosher model describes, in the lowest energy conformation of the 
241, the electronegative α-CF3 would be positioned as shown in Figure 5.7 to avoid the 
antibonding orbitals of the ester carbonyl, and the Ha would also be eclipsed with the ester 
carbonyl to minimise steric hindrance. Considering the two configurations of the propargylic 
alcohol, the Hb protons on the substituent would experience a through-space deshielding or 
shielding effect from the methoxy or phenyl group on the same side, respectively (Figure 5.7).  
 
Figure 5.7: Using Mosher’s ester method to determine the configuration at the new 
propargylic centre. 
The propargylic protons Hc may also be influenced in the opposite way, but the extended 
distance would mean a very weak effect. If the product 240 is present as a mixture of the two 
configurations at the new stereocentre, the ratio of the two isomers can be determined by 
comparing the integrals of the two pairs of chemical shifts after derivatization of the 
stereoisomers with either R- or S-MTPA. However, this will be complicated by the fact that 
the starting material 234 is racemic.When R-MTPA was used, the compound with a shift of Hb 
signal to lower field would bear the S-configuration at the newly formed propargylic centre, 
and the shift to higher field would indicate R-configuration. If the asymmetric alkynylation is 
entirely stereoselective, the configuration at the new propargylic centre will be determined by 
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comparing the chemical shift of Hb in the derivatization products from both S- and R-MTPA 
(δS and δR, respectively). The ΔδSR (defined as δS – δR) value will be calculated, and a positive 
value would suggest the R-configuration and a negative value the S-isomer. 
 
To produce the desired Mosher ester 241, Steglich esterification with R-MTPA was attempted 
first, but only starting material 240 was observed by TLC analysis and 1H NMR spectroscopy 
after 14 hours. Yamaguchi esterification was then attempted, but it did not reach completion 
after 20 hours. The 1H NMR spectrum of crude product showed that 25% of the alcohol starting 
material remained.  
 
Scheme 5.23: Derivatization of 240 with R-MTPA. 
 
Two overlapping spots with slightly different Rf was observed on TLC plate, which were 
thought to be the stereoisomers. Therefore, the products was isolated from column 
chromatography as two mixtures at 11 mg and 3 mg in weight, and the later contains less of 
the compound with higher Rf. NMR data were obtained from a 600MHz machine equipped 
with an indirect detection cold probe to have sufficient resolution to differentiate all of the 
potential isomers. Six closely related compounds were identified in each mixture, which were 
sorted into three isomeric pairs according to their intensities, chemical shifts, multiplet pattern 
and through-bond correlations. The six compounds are likely to be the four stereoisomers of 
241 and two by-products. The signals from the pair of by-products were differentiated from 
the desired stereoisomers of 241 with the assistance of COSY, HSQC and HMBC NMR 
spectroscopy. Observed in the 1H and 13C NMR spectra, significantly less by-product was 
present in the 3 mg mixture than the 11 mg, thus the compound with higher Rf was likely to 
the by-product. It was also found that the by-products are likely to be a pair of stereoisomers, 
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and contain the same cinnamate and propargylic systems as the desired products, because most 
of the signals attributed to those systems overlap with the desired ones (Figure 5.8). However, 
the by-product displayed a distinctively higher chemical shift for the oxymethine proton at the 
newly formed ester, 5.59 ppm compared to the 5.51 and 5.48 ppm found for the desired 
products. The 13C NMR signal of the oxymethine was found at 163.1 ppm, which showed 
HMBC correlation to two singlet peaks in the aromatic region. The two peaks have chemical 
shifts of 7.30 and 7.31 ppm, close to the aromatic signals reported for 2,4,6-trichlorobenzoyl 
functionality (7.33 ppm).55 Therefore, partial reaction of the alcohol 240 with TCBC, instead 
of MTPA was suspected. The presence of 2,4,6-trichlorobenzoate by-product 242 was 
confirmed by HRMS.  
 
Figure 5.8: 1H NMR spectrum of the mixture containing 241 and the proposed by-products, 
with distinctive signals attributed to the by-product 242 indicated. 
 
The formation of 242 could be from direct reaction of alcohol 241 and TCBC. The TCBC was 
added in excess, and the direct esterification of alcohol and acyl chloride can occur in the 
presence of base, but high temperature is often required for sterically hindered substrates 
(Scheme 5.24, pathway I).56 The attack of 240 at the trichlorophenylcarbonyl in 243 to produce 
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242 is also possible, because of the high steric hindrance at the MTPA-originated carbonyl 
(pathway II). Two heteroatom-linked ethyl groups were also identified: one involves a quartet 
at 3.15 ppm and the triplet at 1.14 ppm; the other one has the distinctive triplet at 1.27 ppm and 
an obscured multiplet at 3.60 ppm (Figure 5.8). The source of the ethyl moieties was thought 
to be triethylamine, as the chemical shifts were similar to triethylamine hydrochloride (3.16 
and 1.43 ppm).57 However, due to the lack of additional information in a clean spectrum, no 
conclusion can be firmly drawn. 
 
Scheme 5.24: Possible pathways for the formation of 242. 
 
HRMS confirmed the presence of the desired Mosher ester 242. The observation of four sets 
of 242 signals in the NMR spectra suggested that both configurations of the propargylic alcohol 
were formed. Signals of Hb are slightly differentiated for the two groups of stereoisomers 
(insert C, Figure 5.9), and the COSY and HSQC signals were used to define the boundary of 
multiplets. It is clear that the major pair of signals has a lower chemical shift than the minor 
pair. According to the discussion before, the major pair of stereoisomers would bear the desired 
R-configuration at the propargylic centre, while the minor pair of stereoisomers would have S-
configuration. The ratio of the stereoisomers cannot be accurately determined based on the 
integrals of Hb in the 1H NMR spectrum, because of the overlapping of the two complex 
multiplets associated with the major and minor pair of stereoisomers (insert C). Careful 
examination of the 1H NMR spectrum led to the decision of using the multiplets at 5.53–5.47 
ppm (insert B), and doublets at 6.46–6.39 ppm (insert A), which are the signals for the 
oxymethine protons next to the cinnamate ester and the α-protons of the cinnamate group. The 
boundary of the major and minor multiplets at 5.53–5.47 ppm is reasonably defined, while the 
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doublets at 6.46–6.39 ppm are all partially overlapping, but contain a few well-isolated single 
peaks which can provide representative ratios for the four constituent compounds.  The 
integrals for both oxymethine and α-protons agreed that the ratio of the major and minor 
products is consistent in both mixtures, and measured to be 3:2 R:S-configuration, which 
indicates poor stereoselectivity of the method. The ratio was also obtained from the 1H NMR 
spectrum of the crude product to better representate the composition of the mixture formed in 
the reaction, which agreed with the ratio of 3:2, with the R-configuration as major. Further 
optimization of the stereoselectivity will be required.  
  
 
Figure 5.9: 1H NMR spectrum of the mixture containing 242, with inserts A, B and C showing 
expansion of the multiplets at 6.42, 5.50 and 1.80 ppm, respectively. 
 
The viability of subjecting the advanced fragment 208 to Trost’s asymmetric alkynylation with 
analogue aldehyde 177 was also tested, but only 4% of the desired product 244 was obtained, 
alongside 17% of recovered starting material (Scheme 5.25). A substantial amount of the de-
esterified product 245 was obtained, which was not purified. The presence of 245 was 
confirmed by HRMS and comparing 1H NMR signals with those of a purified and characterized 
A     
B 
B 
A                                                            C 
 C 
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sample of compound 245 provided by PhD student Geyrhofer. The absence of alkene signals 
and a signal at 3.96 ppm corresponding to the de-esterified H19 were observed in the 1H NMR 
spectrum. Using Pu’s alkynylation method involving in situ generation of diethylzinc, 
Geyrhofer had previously isolated mostly the de-esterified product 245, even with model 
alkynes similar to 234. Although Trost’s method provided a good yield for model alkyne 234, 
the dienoate in fragment 208 was too unstable under the reaction condition. The 
stereoselectivity of this reaction was expected to be similar as the model system, but substrate 
influence from the additional stereocenter and the larger substituent could also be a factor.  Due 
to time constraints, Mosher’s ester analysis was not performed on 244. 
Scheme 5.25: Use of Trost’s alkynylation method with substrates 208 and 177. 
 
5.4 Summary 
 
In summary, the side arm attachment by a chiral boron reagent-promoted aza-aldol reaction 
failed to produce the desired product with a simple aldehyde model.  However, model 
substrates that better account for the functionality of the zampanolide macrocycle should be 
tested in this reaction. If unsuccessful, reliable alternative methods for the aza-aldol reaction 
can be attempted next. The oxidation of the alcohol group at C20 was briefly tested on a model 
of zampanolide /dactylolide. Although the well-precedented DMP oxidation led to degradation, 
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it could be a problem specific to the substrate used, thus substrates better represent dactylolide 
(21) could be investigated.  
Alkynylation to form the C15-C16 bond was also investigated. While unsatisfying results were 
obtained from Carreira’s non-stereoselective and Xiong’s methods, alkynylation involving 
ProPhenol and diethylzinc produced an excellent yield with a model alkyne. Although the 
stereoselectivity of the Et2Zn/ProPhenol alkynylation is yet to be optimized, it was also tested 
on the full zampanolide fragment generated from the Bestmann ylide reaction. A small amount 
of the desired product was isolated, alongside the de-esterified major product. Further 
optimization of this reaction and its stereoselectivity are underway. 
 
5.5 Experimental data 
General experimental information 
Unless otherwise stated, all reactions were carried out in oven-dried glassware under a positive 
pressure of nitrogen, delivered via a manifold. Dry tetrahydrofuran, dichloromethane and 
toluene were obtained from a PureSolv MD 5 solvent purification system (Innovative 
Technology). Analytical grade solvents were used for aqueous work-up and column 
chromatography (petroleum ether, ethyl acetate, diethyl ether, methanol and dichloromethane). 
Column chromatography was performed on silica gel 60 Å (Pure Science, 40–63 micron) with 
the eluent mixtures as stated in the corresponding procedures. Thin-layer chromatography was 
performed on silica-coated plastic plates (Macherey-Nagel, POLYGRAM® Sil G/UV254). All 
compounds were detected under UV irradiation (λ = 254 nm), followed by visualization with 
anisaldehyde staining solutions.  
All other chemicals were purchased from Pure Science, Sigma-Aldrich, Panreac, Merk and AK 
scientific. Infra-red (IR) spectra were collected on an ALPHA FT-IR spectrometer (Bruker) 
fitted with attenuated total reflectance (ATR). The intensities of signals are defined as: br = 
broad, s = strong, m = medium, w = weak. Mass spectra were collected on an Agilent 6530 
Accurate-Mass Q-TOF LC/MS high-resolution mass spectrometer (HRMS). The specific 
rotations were collected on an AUTOPOL II automatic polarimeter (Rudolph Research 
Analytical), and the reported values are an average of 10 measurements and concentrations are 
reported in g/100 mL. 
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Nuclear magnetic resonance (NMR) spectra were obtained in deuterated chloroform (CDCl3) 
using Varian Inova instruments operating at 500 or 600 MHz for proton and 125 or 150 MHz 
for carbon. Proton and carbon chemical shifts are reported in parts per million (ppm) relative 
to residual CHCl3 [δ(1H) = 7.26 ppm] and CDCl3 [δ(13C) = 77.0 ppm], respectively. Signals 
are defined as: s = singlet, d = doublet, t = triplet, q = quartet, quin = quintet, m = multiplet, 
app. = apparent, obs. = obscured peak.  Coupling constants (J) are reported in Hertz (Hz). 
Assignments were determined by two-dimensional NMR experiments (COSY, HSQC, and 
HMBC). 
 
Methyl 2-hydroxy-3-phenylpropanoate (220)  
To a solution of (S)-phenylalanine (4.00 g, 24.2 mmol) in aqueous H2SO4 
solution (36.0 mL, 3% V/V in H2O, 4.66 mmol) at 0 ºC, a solution of 
NaNO2 (2.51 g, 36.4 mmol) in H2O (4.8 mL, 7.5 M) was added dropwise 
over 1 h. After the addition, the reaction was slowly warmed to r.t. and stirred for 16 h. The 
reaction mixture was extracted with EtOAc (3 × 100 mL), and the organic layers were 
combined, dried over MgSO4 and the solvent was removed under reduced pressure to produce 
2-hydroxy-3-phenylpropanoic acid as a yellow crystalline material (2.29 g). This yellow solids 
and K2CO3 (2.30 g, 16.6 mmol) were dissolved in acetone (81 mL), and MeI (1.9 mL, 27.8 
mmol) was added. This reaction mixture was heated at 50 ºC for 4 h. The reaction mixture was 
concentrated under reduced pressure and dissolved in H2O (30 mL) and EtOAc (30 mL). The 
aqueous layer was separated and extracted with EtOAc (3 × 30 mL). The organic layers were 
combined, dried over MgSO4 and under reduced pressure to yield 220 as a pale yellow solid 
(1.58 g, 44% yield from (S)-phenylalanine).  
1H NMR (500 MHz, CDCl3): δ 7.34–7.29 (m, 2H, CH, Ph), 7.26–7.20 (m, 3H, CH, Ph), 4.47 
(ddd, J = 6.7, 5.6, 4.2 Hz, 1H, 2-CH), 3.79 (s, 3H, CH3, Me), 3.14 (dd, J = 13.9, 4.4 Hz, 1H, 
one of 3-CH2), 2.98 (dd, J = 13.9, 6.8 Hz, 1H, one of 3-CH2), 2.70 (d, J = 6.1 Hz, 1H, OH). 
13C NMR (125 MHz, CDCl3): δ 174.6 (C, C1), 136.3 (C, Ph), 129.5 (CH, Ph), 128.4 (CH, Ph), 
126.9 (CH, Ph), 71.2 (CH, C2), 52.5 (CH3, Me), 40.6 (CH2, C3). 
The data agree with previously reported.58 
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Methyl 2-(t-butylcarbonate)-3-phenylpropanoate (224)  
A mixture of 220 (304 mg, 1.69 mmol), Zn(OAc)2·2H2O (37 mg, 0169 
mmol) and Boc2O (0.43 mL, 407 mg, 1.86 mmol) were stirred at 50 ºC 
for 4 h. Upon cooling, the reaction mixture was diluted with CH2Cl2 (10 
mL) and H2O (10 mL). The aqueous layer was separated and extracted 
with CH2Cl2 (2 × 10 mL), the organic layers were combined, dried over MgSO4 and 
concentrated under reduced pressure. The crude product was purified by column 
chromatography (silica, 10:1 pet. ether:EtOAc, Rf = 0.29) to yield the product 224 as a pale 
yellow solid (397 mg, 85% yield). Only 1H NMR data was collected when 224 was first 
prepared. After over three years of storage, some decomposition occurred. The 13C NMR, IR 
and HRMS data were collected on this partially decomposed product, and the desired carbon 
signals were identified in the mixture by 2D correlations. 
1H NMR (500 MHz, CDCl3): δ 7.34–7.28 (m, 2H, CH, Ph), 7.28–7.22 (m, 3H, CH, Ph), 5.10 
(dd, J = 8.3, 4.4 Hz, 1H, 2-CH), 3.74 (s, 3H, CH3, Me), 3.19 (dd, J = 14.2, 4.1 Hz, 1H, one of 
3-CH2), 3.11 (dd, J = 14.0, 8.6 Hz, 1H, one of 3-CH2), 1.45 (s, 9H, CH3, tBu). 
13C NMR (125 MHz, CDCl3): δ 170.3 (C, C1), 152.8 (C, C4), 135.7 (C, Ph), 129.4 (CH, Ph), 
128.5 (CH, Ph), 127.0 (CH, Ph), 83.2 (C, tBu), 75.2 (CH, C2), 52.4 (CH3, OMe), 37.5 (CH2, 
C3), 27.6 (CH3, tBu).  
IR (neat) cm-1: 3031 (w, C–H), 2980 (m, C–H), 1739 (s, C=O), 1604 (w, C–H), 1278 (s, C–O), 
1154 (s, C–O), 1103 (s, C–O), 792 (m, C–H), 698 (s, C–H). 
HRMS (ESI) m/z: found 298.1549, calcd for C15H24O5N 298.1547 [M+NH4]
+ (Δ = 0.7 ppm). 
 
2-(t-Butylcarbonate)-3-phenylpropanal (223)  
To a solution of ester 224 (63 mg, 0.225 mmol) in CH2Cl2 (1.3 mL, 0.17 
M) at -78 ºC, a solution of DIBAL-H (0.25 mL, 1.0 M in cyclohexane, 
0.25 mmol) was added dropwise. The reaction was stirred at -78 ºC for 
3 h 30 min, and then quenched by the addition of MeOH (0.5 mL) and 
sat. aq. Rochelle salt (1.0 mL). The mixture was warmed to r.t.. After stirring vigorously for 2 
h, the reaction mixture was extracted with EtOAc (3 × 10 mL). The organic layers were 
combined, dried over MgSO4 and concentrated under reduced pressure. The crude material was 
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purified by column chromatography (silica, 10:1 pet. ether:EtOAc, Rf = 0.12) to yield the 
product 223 as a pale yellow solid (21 mg, 38% yield) and a mixture of starting material and 
product (31 mg, 4:1 224:223). Only 1H NMR and HRMS data were collected. 
1H NMR (500 MHz, CDCl3): δ 9.61 (s, 1H, 1-CH), 7.35–7.29 (m, 2H, CH, Ph), 7.29–7.20 (m, 
3H, CH, Ph), 5.06 (dd, J = 8.0, 5.0 Hz, 1H, 2-CH), 3.18 (dd, J = 14.4, 4.5 Hz, 1H, one of 3-
CH2), 3.04 (dd, J = 14.4, 8.8 Hz, 1H, one of 3-CH2), 1.46 (s, 9H, CH3, tBu). 
HRMS (ESI) m/z: found 251.1300, calcd for C14H19O4 [M+H]
+ 215.1278 (Δ = 1.0 ppm).  
 
(5′-Trimethylsilyl)pent-4′-yn-2′-yl 5-phenylpenta-2,4-dienoate (227) 
To a stirred solution of the PMB-ether 206 (131 mg, 0.292 mmol) 
in CH2Cl2:H2O (10:1 V/V, 3.9 mL) at r.t., DDQ (79 mg, 0.348 
mmol) was added. The reaction mixture was stirred at r.t. for 1 h 
30 min. The solvent was removed under reduced pressure. The 
crude product was purified by column chromatography (silica, 5:1 pet. ether:EtOAc, Rf = 0.15) 
to yield the alcohol 227 as a yellow oil (91 mg, 95% yield). 
1H NMR (500 MHz, CDCl3) δ 7.51 (dd, J = 16.2, 10.2 Hz, 1H, 2-CH), 7.49 – 7.46 (m, 2H, 7-
CH), 7.39 – 7.30 (m, 3H, 8-CH and 9-CH), 6.96 – 6.84 (m, 2H, 4-CH and 5-CH), 6.02 (d, J = 
15.3 Hz, 1H, 2ʹ-CH), 5.09 (dtd, J = 7.1, 5.8, 3.6 Hz, 1H, 2-CH), 3.95–3.89 (m, 1H, one of 1ʹ-
CH2), 3.89–3.83 (m, 1H, one of 1ʹ-CH2), 2.67 (dd, J = 14.9, 4.0 Hz, 1H, one of 3ʹ-CH2), 2.65 
–2.60 (m, 1H, one of 3ʹ-CH2), 0.15 (s, 9H, CH3, Me). 
13C NMR (125 MHz, CDCl3) δ 166.6 (C, C1), 145.6 (CH, C3), 141.1 (CH, C5), 135.9 (C, C6), 
129.2 (CH, C8), 128.8 (CH, C9), 127.3 (CH, C7), 126.0 (CH, C4), 120.5 (CH, C2), 101.4 (C, 
C4′), 87.6 (C, C5′), 72.8 (CH, C2′), 63.6 (CH2, C1′), 22.0 (CH2, C3′), -0.05 (CH3, Me). 
HRMS (ESI) m/z: found 329.1572, calcd for C19H25O3Si [M+H]
+ 329.1567 (Δ = 1.4 ppm). 
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1′-(para-Methoxybenzyloxy)pent-4′-yn-2′-yl 3-phenylprop-2-enoate (234) 
To a solution of alcohol 153 (100 mg, 0.454 mmol) 
in CH2Cl2 (1.0 mL, 0.15 M) at r.t., cinnamic acid 
(75 mg, 0.51 mmol) and DMAP (3 mg, 0.02 mmol) 
were added. This solution was stirred for 10 min. 
Upon the addition of DCC (103 mg, 0.499 mmol), 
the clear solution turned cloudy. The reaction was stirred for 4 h at r.t., filtered through Celite, 
and the filtrate was concentrated under reduced pressure. The crude product was purified by 
column chromatography (silica, 10:1 pet. ether:EtOAc, Rf = 0.14) to yield the ester 234 as a 
colourless oil (158 mg, 99% yield). 
1H NMR (500 MHz, CDCl3): δ 7.71 (d, J = 16.1 Hz, 1H, 3-CH), 7.53 (d, J = 6.2 Hz, 2H, 5-
CH), 7.41–7.37 (complex m, 3H, 6-CH & 7-CH), 7.27 (obs. d, J = 8.5 Hz, 2H, 8′-CH), 6.88 (d, 
J = 8.5 Hz, 2H, 9′-CH), 6.47 (d, J = 15.9 Hz, 1H, 2-CH), 5.23 (app. quin, J = 5.4 Hz, 1H, 2′-
CH), 4.55 (d, J = 11.7 Hz, 1H, one of 6′-CH2), 4.50 (d, J = 11.7 Hz, 1H, one of 6′-CH2), 3.79 
(s, 3H, 11′-CH3), 3.72 (dd, J = 10.5, 5.1 Hz, 1H, one of 1′-CH2), 3.69 (dd, J = 10.7, 4.6 Hz, 1H, 
one of 1′-CH2), 2.69 (ddd, J = 16.9, 6.6, 2.4 Hz, 1H, one of 3′-CH2), 2.63 (ddd, J = 16.9, 5.9, 
2.7 Hz, 1H, one of 3′-CH2), 2.00 (t, J = 2.6 Hz, 1H, 5′-CH). 
13C NMR (125 MHz, CDCl3): δ 166.2 (C, C1), 159.3 (C, C10′), 145.4 (CH, C3), 134.3 (C, C4), 
130.4 (CH, C7), 129.9 (C, C7′), 129.3 (CH, C8′), 128.9 (CH, C6), 128.1 (CH, C5), 117.8 (CH, 
C2), 113.8 (CH, C9′), 79.4 (C, C4′), 73.0 (CH2, C6′), 70.6 (CH, C2′/ C5′), 70.5 (CH, C5′/ C2′), 
69.4 (CH2, C1′), 55.3 (CH3, C11′), 21.0 (CH2, C3′).  
IR (neat) cm-1: 3290 (m, C–H), 2909 (m, C–H), 2863 (m, C–H), 2120 (w, C≡C), 1709 (s, C=O), 
1636 (s, C=C), 1511 (s, C–O), 1245 (s, C–O), 1165 (s, C–O), 710 (s, C–Si). 
HRMS (ESI) m/z: found 368.1859, calcd for C22H26O4N [M+NH4]
+ 368.1856 (Δ = 0.8 ppm).  
 
(1R,2R)-2-(N,N-Dimethylamino)-1-(4ʹ-nitrophenyl)propane-1,3-diol (238) 
(1R,2R)-2-amino-1-(4ʹ-nitrophenyl)propane-1,3-diol (233, 1.00 g, 
5.98 mmol), aqueous formaldehyde solution (1.5 mL, 37%) and 
formic acid (2.0 mL, 98%) were mixed in a flask. The starting 
material 233 dissolved upon heating, and the solution was heated at 
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100 ºC for 8 h. After cooling to r.t., the yellow solution was neutralized with aqueous NaOH 
(1N) solution to pH 8 to precipitate out the solid. The aqueous mixture was extracted with 
CH2Cl2 (5 × 50 mL), and the organic layers were combined, dried over MgSO4 and 
concentrated under reduced pressure. The yellow oil obtained was then purified by column 
chromatography (SiO2, 10:1 CH2Cl2:MeOH) to yield the product 238 as yellow crystals (1.06 
g, 94%). 
1H NMR (500 MHz, CDCl3) δ 8.20 (d, J = 8.7 Hz, 2H, 3ʹ-CH), 7.60 (d, J = 8.7 Hz, 2H, 2ʹ-
CH), 4.59 (d, J = 9.7 Hz, 1H, 1-CH), 3.61 (d, J = 4.7 Hz, 2H, 3-CH2), 2.59 (dt, J = 10.4, 5.2 
Hz, 1H, 2-CH), 2.54 (s, 6H, CH3, Me). 
13C NMR (125 MHz, CDCl3): δ 149.9 (C, C4ʹ), 128.0 (CH, C2ʹ), 123.6 (CH, C3ʹ), 71.3 (CH, 
C2), 69.9 (CH, C1), 57.9 (CH2, C3), 41.6 (CH3, Me). 
IR (neat) cm-1: 3359 (br, C–O), 2981 (w, C–H). 2917 (m, C–H), 2796 (w, C–H), 1519 (s, C–
C), 1348 (s, N–C), 1244 (m, N–C), 1177 (m, N–C), 1059 (s, C–O). 
HRMS (ESI) m/z: found 241.1183, calcd for C11H17N2O4 [M+H]
+ 241.1183 (Δ = 0.0 ppm). 
M.p.: 102.0 – 103.4 ºC. (Lit. for (1S,2S)-isomer: 88.8 – 89.1 ºC.)47 
Specific rotation: [𝑎]𝐷
21 = -15.4 (c = 0.532, CH2Cl2). (Lit. for (1S,2S)-isomer: +25.7 (c = 0.505, 
CH3OH).)
47 
The carbon signal for C1ʹ was missing, but the overall agreement of the NMR and IR data with 
those reported for the (1S,2S)-isomer and the HRMS data suggest that 238 was successfully 
prepared.47 The optical rotation data obtained has opposite sign with the (1S,2S)-isomer.47 
 
(1R,2R)-3-(t-Butyldimethylsilyloxy)-2-(N,N-dimethylamino)-1-(4ʹ-nitrophenyl)propan-1-
ol (232) 
A solution of the diol 238 (1.05 g, 4.37 mmol), TBSCl (676 mg, 
4.49 mmol), imidazole (734 mg, 10.8 mmol) and DMAP (5 mg, 
0.04 mmol) in CH2Cl2 (15 mL) was stirred at r.t. for 15 h. The 
reaction was diluted with H2O (10 mL) and basified with aqueous NaOH (1N) to pH 9. The 
aqueous layer was separated and extracted with CH2Cl2 (2 × 20 mL). The organic layers were 
combined, dried over MgSO4 and concentrated under reduced pressure. The yellow oil 
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obtained was then purified by column chromatography (SiO2, 10:1 pet. ether:EtOAc, Rf = 0.35) 
to yield the product 232 as a yellow oil (946 mg, 61%). 
1H NMR (500 MHz, CDCl3) δ 8.18 (d, J = 8.6 Hz, 2H, 3ʹ-CH), 7.59 (d, J = 8.6 Hz, 2H, 2ʹ-
CH), 4.62 (d, J = 9.7 Hz, 1H, 1-CH), 3.64 (dd, J = 11.3, 2.2 Hz, 1H, one of 3-CH2), 3.46 (dd, 
J = 11.4, 5.9 Hz, 1H, one of 3-CH2), 2.48 (s, 6H, CH3, NMe2), 2.48–2.45 (obs. m, 1H, 2-CH) 
0.86 (s, 9H, tBu, TBS), -0.04 (s, 3H, Me, TBS), -0.05 (s, 3H, Me, TBS). 
13C NMR (125 MHz, CDCl3) δ 150.3 (C, C4ʹ), 147.4 (C, C1ʹ), 128.1 (CH, C2ʹ), 123.4 (CH, 
C3ʹ), 71.4 (CH, C2), 69.1 (CH, C1), 57.1 (CH2, C3), 41.7 (CH3, Me), 25.8 (CH3, tBu, TBS), 
18.0 (C, tBu, TBS), -5.8 (CH3, Me, TBS), -5.8 (CH3, Me, TBS). 
IR (neat) cm-1: 3333 (br, O–H), 2929 (w, C–H). 2857 (m, C–H), 2795 (w, C–H), 1521 (s, C–
C), 1346 (s, N–C), 1253 (m, N–C), 1110 (s, C–O), 833 (s, C–H and Si–C), 775 (s, Si–C). 
HRMS (ESI) m/z: found 355.2054, calcd for C17H30N2O4Si [M+H]
+ 355.2048 (Δ = 1.7 ppm). 
Specific rotation: [𝑎]𝐷
23 = +12.6 (c = 0.400, CH2Cl2). (Lit. for (1S,2S)-isomer: -15.8 (c = 1.09, 
CHCl3).)
47 
The NMR and IR data matches those reported for the (1S,2S)-isomer, and the optical rotation 
data obtained has opposite sign.47 
 
(1R,2R)-1,3-Bis-(t-butyldimethylsilyloxy)-2-N,N-dimethylamino-1-(4ʹ-nitrophenyl) 
propane (239) 
The di-TBS protected product 239 was a minor product in the 
TBS protection reaction and was obtained as a yellow oil (62 mg, 
3%). Rf (3:1 pet. Ether:EtOAc) = 0.55. 
1H NMR (500 MHz, CDCl3) δ 8.15 (d, J = 7.5 Hz, 2H, 3ʹ-CH), 7.50 (d, J = 7.9 Hz, 2H, 2ʹ-
CH), 5.01 (d, J = 3.7 Hz, 1H, 1-CH), 3.81 (dd, J = 9.6, 7.0 Hz, 1H, one of 3-CH2), 3.63 (dd, J 
= 9.7, 6.4 Hz, 1H, one of 3-CH2), 2.55 (app. q, J = 5.5 Hz, 1H, 2-CH), 2.35 (s, 6H, CH3, Me), 
0.91 (s, 18H, CH3, tBu, TBS), 0.07 (s, 3H, CH3, Me, TBS), 0.05 (s, 3H, CH3, Me, TBS), 0.04 
(s, 3H, CH3, Me, TBS), -0.20 (s, 3H, CH3, Me, TBS). 
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13C NMR (125 MHz, CDCl3) δ 151.9 (C, C4ʹ), 146.8 (C, C1ʹ), 127.6 (CH, C2ʹ), 122.8 (CH, 
C3ʹ), 74.3 (CH, C1), 71.0 (CH, C2), 59.3 (CH2, C3), 43.5 (CH3, Me), 25.9 (CH3, tBu, TBS), 
25.8 (CH3, tBu, TBS), 18.1 (C, tBu, TBS), -4.7 (CH3, Me, TBS), -5.1 (CH3, Me, TBS), -5.38 
(CH3, Me, TBS), -5.44 (CH3, Me, TBS). 
IR (neat) cm-1: 2929 (w, C–H). 2857 (m, C–H), 2795 (w, C–H), 1522 (s, C–C), 1388 (s, N–C), 
1255 (m, N–C), 1094 (s, C–O), 833 (s, C–H and Si–C), 774 (s, Si–C). 
HRMS (ESI) m/z: found 469.2917, calcd for C23H45N2O4Si2 [M+H]
+ 469.2912 (Δ = 1.1 ppm). 
 
1-Phenyloct-1-yn-3-ol (237) 
 
1H NMR (500 MHz, CDCl3): δ 7.45–7.40 (m, 2H, Ph), 7.33–7.29 (m, 3H, Ph), 4.60 (app. q, J 
= 6.2 Hz, 1H, 3-CH), 1.88 (d, J = 5.8 Hz, 1H, OH), 1.86–1.74 (m, 2H, 4-CH2), 1.57–1.48 (m, 
2H, 5-CH2), 1.40–1.31 (complex m, 4H, 6-CH2 and 7-CH2), 0.91 (t, J = 7.0 Hz, 3H, 8-CH3). 
13C NMR (125 MHz, CDCl3): δ 131.7 (CH, Ph), 128.3 (CH, Ph), 128.3 (CH, Ph), 122.7 (C, 
Ph), 90.2 (C, C2), 84.8 (C, C1), 63.0 (CH, C3), 37.9 (CH2, C4), 31.5 (CH2, C6/C7), 24.9 (CH2, 
C5), 22.6 (CH2, C6/C7), 14.0 (CH3, C8). 
These data were consistent with those reported previously.59 
 
1′-(para-Methoxybenzyloxy)-6ʹ-hydroxy-10ʹ-(t-butyldimethylsilyloxy)dec-4′-yn-2′-yl 3-
phenylprop-2-enoate (240)  
To a solution of alkyne 234 (98 mg, 0.28 mmol), 
(R,R)-ProPhenol (13 mg, 0.020 mmol) and 
triphenylphosphine oxide (11 mg, 0.040 mmol) 
in toluene (0.3 mL) at r.t., Et2Zn (0.30 mL, 1.0 
M in hexane, 0.30 mmol) was added dropwise. 
After the reaction was stirred at r.t. for 64 h, a 
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solution of aldehyde 177 (38 mg, 0.18 mmol) in toluene (0.3 mL) was added. The reaction was 
stirred at r.t. for an additional 24 h, and then quenched with sat. aq. NH4Cl (15 mL). The 
reaction mixture was extracted with Et2O (3 × 20 mL), and the organic layers were combined, 
dried over MgSO4 and concentrated under reduced pressure. The crude product was purified 
by column chromatography (SiO2, 5:1 Pet. ether:EtOAc) to yield the product 240 as a 
colourless, clear oil (76 mg, 76% yield). 
1H NMR (500 MHz, CDCl3): δ 7.71 (d, J = 15.9 Hz, 1H, 3-CH), 7.56–7.50 (m, 2H, 5-CH), 
7.41–7.36 (complex m, 3H, 6-CH & 7-CH), 7.27 (obs. d, J = 7.1 Hz, 2H, 14ʹ-CH), 6.88 (d, J = 
7.5 Hz, 2H, 13ʹ-CH), 6.46 (d, J = 16.0 Hz, 1H, 2-CH), 5.21 (app. quin, J = 5.2 Hz, 1H, 2′-CH), 
4.55 (d, J = 11.9 Hz, 1H, one of 11′-CH2), 4.49 (d, J = 11.7 Hz, 1H, one of 11′-CH2), 4.34–
4.27 (m, 1H, 6ʹ-CH), 3.79 (s, 3H, CH3, C16ʹ), 3.72–3.63 (m, 2H, 1′-CH2), 3.59 (t, J = 6.2 Hz, 
2H, 10′-CH2), 2.69 (dd, J = 16.7, 6.8 Hz, 1H, one of 3′-CH2), 2.63 (dd, J = 16.8, 5.9 Hz, 1H, 
one of 3′-CH2), 1.81 (br. s, 1H, OH), 1.72–1.58 (m, 2H, 7ʹ-CH2), 1.53 (app. quin, J = 6.3 Hz, 
2H, 9ʹ-CH2), 1.46 (app. quin, J = 6.6 Hz, 2H, 8ʹ-CH2), 0.88 (s, 9H, CH3, tBu, TBS), 0.04 (s, 
6H, CH3, Me, TBS). 
13C NMR (126 MHz, CDCl3): δ 166.3 (C, C1), 159.3 (C, C15ʹ), 145.4 (CH, C3), 134.3 (C, C4), 
130.4 (CH, C7), 129.9 (C, C12ʹ), 129.4 (CH, C14ʹ), 128.9 (CH, C6), 128.1 (CH, C5), 117.8 
(CH, C2), 113.8 (CH, C13ʹ), 83.5 (C, C5ʹ), 80.3 (C, C4ʹ), 73.0 (CH2, C11′), 70.9 (CH, C2′), 
69.3 (CH2, C1′), 63.0 (CH2, C10′), 62.5 (CH, C6′), 55.3 (CH3, PMB), 37.7 (CH2, C7′), 32.4 
(CH2, C9′), 26.0 (CH3, tBu, TBS), 21.5 (CH2, C8′), 21.2 (CH2, C3′), 18.3 (C, tBu, TBS), -5.3 
(CH3, Me, TBS). 
IR (neat) cm-1: 3477 (br, O–H), 3190 (w, C–H), 2933 (m, C–H). 2857 (m, C–H), 1712 (s, C=O), 
1637 (m, C–C), 1513 (m, C–C), 1388 (m, C–H), 1280 (m, C–H), 1248 (s, C–O), 1171 (s, C–
O), 1095 (s, C–O), 1033 (s, C–O), 833 (s, C–Si), 767 (s, C–Si), 682 (C–H). 
HRMS (ESI) m/z: found 605.2698, calcd for C33H46O6SiK [M+K]
+ 605.2695 (Δ = 0.5 ppm). 
Specific rotation: [𝑎]𝐷
21 = -0.51 (c = 1.36, CH2Cl2). 
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Mosher’s ester of alcohol 241 derived from alcohol 240 and 242 
To a solution of (R)-methoxy-α-(trifluoromethyl)phenylacetic acid (11 mg, 0.047 mmol) in 
toluene (0.2 mL, 0.24 M) at r.t., Et3N (147 μL, 107 mg, 1.06 mmol) and 2,4,6-trichlorobenzoyl 
chloride (12 μL, 19 mg, 0.078 mmol) were added. After stirring at r.t. for 1 h 10 min, a solution 
of alcohol 240 (17 mg, 0.030 mmol) and DMAP (6 mg, 0.05 mmol) in toluene (0.2 mL) was 
added dropwise. The reaction was stirred for 20 h at r.t.. The solvent was removed under 
reduced pressure, and the crude product was purified by column chromatography (SiO2, 5:1 
Pet. ether:EtOAc, Rf = 0.33) to yield two fractions consisting of mixtures of  isomeric products 
241 and by-product 242 as colourless oils (The 11 mg sample contains more by-product 242, 
and 3 mg with less 242). 
Table 5.1: Molar ratios of 6ʹR-241, 6ʹS-241 and 242 in the 11 mg and 3 mg samples, calculated 
based on the 1H NMR integrals of 2ʹ-CH. 
 Molar ratios of isomeric products 241 and by-product 242 
(6ʹR)-241 (6ʹS)-241 242 
11 mg sample 3 2 3 
3 mg sample 3 2 1 
 
1H NMR of the 3 mg sample (600 MHz, CDCl3): δ 7.695 and 7.686 (2 × d, J = 16.1 Hz, 0.17H, 
3-CH-242), 7.690 and 7.677 (2 × d, J = 16.1 Hz, 0.33H, 3-CH-(6ʹS)-241), 7.683 and 7.677 (2 
× d, J = 16.1 Hz, 0.50H, 3-CH-(6ʹR)-241), 7.56–7.50 (m, 1H, CH, Ph), 7.52–7.47 (m, 2H, CH, 
Ph), 7.31 (s, 0.17H, 20ʹ/22ʹ-CH-242), 7.30 (s, 0.17H, 20ʹ/22ʹ-CH-242), 7.41–7.35 (m, 5H, CH, 
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Ph), 7.27–7.22 2H (m, 1H, CH, Ph), 6.86 (d, J = 8.6 Hz, 2H, 13ʹ-CH), 6.445 and 6.441 (2 × d, 
J = 16.0 Hz, 0.17H, 2-CH-242), 6.435 and 6.408 (2 × d, J = 16.0 Hz, 0.33H, 2-CH-(6ʹS)-241), 
6.415 and 6.410 (2 × d, J = 16.0 Hz, 0.50H, 2-CH-(6ʹR)-241), 5.59 (t, J = 6.9 Hz, 0.17H, 6ʹ-
CH-242), 5.53–5.49 (m, 0.50H, 6ʹ-CH-(6ʹR)-241), 5.49–5.46 (m, 0.33H, 6ʹ-CH-(6ʹS)-241), 
5.22–5.13 (m, 1H, 2ʹ-CH), 4.55–4.43 (m, 2H, 11ʹ-CH2), 3.78 (s, 3H, 16ʹ-CH3), 3.55 (s, 1.5H, 
20ʹ-CH3-(6ʹR)-241), 2.53 (s, 1.0H, 20ʹ-CH3-(6ʹS)-241), 3.72–3.61 (m, 2H, 1ʹ-CH2), 3.61–3.50 
(m, 2H, 10ʹ-CH2), 2.76–2.60 (m, 2H, 3ʹ-CH2), 1.93–1.87 (m, 0.34H, 9ʹ-CH2-242), 1.87–1.82 
(m, 0.66H, 9ʹ-CH2-(6ʹS)-241), 1.82–1.69 (m, 1.0H, 9ʹ-CH2-(6ʹR)-241), 1.57–1.47 (m, 0.34H, 
7ʹ-CH2-242 and 8ʹ-CH2-242), 1.48–1.40 (m, 3.32H, 7ʹ-CH2-(6ʹR) and (6ʹS)-241 and 8ʹ-CH2-
(6ʹR) and (6ʹS)-241), 0.873 and 0.869 and 0.866 (s, 9H, tBu, TBS), 0.027 and 0.018 and 0.011 
(s, 6H, Me, TBS) 
13C NMR (150 MHz, CDCl3) δ 166.16 and 166.14 (C, C1), 165.71 and 165.70 and 165.64 and 
165.63 (C, C17ʹ), 163.7 (CH, C6ʹ), 159.24 and 159.22 (C, C15ʹ), 145.43 and 145.42 and 145.38 
(CH, C3-(6ʹR) and (6ʹS)-241), 145.33 and 145.31 (CH, C3-242), 135.04 and 134.40 (C, 
C18ʹ/C19ʹ/21ʹ-242), 134.30 and 134.29 (C, C4-242), 134.26 and 134.25 and 134.23 and 134.21 
(C, C4-(6ʹR) and (6ʹS)-241), 132.68 (C, C18ʹ/19ʹ/21ʹ-242), 132.42 (C, Ph), 132.32 (C, Ph), 
131.98 (C, Ph), 131.76 and 131.75 (C, C18ʹ/C19ʹ/21ʹ-242), 130.40 and 130.38 and 130.36 (CH, 
Ph), 129.93 and 129.89 and 129.87 and 129.85 and 129.84 (C, C12ʹ), 129.60 (CH, Ph), 129.30 
(CH, Ph), 128.86 (CH, Ph), 128.37 and 128.35 and 128.34 (CH, Ph), 128.18 and 128.13 and 
128.12 (CH, Ph), 127.98 and 127.97 (CH, C20ʹ-242), 127.44 and 127.30 (CH, Ph), 117.81 and 
117.80 and 117.72 and 117.71 and 117.68 and 117.65 (CH, C2), 113.77 and 113.77 and 113.76 
(CH, C13ʹ), 82.39 and 82.38 (C, C4ʹ-(6ʹR)-241), 82.24 and 82.23 (C, C4ʹ-(6ʹS)-241),  82.21(C, 
C4ʹ-242), 78.73 and 78.72 (C, C5ʹ-242), 78.62 and 78.60 (C, C5ʹ-(6ʹR)-241), 78.44 and 78.43 
(C, C5ʹ-(6ʹS)-241), 73.04 and 73.02 (CH2, C11ʹ), 70.61 and 70.59 and 70.51 and 70.49 and 
70.48 (CH, C2ʹ), 69.31 and 69.22 and 69.21 and 69.17 and 69.15 (CH2, C1ʹ), 66.7 (CH, C6ʹ-
(6ʹR) and (6ʹS)-241), 66.37 and 66.34 (CH, C6ʹ-242), 62.79 and 62.73 (CH2, C10ʹ), 55.49 and 
55.44 (CH3, C20ʹ-(6ʹR) and (6ʹS)-241), 55.2 (CH3, C16ʹ), 34.58 and 34.41 and 34.39 (CH2, C9ʹ), 
32.15 and 32.10 and 32.02 (CH2, C7ʹ), 25.94 and 25.92 (CH3, tBu, TBS), 21.55 and 21.45 and 
21.26 and 21.20 (CH2, C8ʹ), 21.14 and 21.13 and 21.09 and 21.06 (CH2, C3ʹ), 18.32 and 18.30 
(C, tBu, TBS), -5.31 and -5.34 (CH3, Me, TBS).  
HRMS (ESI) m/z: 241 found 800.3815, calcd for C43H57F3O8SiN [M+NH4]
+ 800.3800 (Δ = 
1.9); 242 found 811.1802, calcd for C40H57
35Cl3O7SiK [M+K]
+ 811.1788 (Δ = 1.8 ppm). 
 169 
 
1′-(para-Methoxybenzyloxy)-6′-hydroxy-10′-(t-butyldimethylsilyloxy)dec-4′-yn-2′-yl 5-
methyl-7-( t-butyldimethylsilyloxy)non-2,4,8-trienoate (244)  
To a solution of 208 (48 mg, 0.096 mmol), 
(R,R)-ProPhenol (12 mg, 0.019 mmol) and 
TPPO (11 mg, 0.038 mmol) in toluene (0.25 
mL) at r.t., a solution of Et2Zn (0.11 mL, 1.0 
M in cyclohexane, 0.11 mmol) was added 
dropwise. The reaction was stirred for 71 h, 
and a solution of aldehyde 177 (26 mg, 0.120 
mmol) in toluene (0.1 mL) was added dropwise. After stirring for 23 h at r.t., the reaction was 
quenched with sat. aq. NH4Cl (10 mL), and extracted with CH2Cl2 (3 × 20 mL). The organic 
layers were combined, dried over MgSO4 and concentrated under reduced pressure. The crude 
product was purified by column chromatography (SiO2, gradient elution: 20:1 then 10:1 then 
5:1 Pet. ether:EtOAc, then 100% EtOAc, Rf = 0.15 in 5:1 Pet. ether:EtOAc). Unsatisfactory 
separation was achieved, and the mixture containing the majority of the desired product 
isomers (11mg) were further purified by column chromatography (SiO2, 100% CH2Cl2, Rf = 
0.06) to yield the product as a colourless, clear oil (3 mg, 4% yield). Evidence of a trace amount 
of the 2Z-isomer of 244 was observed. Due to the complexity of the mixture and the weak 
signals from the minor compounds, only the signals of the major compound were quoted below.  
1H NMR (600 MHz, CDCl3): δ 7.57 (dd, J = 15.0, 11.5 Hz, 1H, 3-CH), 7.25 (d, J = 7.5 Hz, 
2H, 14ʹ-CH), 6.87 (d, J = 7.2 Hz, 2H, 13ʹ-CH), 6.06 (d, J = 11.6 Hz, 1H, 4-CH), 5.86–5.73 (m, 
1H, 8-CH), 5.79 (d, J = 15.0 Hz, 1H, 2-CH), 5.17 (d, J = 17.4 Hz, 1H, one of 9-CH2), 5.22–
5.10 (m, 1H, 2ʹ-CH), 5.04 (d, J = 10.3 Hz, 1H, one of 9-CH2), 4.53 (d, J = 11.9 Hz, 1H, one of 
11ʹ-CH2), 4.47 (d, J = 11.5 Hz, 1H, one of 11ʹ-CH2), 4.29 (app. q, J = 5.7 Hz, 1H, 6ʹ-CH), 4.24 
(app. q, J = 6.7 Hz, 1H, 7-CH), 3.80 (s, 3H, 16ʹ-CH3), 3.69–3.54 (complex m, 4H, 1ʹ-CH2 and 
10ʹ-CH2), 2.69–2.52 (complex m, 3H, 6-CH2 and one of 3ʹ-CH2), 2.40–2.30 (m, 1H, one of 3ʹ-
CH2), 1.91 (s, 3H, 10-CH3), 1.80–1.29 (complex m, 6H, 7ʹ-CH2, 8ʹ-CH2 and 9ʹ-CH2), 0.94–
0.81 (m, 18H, TBS), 0.08– -0.02 (m, 12H, TBS). 
13C NMR (150 MHz, CDCl3): δ 166.8 (C, C1), 159.2 (C, C15ʹ), 146.8 (C, C5), 141.9 (CH, C3), 
140.89 and 140.87 and 140.85 (CH, C8), 130.0 (C, C12ʹ), 129.3 (CH, C13ʹ), 126.1 (CH, C4), 
118.7 (CH, C2), 114.2 (CH2, C9), 113.7 (CH, C14ʹ), 83.3 (C, C5ʹ), 80.46 and 80.45 (C, C4ʹ), 
72.9 (CH2, C11ʹ), 72.79 and 72.77 (CH, C7), 70.45 and 70.43 (CH, C2ʹ), 69.31 and 69.27 (CH2, 
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C1ʹ), 63.0 (CH2, C10ʹ), 62.5 (CH, C6ʹ), 55.3 (CH3, C16ʹ), 41.7 (CH2, C6), 37.7 (CH2, C7ʹ), 32.4 
(CH2, C9ʹ), 26.0 and 25.8 (CH3, tBu, TBS), 25.6 and 25.5 (CH3, C10), 21.5 (CH2, C8ʹ), 21.2 
(CH2, C3ʹ), 18.4, and 18.3 (C, tBu, TBS), -4.6 and -4.9 and -5.27 and -5.33 (CH3, Me, TBS). 
HRMS (ESI) m/z: found 715.4453, calcd for C40H67O7Si2 [M+H]
+ 715.4420 (Δ = 4.6 ppm). 
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Chapter 6: Summary and Future work 
 
In this project, progress was made towards the synthesis of zampanolide (19) and its analogues. 
According to the first-generation synthetic plan, precursors to fragments C1-C8, C9-C15, C16-
C20 and a des-methyl analogue of the C1-C8 fragment were successfully synthesized. However, 
some difficulties were encountered in advancing the precursors to the desired fragments, 
namely in protection at the O19 position, incomplete of Wittig reaction to construct the C2-C3 
alkene and oxidation at C15 of the C9-C15 precursor to aldehyde. The synthesis was then 
revised, and a more efficient second-generation synthesis utilizing a linchpin approach was 
developed. This was made possible by the use of Bestmann ylide as a linchpin. This is an 
expanded application of Bestmann ylide, therefore the scope of the Bestmann ylide reaction to 
construct α,β,γ,δ-unsaturated esters (dienoates) was explored, and it was successfully applied 
to the coupling of the C3-C8 (127) and C15-C20 (147 and 153) fragments. Late stage strategies 
were also tested on model compounds, including the side-arm attachment via aza-aldol reaction 
with chiral boron reagents, oxidation of the C20 alcohol to an aldehyde and C15-C16 
alkynylation of aldehydes. Although more research is required, an alkynylation method was 
found to produce a small amount of the desired product 244, which established 16 out of the 
18 carbons of the macrocycle.  
 
Research to optimize the asymmetric alkynylation is already underway, and the alkynylation 
product 244 will be transformed to an analogue macrocycle using the methods outlined in 
chapter 3, or a truncated simplified macrocycle in four steps. An alternative route to the C3-C8 
fragment (127) is also necessary, due to the scarce supply of the starting material acrolein (93).  
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6.1  Alternatives to the acrolein-dependent C3-C8 fragment 
 
An alternative method for the synthesis of C3-C8 fragment is required, because of the 
environmental and safety hazards that acrolein (93) possesses, and the fact that its supply is 
now expensive and unreliable. Synthesis of 93 from allyl alcohol (246) was briefly attempted 
(Scheme 6.1, equation 1). To minimise handling of the highly volatile and toxic 93, oxidation 
of allyl alcohol (246) with MnO2 in THF was performed in the hope that, after a simple 
filtration, the acrolein (93) solution in THF could be used directly for reaction. However, only 
a small amount of the allyl alcohol was converted to acrolein (93), and an attempt to purify 93 
by distillation did not provide satisfying separation from 246, while loss of product occurred 
even though the collection vessel was kept at 0 ºC.  
 
Scheme 6.1: Alternative synthesis of the C3-C8 fragment precursor 120. 
 
Acryloyl chloride (247) was then considered as a starting material, where the chloride can be 
substituted by a propargyl group. Upon reduction of the ketone and silyl protection, the 
precursor to C3-C8 fragment, 120, would be produced (Scheme 6.1, equation 2). One foreseen 
problem in this sequence is that the reaction of the acyl halide is prone to disubstitution, and 
reaction conditions to minimise the disubstitution can be hard to find. In addition, no 
commercial supply and little literature precedence was found on the production of the propargyl 
Grignard reagent, so it could be hard to obtain. Preparation of 120 from but-3-yn-1-ol (248) 
via a one-pot oxidation and vinyl addition reaction followed by silyl protection was also 
planned (equation 3). Possible oxidation methods include Swern and TEMPO/BAIB oxidation. 
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6.2  A new strategy involving a dithiane at C15 
 
Introduced in Chapter 1, dithiane has long been a well-established linchpin, that can be 
converted to a carbonyl group upon oxidative cleavage.  As a protecting group, dithiane allows 
umpolung-type reactions, where the electrophilic carbon of the carbonyl is converted into a 
nucleophile. As shown in Scheme 6.2, an approach using a dithiane for the C15 position, 
together with RCM and the Bestmann ylide linchpin, can lead retrosynthetically to fragments 
C3-C8 (127), C10-C14 (249) and C15-C20 (250). As discussed in section 3.1, a TBS or MOM-
protecting group would be used in fragment 249. The MOM-protected variant of 249 has been 
previously reported, and the TBS-protected variant can be prepared via a similar strategy.1 
 
Scheme 6.2: Proposed dithiane approach in retrosynthetic analysis. 
 
Interestingly, the above analysis revealed a symmetry in zampanolide macrocycle, where the 
C16-C20 fragment (250) is structurally similar to an alternative precursor of the C3-C8 
fragment, 251. Therefore, the two fragments 127 and 250 could be synthesized via the same 
route with late stage modification. This convergent synthesis would improve the efficiency of 
 177 
 
the synthesis greatly. This strategy cannot be applied using the current precursors to the 
tetrahydropyran fragments. With the hope this would also lead to an alternative route to 
fragment C3-C8 (127), literature research on the fragment synthesis of this new synthetic plan 
was carried out. 
 
A divergent synthesis of the C3-C8 and C16-C20 fragments from a common intermediate is 
theoretically possible. The synthesis can start with a cross-metathesis between the cheap and 
readily available 3-buten-2-one (252) and allyl alcohol (246) (Scheme 6.3). Grubbs’ second 
generation catalyst can be used for this reaction, because it was reported to promote E-selective 
 
Scheme 6.3: Divergent synthesis of fragments 127 and 250. 
cross-metathesis in the presence of unprotected allyl alcohols.2 An asymmetric O-Michael 
reaction, achieved by treatment with phenylboronic acid and hydrogen peroxide, can then be 
carried out to produce diol 253. This process is facilitated and directed by interaction of the 
boron reagent with the allylic hydroxyl and chiral amine base 254.3 After protecting the diol 
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253 as a PMP-acetal (255),4 E- and Z-selective olefination of the ketone 255 can be used to 
diverge the synthesis to intermediates 256 and 257. Olefination is a well-explored strategy with 
a lot of methods available, and can be stereoselective for Z- or E-alkenes.5 The Horner-
Wadsworth-Emmons (HWE) olefination is reliabe and employs readily available reagents. In 
general, this olefination favours the formation of E-alkenes, and the use of methylmagnesium 
bromide as the base was reported to improve the E-selectivity greatly.6 To achieve Z-selectivity, 
Still-Gennari’s modification of the HWE olefination using bis(2,2,2-trifluoroethyl) 
phosphonates can be used.7 Both HWE olefination and Still-Gennari’s method have been 
explored mostly on aldehyde substrates. In case that the ketone substrates in this study do not 
achieve the required stereoselectivity, chromatographic separation of the E- and Z-products 
would be employed. The E-isomer 256 would need to be reduced to an aldehyde before the 
dithiane protection to produce the required fragment 250. The Z-isomer 257 can lead to 
fragment C3-C8 by regioselective acetal ring-opening, oxidation and a Wittig reaction to 
establish the terminal alkene, followed by conversion of the ester to an aldehyde. Changing the 
PMB group to a TBS ether would deliver the current C3-C8 fragment 127, although retaining 
the PMB group in 258 would also be compatible with the end-game strategy.  
 
Following the procedure described, synthesis of both C3-C8 and C15-C20 fragments can be 
achieved from a common precursor. The nucleophilic substitution of the bromide 249 by a 
dithiane anion and the subsequent O-Michael addition leads to an alternative route to the pyran 
fragment. The Bestmann ylide linchpin reaction studied in this thesis and the well-established 
ring-closing metathesis provide an end-game strategy to complete the synthesis of the 
zampanolide macrocycle, which is compatible with both the current alkynylation and the 
proposed dithiane approaches. 
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Appendix: NMR spectra 
 
(Hex-1-en-5-yn-3-yloxy)tert-butyldimethylsilane (118) 
 
1H NMR (500 MHz, CDCl3) spectrum of 118 
 
13C NMR (125 MHz, CDCl3) spectrum of 118 
 181 
 
Methyl 5-tert-butyldimethylsilyloxy-6-hepten-2-ynoate (119) 
 
1H NMR (500 MHz, CDCl3) spectrum of 119 
 
13C NMR (125 MHz, CDCl3) spectrum of 119 
 182 
 
(2Z)-Methyl 5-(tert-butyldimethylsilyloxy)-3-methyl-2,6-heptadienoate (125) 
 
1H NMR (500 MHz, CDCl3) spectrum of 125 
 
13C NMR (125 MHz, CDCl3) spectrum of 125 
 183 
 
(2Z)-3-Methyl-5-(tert-butyldimethylsilyloxy)hepta-2,6-dien-1-ol (128)  
 
1H NMR (500 MHz, CDCl3) spectrum of 128 
 
13C NMR (125 MHz, CDCl3) spectrum of 128 
 184 
 
(2Z)-3-Methyl-5-(tert-butyldimethylsilyloxy)hepta-2,6-dienal (126) 
 
1H NMR (500 MHz, CDCl3) spectrum of 126 
 
13C NMR (125 MHz, CDCl3) spectrum of 126 
 185 
 
Mixture of (2Z)-methyl 5-(tert-butyldimethylsilyloxy)-2,6-heptadienoate (130) and (2Z)-
methyl 5-(tert-butyldimethylsilyloxy)-2-heptenoate (131) (3:2) 
 
1H NMR (500 MHz, CDCl3) spectrum of 130 and 131 
 
13C NMR (125 MHz, CDCl3) spectrum of 130 and 131 
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5-tert-Butyldimethylsilyloxy-6-hepten-2-yn-1-ol (132)  
 
1H NMR (500 MHz, CDCl3) spectrum of 132 
 
13C NMR (125 MHz, CDCl3) spectrum of 132 
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2E-5-(tert-Butyldimethylsilyloxy)hepta-2,6-dien-1-ol (133) 
 
1H NMR (500 MHz, CDCl3) spectrum of 133 
 
13C NMR (125 MHz, CDCl3) spectrum of 133 
 188 
 
Mixture of (2Z)-5-(tert-butyldimethylsilyloxy)hepta-2,6-dienal (135) and (2E) 5-(tert-
butyldimethylsilyloxy)hepta-2,6-dienal (136) (7:3) 
 
1H NMR (500 MHz, CDCl3) spectrum of 135 and 136 
 
13C NMR (125 MHz, CDCl3) spectrum of 135 and 136 
 189 
 
2-(tert-Butyldiphenylsilyloxy)methyloxirane (140) 
 
1H NMR (500 MHz, CDCl3) spectrum of 140 
 
13C NMR (125 MHz, CDCl3) spectrum of 140 
 190 
 
1-(tert-Butyldiphenylsilyloxy)-5-trimethylsilyl-4-pentyn-2-ol (141) 
 
1H NMR (500 MHz, CDCl3) spectrum of 141 
 
13C NMR (125 MHz, CDCl3) spectrum of 141 
 191 
 
(S)-2-(para-Methoxybenzyl)methyloxirane (150) 
 
1H NMR (500 MHz, CDCl3) spectrum of 150 
 
13C NMR (125 MHz, CDCl3) spectrum of 150 
 192 
 
(S)-1-(para-Methoxybenzyl)oxy-5-trimethylsilyl-4-pentyn-2-ol (146) 
 
1H NMR (500 MHz, CDCl3) spectrum of 146 
 
13C NMR (125 MHz, CDCl3) spectrum of 146 
 193 
 
(S)-1-(para-Methoxybenzyl)oxy-4-pentyn-2-ol (152) 
 
1H NMR (500 MHz, CDCl3) spectrum of 152 
 
13C NMR (125 MHz, CDCl3) spectrum of 152 
 194 
 
(S)-Bromosuccinic acid (157) 
 
1H NMR (500 MHz, D2O) spectrum of 157 
 
13C NMR (125 MHz, D2O) spectrum of 157 
 195 
 
(S)-2-Bromobutane-1,4-diol (160) 
 
1H NMR (500 MHz, CDCl3) spectrum of 160 
 
13C NMR (125 MHz, CDCl3) spectrum of 160 
 196 
 
(R)-Triethyl-(2-oxiran-2-yl)ethoxysilane (155) 
 
1H NMR (500 MHz, CDCl3) spectrum of 155 
 
13C NMR (125 MHz, CDCl3) spectrum of 155 
 197 
 
(S)-Triethyl-(3-hydroxy)hex-5-enoxysilane (156) 
 
1H NMR (500 MHz, CDCl3) spectrum of 156 
 
13C NMR (125 MHz, CDCl3) spectrum of 156 
 198 
 
(S)-1-Triethylsilyloxy-(3-t-butyldimethylsilyloxy)hex-5-ene (161) 
 
1H NMR (500 MHz, CDCl3) spectrum of 161 
 
13C NMR (125 MHz, CDCl3) spectrum of 161 
 199 
 
2-(But-3′-enyl)-3-hydroxyoct-7-enal (170, in a a mixture) 
 
1H NMR (500 MHz, CDCl3) spectrum of 170 mixture 
 
13C NMR (125 MHz, CDCl3) spectrum of 170 mixture 
 200 
 
5-(t-Butyldimethylsilyloxy)pentanal (177) 
 
1H NMR (500 MHz, CDCl3) spectrum of 177 
 
13C NMR (125 MHz, CDCl3) spectrum of 177 
 201 
 
(Triphenylphosphoranylidene)acetate (179) 
 
1H NMR (500 MHz, CDCl3) spectrum of 179 
 
13C NMR (125 MHz, CDCl3) spectrum of 179 
 202 
 
 
 
31P NMR (120 MHz, CDCl3) spectrum of 179 
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(Triphenylphosphoranylidene)ketene (178) 
 
13C NMR (125 MHz, CDCl3) spectrum of 178 
 
31P NMR (120 MHz, CDCl3) spectrum of 178 
 204 
 
 
IR (neat) spectrum of 178 
 
  
 205 
 
(2′E,2E,4E)-Hex-2′-enyl 5-phenylpenta-2,4-dienoate (184) 
 
1H NMR (500 MHz, CDCl3) spectrum of 184 
 
13C NMR (125 MHz, CDCl3) spectrum of 184 
 206 
 
(2′E,2E,4E)-Oct-2′-enyl 5-phenylpenta-2,4-dienoate (186)  
 
1H NMR (500 MHz, CDCl3) spectrum of 186 
 
13C NMR (125 MHz, CDCl3) spectrum of 186 
 207 
 
(2′Z,2E,4E)-Hex-2′-enyl 5-phenylpenta-2,4-dienoate (188) 
 
1H NMR (500 MHz, CDCl3) spectrum of 188 
 
13C NMR (125 MHz, CDCl3) spectrum of 188 
 208 
 
(2E,4E)-Oct-1′-en-3′-yl 5-phenylpenta-2,4-dienoate (190) 
 
1H NMR (500 MHz, CDCl3) spectrum of 190
 
13C NMR (125 MHz, CDCl3) spectrum of 190 
 209 
 
(1′R,2′S,5′R,2E,4E)-2′-iso-Propyl-5′-methylcyclohex-1′-yl 5-phenylpenta-2,4-dienoate 
(192) 
 
1H NMR (500 MHz, CDCl3) spectrum of 192 
 
13C NMR (125 MHz, CDCl3) spectrum of 192 
 210 
 
(1′R,2′S,5′R,2E,4E,6E)- 2′-iso-Propyl-5′-methylcyclohex-1′-yl deca-2,4,6-trienoate (194)  
 
1H NMR (500 MHz, CDCl3) spectrum of 194 
 
13C NMR (125 MHz, CDCl3) spectrum of 194 
 211 
 
Mixture of (2E,4E)-[1′-(tert-butyldiphenylsilyloxy)-5′-trimethylsilyl]pent-4′-yn-2′-yl 5-
phenylpenta-2,4-dienoate (196) and the silyl migrated product (2E,4E)-[2′-(tert-
butyldiphenylsilyloxy)-5′-trimethylsilyl]pent-4′-yn-1′-yl 5-phenylpenta-2,4-dienoate (199) 
 
1H NMR (500 MHz, CDCl3) spectrum of 196 and 199 
 
13C NMR (125 MHz, CDCl3) spectrum of 196 and 199 
 212 
 
 
CIGAR-HMBC spectrum of 196 and 199 
  
 213 
 
Mixture of (2E,4E)-[1′-(tert-butyldiphenylsilyloxy)-5′-trimethylsilyl]pent-4′-yn-2′-yl 
nona-2,4-dienoate (198) and the silyl migrated product, (2E,4E)-[2′-(tert-
butyldiphenylsilyloxy)-5′-trimethylsilyl]pent-4′-yn-1′-yl nona-2,4-dienoate  
 
1H NMR (500 MHz, CDCl3) spectrum of 198 and silyl migrated product 
 
13C NMR (125 MHz, CDCl3) spectrum of 198 and silyl migrated product 
 214 
 
Mixture of (2E,4Z)-1′-(tert-butyldiphenylsilyloxy)-5′-(trimethylsilyl)pent-4′-yn-2′-yl 7-
(tert-butyldimethylsilyloxy)-5-methylnona-2,4,8-trienoate (204) and the silyl migrated 
product, (2E,4Z)-2′-(tert-butyldiphenylsilyloxy)-5′-(trimethylsilyl)pent-4′-yn-1′-yl 7-(tert-
butyldimethylsilyloxy)-5-methylnona-2,4,8-trienoate (205) 
 
1H NMR (500 MHz, CDCl3) spectrum of 204 and 205 
13C NMR (125 MHz, CDCl3) spectrum of 204 and 205 
 215 
 
 
CIGAR-HMBC spectrum of 204 and 205 
 
 216 
 
(2E,4E)-[1′-(para-Methoxybenzyloxy)-5′-trimethylsilyl]pent-4′-yn-2′-yl 5-phenylpenta-
2,4-dienoate (206) 
 
1H NMR (500 MHz, CDCl3) spectrum of 206 
 
13C NMR (125 MHz, CDCl3) spectrum of 206 
 217 
 
(2E,4Z)-1′-(para-Methoxybenzyloxy)-5′-(trimethylsilyloxy)pent-4′-yn-2′-yl 7-(tert-
butyldimethylsilyloxy)-5-methylnona-2,4,8-trienoate (207) 
 
1H NMR (500 MHz, CDCl3) spectrum of 207 
 
13C NMR (125 MHz, CDCl3) spectrum of 207 
 218 
 
(2E,4Z)-1′-(para-Methoxybenzyloxy)pent-4′-yn-2′-yl 7-(tert-butyldimethylsilyloxy)-5-
methylnona-2,4,8-trienoate (208) 
 
1H NMR (500 MHz, CDCl3) spectrum of 208 
 
13C NMR (125 MHz, CDCl3) spectrum of 208 
 219 
 
Methyl 2-hydroxy-3-phenylpropanoate (220)  
 
1H NMR (500 MHz, CDCl3) spectrum of 220 
 
13C NMR (125 MHz, CDCl3) spectrum of 220 
 220 
 
2-(t-Butylcarbonate)-3-phenylpropanal (223) 
 
1H NMR (500 MHz, CDCl3) spectrum of 223 
 
  
 221 
 
Methyl 2-(t-butylcarbonate)-3-phenylpropanoate (224) 
 
1H NMR (500 MHz, CDCl3) spectrum of 224 
 
13C NMR (125 MHz, CDCl3) spectrum of 224 
 222 
 
(5′-Trimethylsilyl)pent-4′-yn-2′-yl 5-phenylpenta-2,4-dienoate (227) 
 
1H NMR (500 MHz, CDCl3) spectrum of 227 
 
13C NMR (125 MHz, CDCl3) spectrum of 227 
 223 
 
1′-(para-Methoxybenzyloxy)pent-4′-yn-2′-yl 3-phenylprop-2-enoate (234) 
 
1H NMR (500 MHz, CDCl3) spectrum of 234 
 
13C NMR (125 MHz, CDCl3) spectrum of 234 
 224 
 
(1R,2R)-3-(t-Butyldimethylsilyloxy)-2-N,N-dimethylamino-1-(4ʹ-nitrophenyl)propane-1-
ol (232) 
 
1H NMR (500 MHz, CDCl3) spectrum of 232 
 
13C NMR (125 MHz, CDCl3) spectrum of 232 
 225 
 
1-Phenyloct-1-yn-3-ol (237) 
 
1H NMR (500 MHz, CDCl3) spectrum of 237 
 
13C NMR (125 MHz, CDCl3) spectrum of 237 
 226 
 
(1R,2R)-2-N,N-Dimethylamino-1-(4ʹ-nitrophenyl)propane-1,3-diol (238) 
 
1H NMR (500 MHz, CDCl3) spectrum of 238 
 
 
13C NMR (125 MHz, CDCl3) spectrum of 238 
 227 
 
(1R,2R)-1,3-Bis-(t-butyldimethylsilyloxy)-2-N,N-dimethylamino-1-(4ʹ-nitrophenyl) 
propane (239) 
 
1H NMR (500 MHz, CDCl3) spectrum of 239 
 
13C NMR (125 MHz, CDCl3) spectrum of 239 
 228 
 
1′-(para-Methoxybenzyloxy)-6ʹ-hydroxy-10ʹ-(t-butyldimethylsilyloxy)dec-4′-yn-2′-yl 3-
phenylprop-2-enoate (240)  
 
1H NMR (500 MHz, CDCl3) spectrum of 240 
 
13C NMR (125 MHz, CDCl3) spectrum of 240 
 229 
 
Mosher’s ester of alcohol 240 (241) 
 
1H NMR (600 MHz, CDCl3) spectrum of 241 and 242 
 
13C NMR (150 MHz, CDCl3) spectrum of 241 and 242 
 230 
 
1′-(para-Methoxybenzyloxy)-6ʹ-hydroxy-10ʹ-(t-butyldimethylsilyloxy)dec-4′-yn-2′-yl 5-
methyl-7-( t-butyldimethylsilyloxy)non-2,4,8-trienoate (244)  
 
1H NMR (600 MHz, CDCl3) spectrum of 244 
 
13C NMR (150 MHz, CDCl3) spectrum of 244 
